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SUMMARY
Hypertension is a major public health problem affecting approximately 
15-20% of adult western populations, and is a leading cause of cardio­
vascular disease and death due to cerebral haemorrage, cardiac failure 
and kidney disease. Evidence from twin studies, population-based 
epidemiological studies and adoption studies, demonstrate hypertension 
is inherited as a multifactorial polygenic trait, where several dif­
ferent genes may be involved in the regulation of blood pressure and 
the development of high blood pressure. The specific genes involved 
however are not known, and several potential candidate genes have been 
identified based on animal and human studies.
In the present study the candidate gene approach was employed to 
identify genetic determinants of high blood pressure in four groups of 
offspring with contrasting predispositions to high blood pressure; 
Group A (high offspring blood pressure, low parental blood pressure), 
Group B (high offspring blood pressure and high parental blood pres­
sure), Group C (low offspring blood pressure and low parental blood 
pressure) and Group D (low offspring blood pressure high parental 
blood pressure), in parents with high and low blood pressures and in 
affected and unaffected sibling pairs.
Hie Hindlll RFLP of the renin gene was examined in 192 offspring., 
including 45 high/high and 48 low/low offspring. The allele frequen­
cies determined in the high/high and low/low offspring were 0.65 for 
the 9.0kb allele ai*i 0.35 for the 6.2kb allele, in close agreement 
with the allele frequencies of 0.67 and 0.33 respectively, in all 
offspring examined. Chi-square analysis showed no statistically sig­
nificant difference in the genotype distribution between the high/high
1
and low/low offspring (X^S.77 p=0.01-0.05). Analysis of this RFLP in 
44 parents with high blood pressure and 47 with low blood pressure 
showed no statistically significant difference in the genotype distri­
bution between the two groups (X^=0.53 p=0.50-0.80).
The BbltiI RFLP of the beta-2—adrenergic receptor gene was analysed in 
182 offspring* including 43 high/high and 47 low/low offspring. The 
allele frequencies in the high/high offspring were 0.27 for the 3.7kb 
allele and 0.73 for the 3.4kb allele, and in the low/low offspring 
were 0.16 for the 3.7kb allele and 0.84 for the 3.4kb allele, similar 
to the frequencies of 0.25 and 0.75 respectively in all offspring 
studied. Chi-square analysis showed no statistically significant 
difference in the genotype distribution between the high/high and 
low/low offspring (X^=4.43 p=0.10-0.20). Analysis of this RFLP in 49 
parents with high blood pressure and 48 with low blood pressure showed 
no statistically significant difference in the genotype distribution 
between the two groups of parents (X^=2.88 p=0.20-0.50).
The Bgl RFLP of the beta-1-adrenergic receptor gene was examined in 
173 offspring* including 42 high/high and 45 low/low offspring. The 
allele frequencies in low/low offspring were 0.78 for the 6.2kb allele 
and 0.22 for the 4.7kb allele, and in the high/high offspring 0.75 for 
the 6.2kb allele and 0.25 for the 4.7kb allele, in close agreement 
with the frequencies of 0.78 and 0.22 respectively, in all offspring 
examined. Chi-square analysis showed no statistically significant 
difference in the genotype distribution between the high/high and 
low/low offspring (X^=0.215 p=0.80-0.90). Analysis of this RFLP in 44 
parents with high blood pressure and 47 with low blood pressure showed 
no statistically significant difference in the genotype distribution
2
between the two groups (X^  =0.46 p=0.50-0.80).
The Dral RFLP of the alpha—2—adrenergic receptor gene was examined in 
151 offspring including 39 high/high and 40 low/low offspring* The 
allele frequencies of the high/high offspring were 0.90 for the 6.7kb 
allele and 0.10 for the 6.3kb allele, and for the low/low offspring 
0.80 for the 6.7kb allele and 0.20 for the 6.3kb allele, in close 
agreement to the frequencies of 0.86 and 0.14 respectively, in all 
offspring examined. Chi-square analysis showed no statistically sig­
nificant difference in the genotype distribution between the high/high 
and low/low offspring (X2=4.36 p=0.10-0.20). Analysis of this RFLP in 
45 parents with high blood pressure and 45 with low blood pressure 
showed no statistically significant difference in the genotype distri­
bution between the two groups (X^  =0.216 p=0.90).
The SelcI RFLP of the insulin gene was examined in 174 offspring in­
cluding 35 high/high aixi 50 low/low offspring. The allele frequencies 
in the high/high offspring were 0.41 for the 7.5kb allele and 0.59 for 
the 6.0kb allele and in the low/low offspring were 0.25 for the 7.5kb 
allele and 0.75 for the 6.0kb allele, similar to the frequencies of 
0.37 and 0.63 respectively in all offspring examined. Chi-square 
analysis showed no statistically significant difference in the geno­
type distribution between the high/high and low/low offspring (X^=1.76 
p=0.20-0.50). Analysis of this RFLP in 28 parents with high blood 
pressure and 26 with low blood pressure showed no statistically sig­
nificant difference in the genotype distribution between the two 
groups (X^=2.94 p=0.20-0.50).
The Tthlll RFLP of the glucocorticoid receptor gene was examined in 
117 offspring including 30 high/high and 25 low/low offspring* The
3 \
overall allele frequencies were 0.21 for the 3.8kb allele and 0.79 for 
the 3.4kb allele. The allele frequencies in the high/high offspring 
were 0.18 for the 3.8kb allele and 0.82 for the 3.4kb allele and in 
the low/low offspring were 0.32 for the 3.8kb allele and 0.68 for the 
3.4kb allele, similar to the frequencies of 0.21 and 0.79 respective­
ly, in all offspring studied. Chi-square analysis showed no statisti­
cally significant difference in the genotype distribution between the 
two groups (X^=2.18 p=0.20-0.50). Analysis of this RFLP in 27 parents 
with high blood pressure and 28 with low blood pressure showed no 
statistically significant difference in the genotype distribution 
between the two groups (X^  =0.58 p=0.99).
42 parents with high blood pressure and 34 with low blood pressure 
were genotyped for the Bell RFLP of the glucocorticoid receptor gene, 
and no statistically significant difference in the genotype distribu­
tion between the two groups was demonstrated (X=0.56 p=0.50-0.80). 
Similarly, 40 parents with high blood pressure and 33 with low blood 
pressure were genotyped for the Bell RFLP of the beta-fibrinogen gene, 
and again no significant difference in the genotype distribution 
between the two groups was demonstrated (X^  =2.61 p=0.20-0.50). 
Haplotype analysis of 119 offspring for the two RFLPs of the gluco­
corticoid receptor gene the Tthlll and the Bell polymorphisms, showed 
no statistically significant difference between the observed and the 
expected distribution (X^  =2.04 p=0.10-0.20). Linkage equilibria was 
demonstrated between the two restriction sites; the Tthlll and the 
Bell sites of the glucocorticoid receptor gene, with an estimated 
linkage disequilibrium parameter (D) of 0.012.
Sib-pair analysis in 19 affected sib-pairs and 14 unaffected sib-pairs
4
showed a statistically significant lack of allele sharing in affected 
sib-pairs for the alleles of a Hindlll/renin BFLP (X^=9.48 p<0.01). 
Similarly analysis of 16 affected sib pairs and 14 unaffected sib- 
pairs showed a statistically significant lack of allele sharing in 
affected sib-pairs for the alleles of a Bell RFLP of the beta- 
fibrinogen gene (X^=6.46 p<0.05).
Sib-pair analysis also identified increased allele sharing in 18 
affected sib-pairs for the alleles of the BanI RFLP of the beta-2- 
adrenergic receptor gene (X^=4.65 p=0.1-0.05), in 10 affected sibs- 
pairs for the alleles of the Bgll RFLP of the beta-1-adrenergic recep­
tor (X^=5.79 p=0.1-0.05) and in 16 affected sib-pairs for the alleles 
of the Bell RFLP of the glucocorticoid receptor gene (X^=3.21 p=0.20). 
However, these differences were not statistically significant. 
Mutational analysis of the angiotensinogen gene, by hydrolink gel 
electrophoresis in twelve offspring with polarised predispositions to 
high blood pressure identified two molecular variants in exon II of 
the gene. Analysis of these variants in 35 high/high and 40 low/low 
offspring showed an higher frequency in the low/low offspring* however 
this was not statistically significant (X^=0.68 p=0.20-0.50). No molec­
ular variants were identified in the remainder of the gene. Analysis 
of a T174M molecular variant of the angiotensinogen gene in 37 
high/high offspring and 38 low/low offspring* showed no association 
with a predisposition to high blood pressure (X^  =1.39 p=0.20-0.50).
Similarly, analysis of a M235T molecular variant in 38 high/high and 
36 low/low offspring showed no association (X^  =1.33 p=0.20-0.50). 
Mutational analysis of the glucocorticoid receptor cDNA identified a 
molecular variant with an equal frequency in the high/high and
5
low/low offspring.
Therefore from the present study, sib-pair analysis and direct muta­
tional analysis of candidate genes, seems the most promising way 
forward in the identification of genetic factors of etiological sig­
nificance in hypertension.
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CHAPTER 1: INTRODUCTION
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Chapter 1 INTRODUCTION
1.1 Definition and prevalance
Hypertension is a sustained elevation of arterial blood pressure. 
Blood pressure is a quantitative trait that shows a normal distribu­
tion in the general population (Gaomussi 1988), and the upper limit 
of normal in adults is usually taken as a diastolic pressure of 90mmHg 
and a systolic pressure of 160mmHg (Soubrier et al., 1988). The conse­
quence of a blood pressure level in a given individual depends not 
only on the actual level, but also on other risk factors.
Hypertension is thought to represent the top 15-20% of the age/sex 
blood pressure distribution in industrialised countries (Rapp 1983). 
In the majority of hypertensive patients (95%) no detectable abnormal­
ity is present on clinical examination and this is defined as essen­
tial or primary hypertension (Sleigh 1978). Occasionally a definite 
cause, for example kidney disease can be found to explain the hyper­
tension. Such cases are referred to as secondary hypertension (Sleigh 
1978).
1.2 Evidence for a genetic contribution to high blood pressure
Evidence for a genetic contribution in the aetiology of human hyper­
tension steins from several types of studies; animal models of hyper­
tension, correlation of blood pressures in related and unrelated 
individuals, blood pressure tracking studies and studies of offspring 
with differing family histories of high blood pressure.
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1.2.1 Animal studies
A variety of genetically hypertensive rodent strains have been de­
veloped where the level of blood pressure is inherited in a predict­
able manner (Table 1). The Spontaneously Hypertensive Rat (SHR) and 
its close relative, the Stroke Prone Spontaneously Hypertensive Rat 
(SHRSP), have been used extensively as animal models of human essen­
tial hypertension, and the Wistar-Kyoto (WKY) rats as the nonnoten- 
sive control strain.
Parental SHR and WKY strains represent genetically uniform popula­
tions, therefore blood pressure differences are due to environmental 
factors. Cross breeding hypertensive and normotensive strains, re­
sults in SHR-WKY FI genetically uniform hybrids since they are homozy­
gous at every locus at which parents are identical, and heterozygous 
at every locus that parents are different. The variance of blood 
pressure due to environmental factors can then be estimated, since all 
populations are genetically uniform. However, blood pressure variation 
in the SHR-WKY F2 progeny, as a result of FI X FI mating, is a result 
of the segregation of those loci at which FI animals are heterozygous. 
This allows an estimation of the genetic contribution in the aetiolo­
gy of hypertension (Harrap 1986). These forms of analyses have provid­
ed important clues to the genes involved in hypertension in animal 
models, as well as identifying a genetic basis for the disease.
The SHR strain has been developed from the normal Wistar-Kyoto (WKY) 
stock by selective inbreeding for higher blood pressure. A rapid 
response to selection has been demonstrated, with almost 100% hyper­
tension by generation three, indicating that only a few loci are 
involved (Okomato & Aoki 1963). Studies of crosses of rodent strains
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selectively bred for hypertension and normotensive strains and subse­
quent backcrosses further support the idea that few loci appear to be 
involved in the development of SHR hypertension.
Studies between SHR and normo tensive rats have shown the genetics of 
transmission of high blood pressure to follow an additive mode of 
inheritance with a single major gene effect (Tanese et al., 1970). 
Other studies have however, demonstrated dominance effects of alleles 
CHarrap 1986). Louis et al., (1969) were the first to conclude that 
spontaneous hypertension had polygenic control. Tanese et al., (1970) 
then demonstrated the involvement of 2-3 genes in SHR hypertension and 
suggested the possibility of a major gene effect. More recently, 
cross-breeding experiments in the SHR suggested that about 4 inde­
pendent loci are involved and that 64.5% of the variance of blood 
pressure within a segregating population is genetically determined 
(Harrap 1986). Pravnec et al., (1989) developed a set of recombinant 
inbred (RI) strains produced by brother-sister inbreeding between 
members of F2 generation from crosses of normotensive and hypertensive 
(SHR) strains, for the evaluation of markers of spontaneous hyperten­
sion. Statistical analysis demonstrated the involvement of multiple 
genetic loci estimated to number more than seven, with the effect of 
three major genes and multiple minor genes.
In general the genetic contribution to high blood pressure in the SHR 
has been reported to be between 46-96% and the number of loci involved 
between one and six (Rapp 1983). Such studies provide evidence for 
the involvement of genetic factors in animal models of hypertension.
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Table 1: Examples of rodent strains selectively bred for hypertension
Strain Lines* Year 1st report
New Zealand (Dunedin) 
Genetically hypertensive 
rats (GH)
H, C Shirk 1958
USA (Brookhaven)
Salt sensitive (S) and 
Salt resistant (R)
H L Dahl 1962
Japan (Kyoto)
Spontaneously hypertensive 
rats
H Okomata 1963
Israel (Jerusalem)
DOCA salt sensitive (SHB) 
and salt resistant (SNB)
H L Ben-Ishay 1972
France (Lyon) 
Hypertensive (LH) and 
normotensive (NL) and 
Low blood pressure (LL)
H,C,L Dupont 1973
Italy (Milan) 
Hypertensive strain (MHS) 
normotensive (MNS)
H,C Bianchi 1976
* the types of lines developed in each model were: 
H=lines selected for high blood pressure 
L=Lines selected for high blood pressure 
OConto 1 line, unselected, random bred
After Rapp JP. Genetics of experimental Human Hypertension.
In Hypertension Pathophysiology and treatment. Edited by Genest 
Kucknel, Harlet and Larkin. 1983 2nd Eds.
McGraw Hill book company
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1.2.2 Family studies
Blood pressure as a normal physiological trait correlates well in 
families (Brandao et al., 1992). Correlation coefficients observed 
between parent-off spring and sibling relationships are greater than 
between spouse pairs and adopted offspring and parents (Johnson et 
al., 1965, Hayes et al., 1965, Biron et al.,1976, Feinlab et al., 
1977, Feinlab et al., 1979). Table 2 shows blood pressure correla­
tions in different family members. Ihe greater correlation observed 
between related individuals can be explained by gene sharing and 
provides evidence for the involvement of genetic determinants in blood 
pressure variability. However, for correlations to be entirely due to 
genetic factors then the expected correlations between unrelated 
family members should be zero. As can been seen from Table 2 such 
individuals show some degree of correlation, suggesting that shared 
environmental factors complement genetic factors in determining famil­
ial aggregation of blood pressure.
Monozygotic twins (MZ) represent the only model where genetically 
identical individuals can be studied. A comparison with dizygotic 
twins (DZ) where 50% of the genes are in common allows an estimation 
of the genetic variance. Blood pressure correlations are higher in 
monozygotic twins compared to dizygotic twins consistent with a 
significant genetic effect (Table 2). The Medical College of Virginia 
TWin Study, analysed 251 eleven year old twins and demonstrated higher 
blood pressure correlations in monozygotic twins compared to dizygotic 
twins, and the authors provided heritability estimates of approximate­
ly 66% for both SBP and DBP (Schieken et al., 1989).
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Analysis of data from adoption studies (Annest et al., 1979, Mongeau 
et al., 1986) have repeatedly demonstrated stronger correlations
between biological parent-off spring than non-biolpgical parents and 
their adopted children. This again provides strong evidence of a 
genetic role in blood pressure aggregation. Similarly, correlations 
between natural siblings are greater than between adopted children. 
The Montreal Adoption Study (Mongeau et al., 1986) analysed blood 
pressure in 756 adopted, 445 natural offspring and 1176 parents. 
Correlation coefficients reported are summarised in Table 3. The 
estimated genetic contribution for systolic blood pressure correla­
tions between parent-off spring and sib-sib relationships were 61X, 
and the shared environmental effect, 39%. For diastolic blood pressure 
correlations between parent-offspripg, the heritability estimate was 
58% and the environmental contribution 42X.
Regardless of the different heritability estimates in different 
family members, data from the majority of population based studies 
provides evidence for a genetic basis for interindividual variability 
of blood pressure and the contribution from genes is proposed to be 
approximately 25—50%, and 50-75% is influenced by environmental fac­
tors (Corvol et al., 1989).
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Table 2: Familial blood pressure correlations
Relationship Correlation
SBP IBP
Spouse pairs 0.08 0.06
Adoptee-parent 0.03 0.09
Offspripg-parent 0.18 0.18
Sib pairs 0.18 0.14
Dizygotic twins 0.25 0.27
Monozygotic twins 0.55 0.50
Data taken from Williams et al.* (1990)
Table 3: Blood pressure correlations in adopted/natural 
offspring end their parents
Relationship Correlation
SBP IBP
Natural child/mother 0.27 0.26
Natural child/father 0.24 0.21
Adopted child/mother 0.08 0.10
Adopted child/father 0.09 0.13
Natural child/natural child 0.38 0.53
Natural child/adopted child 0.19 0.27
Adopted child/adopted child 0.16 0.29
Data taken from the Montreal Adoption study 
(Mongeau et al.,1986)
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1.2.3 Blood Pressure Tracking Studies.
Childhood blood pressure levels are a strong predictor of future blood 
pressure levels (Lauer et al., 1991). Evidence for this comes from 
longitudual epidemiological studies demonstrating blood pressure
ranking or tracking in several different populations in cohorts of
children, adolescents and adults (Lauer et al., 1986, Shear et al.,
1987). Tracking refers to the maintenance in persons of specific 
levels of blood pressure distribution relative to their peer group 
with age, such that individuals that occupy the upper part of their 
age/sex blood pressure distribution maintain their position or rank 
into adult life (Szklo 1979). Correlation coefficients or tracking
coefficients from such studies are in the range of 0.01-0.07 for SBP 
and 0.02-0.06 for DBP from early to late childhood (Szklo 1979). In 
adult populations this correlation is increased to 0.5-0.6 (Hames et 
al., 1971, Perrera et al., 1972, Hennekens et al., 1979, Zinner et
al., 1979).
Some authors have reported a "horse racing effect" ie. the higher the 
initial blood pressure level the faster the blood pressure rises (Wu 
et al., 1980). In adults, initial blood pressure levels are the most 
powerful predictors of future blood pressure levels (Higgins et al., 
1980, Szklo 1986), and blood pressure tracking coefficients in adults 
are stronger than in children. Similarly correlations in older chil­
dren are stronger than in younger children (Szklo 1979).
This tracking phenomena suggests a universal environmental influence 
is acting on blood pressure levels causing them to rise, however the 
blood pressure distribution at birth may be genetically determined.
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Therefore it seems likely that predictors of blood pressure levels 
operate from an early age (Anonymous 1981). A recent study by De Swiet 
et al., (1992) examined blood pressure tracking in a group of children 
in the South East of England from birth to the age of ten. Correlation 
coefficients gradually became stronger with age; up to the age of one* 
a weak correlation was demonstrated (<0.2), after the age of one* 
correlations gained strength such that the tracking coefficient from 
the age of nine to ten was 0.58. This suggested that at the age of ten 
blood pressure tracking accounts for 35X of the observed blood pres­
sure variability. The Shimane Heart Study (Nishio et al.* 1989) also 
demonstrated the tracking phenomena during childhood and adolescence 
in Japanese children* and its increase with age. Tracking coefficients 
in girls from the age of 6-9 years for SBP were 0.27 and this in­
creased to 0.36 from the age of 9-12 years.
The factors controlling childhood blood pressures are still unclear* 
however familial factors have repeatedly been demonstrated with sig­
nificant correlations between parent and offspring blood pressure 
levels.
1.2.4 Blood pressures in offspring with differing family histories 
of high blood pressure
Blood pressure levels of offspring with a positive family history of 
hypertension generally have higher blood pressure levels than 
offspring with a negative family history (Lauer et al., 1989). Hofman 
et al., (1983) demonstrated a difference of 3mmHg in SBP levels in
newborn infants of parents with high blood pressure compared to new­
borns of parents with low blood pressure. A difference of 7mmHg for 
both SBP and IBP in 20 year-old offspring has also been reported (Van
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Hooft et al., 1988), suggesting the magnitude of familial aggregation 
increases during adolescence and childhood probably reflecting envi­
ronmental factors. The Minneapolis Blood Pressure study (Hunger et 
al., 1988) also examined blood pressure levels of offspring with and 
without a family history of high blood pressure over a period of 
eight years. Offspring with a positive family history consistently 
showed a higher mean systolic blood pressure than offspring with a 
negative family history.
The Ladywel 1 Blood Pressure Study is a large scale study based on a 
population initially recruited for the MRC Mild Qypertension Trial 
(Watt 1986). The present study is based within this project aimed at 
identifying genetic factors in offspring with contrasting predisposi­
tions to high blood pressure, and has demonstrated elevated blood 
pressure levels in offspring of parents with high blood pressure 
compared to offspring of parents with low blood pressure (Watt et al., 
1992). The method employed for the selection of offspring for the 
Ladywel 1 Study is based on the four corner approach (Watt 1986). The 
four corner approach, for the selection of offspring with negative and 
positive family histories of high blood pressure was first demonstrat­
ed in the mid-sixties by Deutscher et al., (1966), where blood pres­
sure data from a large community of almost 9000 subjects was analysed. 
The data shows that the proportion of offspring in the upper 20% of 
their age/sex blood pressure distribution, is greatest when both 
parents lie in the upper 20% of their age/sex blood pressure distribu­
tion. Similarly, the proportion of offspring in the lower 20% is 
greatest when both parents lie in the lower 20% of their age/sex blood 
pressure distribution. A follow up study indicates this relationship
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is maintained over time (Higgins et al., 1980).
Usirjg this approach, four groups of offspripg can be identified;
1) offspring with high personal and high parental blood pressure
2) offspring with low personal and low parental blood pressure
3) offspring with high personal and low parental blood pressure
4) offspring with low personal and high parental blood pressure.
Analysis of the blood presure data by Watt et al., (1992), has shown, 
that offspring whose parental blood pressure was high, generally had 
higher blood pressure levels compared to offspring whose parental 
blood pressure was low, with an average blood pressure difference of 
approximately 23mnHg for SBP and 19nxnHg for IBP.
Thus it is evident that blood pressure tracking starts at an early age 
and is maintained into adult life. The observed familial aggregation 
of blood pressure levels, and the fact that offspring with a family 
history of high blood pressure generally have higher blood pressure 
levels compared to offspring with no family history, all provide 
evidence for a genetic contribution in the aetiology of hypertension. 
These observations have led to the hypothesis that a high-normal blood 
pressure level in childhood may be the antecedent of adult hyperten­
sion (Schieken et al., 1989).
1.3 The mode of inheritance
The number of genetic loci involved in the regulation of blood pres­
sure is not yet fully understood (Corvol et al., 1989). At present 
the concept of the genetic control of high blood pressure is, that 
hypertension is likely a multifactorial disease that shows polygenic
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inheritance and the interaction of several genetic loci (perhaps 4-6 
loci) (Rapp 1983) with multiple environmental factors determine an 
individuals blood pressure level. However, it is not impossible that 
there are some genes with larger effects on the blood pressure distri­
bution, thus the hypertensive population consists of a heterogeneous 
mixture of people with different genetic and environmental contribu­
tions (Williams et al., 1988, Williams et al., 1989). This hypothesis 
of a limited number of genes involved in the aetiology of hypertension 
lies mid-way between the two extremes of the oligogenic and polygenic 
models (Corvol et al., 1989).
1.4 Clues to the nature of the genetic contribution in the
development of hypertension 
Clues to the genes that might contribute to the determination of blood 
pressure levels have been deduced from analysis of biochemical pheno­
types or, increasingly from molecular studies of candidate genes in 
animal models of hypertension, human pedigree studies or cross-sec­
tional comparisons of hypertensives and normotensive controls.
1.4.1 Animal studies
Animal inbreeding results in homozygosity or fixation of previously 
heterozygous loci as a result of selection. Different animal strains 
will therefore fix contrasting alleles, such that genetic polymor­
phisms between strains of hypertensive and normotensive rats will 
exist. These strain specific genetic differences can be demonstrated 
to be responsible for the observed blood pressure differences between 
strains if they remain associated with blood pressure differences in 
segregatipg populations from crosses of hypertensive and normotensives
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animal strains (Rapp et al., 1989). A series of criteria have been 
proposed by Rapp et al., (1989) to identify biochemical/physiological 
traits as primary genetic causes:
1) A blood pressure difference between the two parental strains must 
exist
2) The trait must follow Mendelian inheritance
3) Blood pressure in F2 hybrids must correlate with the trait
If cosegregation of phenotype and blood pressure is observed, then 
this establishes the expression of the gene in the aetiology of hyper­
tension.
Several RFLP (Restiction Fragment Length Polymorphism) studies pre­
formed in animal models of hypertension suggest that RFLPs may be 
useful markers for certain forms of hypertension. Genetic studies of 
hypertension have shown that the renin gene is associated with the 
development of hypertension in Dahl rats. Rapp et al., (1989) demon­
strated that an RFLP in the first intron of the renin gene between 
Dahl salt sensitive (DS) and the Dahl salt resistant (DR) animal 
models cosegregates with a blood pressure increment, providing strong 
evidence that the renin gene or a gene closely linked to the renin 
gene is involved in blood pressure regulation.
Some evidence exists to suggest sex linked loci may be involved in the 
genetics of blood pressure. A study by Ely et al., (1990), compared 
blood pressure levels of FI male and females from crosses of WKY 
mothers and SHR fathers compared to FI progeny from WKY fathers and 
SHR mothers. Blood pressure levels FI males from the first cross were 
significantly higher than blood pressure levels from the reciprocal 
cross. These results suggest a Y linked locus is involved in determin-
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ipg blood pressure levels in the SHR. A study by Hilbert et al., 
(1991) localised a gene on chromosome X, denoted BP/SP 2 that contrib­
uted significantly to blood pressure variation in the F2 population 
(SHRSP X WKY), providing evidence of the involvement of the X chromo­
some in the gender linkage of elevated blood pressure.
A number of studies in animal models of hypertension have provided 
strong evidence of the role of angiotensinogen converting enzyme (ACE) 
in the development of hyper tens ion. Hilbert et al., (1991) developed a 
large collection of polymorphic DNA markers coveripg a large region of 
the rat genome. Linkage analysis in SHRSP, using a series of minisat­
ellite and macrosatellite markers, identified two genes regulating 
blood pressure; BP/SP-1 maps to chromosome 10 and a BP/SP-2 gene 
mapping to the X chromosome in rats. Supporting these observations 
Jacob et al., (1991) have also identified markers linked to genes 
regulating blood pressure on chromosome 10 in rats (BP1). The BP/SP-1 
loci is of particular interest since it maps close to the rat ACE gene 
which is involved in blood pressure regulation via the renin-angioten- 
sin system. The results by Hilbert and Jacobs have been confirmed by 
Nara et al., (1991) and more recently by Deng et al. (1992) who demon­
strated cosegregation of blood pressure in F2 rats from crosses be­
tween normotensive and Dahl Salt sensitive (DS) rats with alleles at 
the rat ACE locus. These studies are the first to carry out linkage 
analysis using e large fraction of the genome (approximately 70%), and 
thus have the potential to identify genes not suspected of being 
involved in the genetic control of blood pressure. In addition Jacobs 
et al., (1991) also provided preliminary evidence that a locus on 
chromosome 18 (BP2) influences blood pressure. Deng et al., (1992)
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also demonstrated cosegregation of the atrial natriuretic peptide 
receptor with blood pressure in F2 rats derived WKY and DS rats. 
Abnormal thermoregulation occurs in hypertensive mice. Barnet et al., 
(1991) have demonstrated a polymorphism of the heat stress protein 
(hsp) gene, the hsp 70 gene, a member of the hsp family is associated 
with an 15mnHg increment in blood pressure in recombinant inbred rat 
strains.
The Sa gene has also been implicated in the development of hyperten­
sion. The exact function of the Sa gene protein remains to be deter­
mined, but it codes for a protein with a carboxyl terminal region 
closely resembling that of luciferase. The F2 offspring, obtained by 
crossbreeding SHR and WKY, showed a more frequent genotype of the SHR 
for the Sa gene in rats with high blood pressure compared to rats with 
low blood pressure (Iwai et al., 1991). This suggests a possible role 
of the Sa gene in hypertension in the SHR.
Additional HFLPs for some genes other than those described above have 
been detected between the genomes of hypertensive rats. These observa­
tions include HFLPs for the gene encoding adducin (Bianchi et al.,
1990) and the phospholipase C gene (Yagisawa et al., 1991).
In addition to the observed genetic differences, several biochemical 
differences have also been reported in animal models of hypertension. 
Studies have shown Dahl salt sensitive (DS) rats to have lower plasma 
renin activity compared to Dahl salt resistant (DR) rats (Rapp 1980). 
Differences have also been reported for the P450 11—beta/18 adrenal 
steroid hydroxylating enzyme and abnormal sodium/potassium fluxes (De 
Mendonca et al., 1980).
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Over recent years, transgenic animals have been used to study genes 
that are involved in blood pressure regulation. Creation of transgenic 
animals involves the introduction of foreign genes into the reproduc­
tive cell line of mammals primarily mice (Jaenish 1988). This may then 
allow for the phenotypic effects of potentially interesting genetic 
alterations to be studied in whole animals and provides a useful tool 
for studying molecular and cellular physiology in whole animals. 
Mullins et al., (1990) introduced the mouse Ren-2 gene into fertilised 
rat embryos, such transgenic rats and their offspring were then shown 
to develop significant increases in arterial blood pressures, and 
raised levels of plasma aldosterone. A similar study by Steinhelper 
et al., (1990) demonstrated a reduction in blood pressure levels in
transgenic mice carrying the atrial natriuretic factor gene and in­
creased atrial natriuretic factor (ANF) production, suggesting that 
high levels of ANF peptide are capable of reducing blood pressure 
levels. Qhkubo et al., (1990) generated transgenic mice with elevated 
blood pressure levels by the introduction of the rat renin and angio­
tensinogen genes, suggesting the combined action of these two genes is 
responsible for an increase in blood pressure in transgenic mice. Such 
transgenic studies provide important clues to the genes responsible 
for animal hypertension.
Hence animal studies provide evidence that mutations at several loci 
may be responsible for high blood pressure, and allows the inference 
that such loci may be candidate genes that can be studied in human 
populations.
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1.4.2 Hunan Studies
In human studies* several difficulties have been encountered in at­
tempts to identify genes involved in the pathogenesis of high blood 
pressure. Such problems include phenotype definition, ascertainment of 
informative families and the heterogeneity of the disease (Hilbert et 
al., 1991). Thus human studies have generally provided contradictory
evidence for the involvement of several loci in the genetic control of 
blood pressure.
1.4.2.1 Biochemical studies
In hypertensive subjects plasma renin levels have been shown to have 
an overall distribution that differs from normal (Morris & Griffiths,
1988). Offspring from hypertensive families have shown significantly 
lower plasma renin levels than offspring from normotensive parents 
(Van Hooft etal., 1989). Similarly, plasma angiotensinogen levels 
correlate well with blood pressure levels in humans, and higher 
plasma concentrations have been observed in hypertensives compared to 
normotensives (Walker et al., 1979). Biochemical findings of offspring 
of the Ladywel 1 Study (Watt et al., personal communication 1990) show 
offspring of hypertensive parents to have raised levels of angioten— 
sinogen compared to offspring of parents with low blood pressure. 
Raised levels of cortisol and 18—OH corticosterone have also been 
demonstrated to be associated with high blood pressure in the Ladywel 1 
offspring (Watt et al., personal communication 1990).
Levels of the atrial natriuretic factor (ANF) hormone have been re 
ported to be significantly elevated in patients with essential hyper­
tension (Sagnella et al., 1985). However Nil Ison et al., (1987) found
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no significant difference in ANf levels between hypertensives and 
normotensives. The Dutch Hypertension study was also unable to demon­
strate significant difference in offspring with differing probabili­
ties of developing high blood pressure (Van Hooft et al., 1989). 
Several biochemical traits thought to be involved in sodium metabolism 
have been studied in populations of hypertensives and normotensives. 
The rate of sodium-1 ithium countertransport (SLC) in human populations 
has been reported to be higher on average in hypertensive populations 
(Williams et al., 1983, Williams et al., 1987). Sodium potassium 
cotransport has also been reported to be higher in patients with 
essential hypertension than normotensive controls (Cusi et al., 1990). 
An altered distribution of sodium and calcium ions have been demon­
strated in vascular smooth muscles in hypertensive patients (Nojma et 
al., 1989).
Kallikrein is a multigene family of highly homologous enzymes includ­
ing a specific enzyme that hydrolyses kininogen to produce the vasoac­
tive peptide kinin. Studies have shown that urinary kallikrein excre­
tion is lower in hypertensives than normotensives (Zinner et al., 
1976, Berry et al., 1989).
The sympathetic nervous system has also been widely studied in human 
populations and shows increased nervous activity in patients with 
genetic hypertension. Studies examining the role of the sympathetic 
nervous system in hypertension have studied levels of circulating 
catecholamines, raised levels of norepinephrine have been observed in 
hypertensive patients (Goldstein 1983), and total urinary catechola­
mine excretion is significantly higher in groups of offspring with a 
family history of hypertension (Ferrera et al., 1988). Higher densi—
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ties of alpha-2-adrenergic receptors have been demonstrated in hyper­
tensive offspring with a positive family history compared to hyperten­
sives without a family history (Fritschka et al., 1987). The Dutch 
hypertension study showed approximately a 20% increase in alpha-2- 
adrenergic receptor density in offspring of hypertensive parents 
compared to offspring of normotensive parents. (Van Hooft et al., 
Personal communication). Increased density of beta-2-adrenergic recep­
tors in lymphocytes have also been reported in patients with essential 
hypertension (Brodde et al., 1987). Michel et al., (1988) have demon­
strated increased platelet alpha-2-adrenergic receptor densities in 
normotensive children with a genetic predisposition to high blood 
pressure, providing evidence that such changes are genetically deter­
mined.
A highly significant relationship has been demonstrated between blood 
pressure and insulin concentration (Rocchini 1991), such that preva­
lence of insulin resistance is greater with higher blood pressure 
levels (Julius et al., 1991), providing evidence for the insulin gene 
as a candidate gene for hypertnesion.
1.4.2.2 Genetic Studies
In light of the biochemical differences observed between hypertensives 
and normotensives a number of genetic studies have been performed in 
human populations. RFLP studies have been performed with the renin 
gene in human populations of normotensive and hypertensives to estab­
lish an association between hypertension and renin (Morris & Griffiths 
1988, Naftilan et al., 1989). However no association between renin 
HFLPs and hypertension has been demonstrated.
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Several intermediate phenotypes of hypertension have been identified 
which show major gene effects. Plasma ACE is one such intermediate 
phenotype and 50% of the inter individual variability of plasma ACE is 
determined by a major gene effect (Cambien et al., 1988).
Elevated sodium lithium conutertransport (SLC) is also a well studied 
hypertension intermediate phenotype demonstrating a major gene effect 
and 34% of the the total variation is due to the segregation of a 
recessive gene (Hasstedt et al., 1988). Normotensive individuals with 
recessive high SLC have been shown to develop hypertension four times 
more often than those with the dominant low SLC genotype (Hunt et al., 
1991). It has been suggested that a mutation in the sodium-proton 
antiporter gene might be responsible for the elevated SLC and a con­
tributor to hypertension.
A major gene effect has also been demonstrated for the kallikrein 
gene, and 51% of the phenotypic variation has been attributed to a 
dominant allele for total urinary kallikrein excretion and 27% due to 
polygenes and shared environment (Berry et al., 1989).
RFLP analysis of the ANF gene has been performed in two different 
ethnic populations (Barley et al., 1991). However no allelic associa­
tion with blood pressure has been demonstrated.
Genetic studies performed in offspring with polarised predispositions 
to high blood pressure (ladywel1 study), have shown an increased 
frequency of the larger allele of the Bell RFLP of the glucocorticoid 
receptor gene in offspring with the high blood pressure and high 
parental blood pressure compared to offspring with low personal and 
low parental blood pressure, suggesting that homozygosity of the 
larger allele is associated with hypertension.
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Genetic studies have also been performed on the sodium-1 ithium coun­
tertransport gene and hypertension. However the two studies to date 
have reported no evidence of genetic linkage between the sodium-proton 
antiporter gene and hypertension (Dudley et al., 1990, Lifton et al.,
1991).
Blood groups have been suggested to play a role in the development of 
hypertension. The human leucocyte antigens (HLA) and the alleles of 
the MNS blood group have both been the subject of investigation. HLA 
haplotype analysis has been performed in sib pairs and show signifi­
cant distortion of the normal segregation patterns of inheritance of 
HLA haplotypes, suggesting a loci closely positioned or within the HLA 
complex is involved in the determination of blood pressure levels 
(Gerbase-DeLima et al., 1989). A difference in the distribution of MN 
alleles in hypertensives subjects compared to normotensive subjects 
has been observed (Heise et al., 1987) such that hypertensives have 
an excess of the N phenotype and a deficiency of the M phenotype. 
There is also evidence for linkage between the MN locus and the sodium 
lithium countertransport phenotype (Weder et al., 1991).
RFLP analysis of patients with hypertension and normotensive controls 
of the insulin gene have failed to demonstrate an association between 
the insulin gene and hypertension. However, a statistically signifi­
cant association of a polymorphism of the insulin receptor gene with 
high blood pressure has been reported (Yipg et al., 1991).
Other human genetic studies have suggested a connection between genet­
ic markers and hyper tens ion haptoglobin protein polymorphisms (Beret— 
tai-Picolli et al., 1986).
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In addition, to the observed biochemical and genetic differences, a 
number of Mendel ian hypertensive syndromes have been identified, that 
may provide clues to the genes involved in hypertension. Glucocorti­
coid Remediable Aldosteronism (GRA), is one such syndrome, where 
hypertension follows an autosomal mode of inheritance. A chimaeric 
gene duplication as a result of unequal crossing over between the 5* 
region of the 1 llMiydroxylase gene and the distal sequences of the 
aldosterone gene is responsible for the disease CLifton et al., 1992). 
These genes therefore represent potential candidate genes for hyper­
tension.
Multiple candidate genes have therefore been identified from both 
human and animal studies, however the results from such studies gener­
ally provided conflicting evidence. This may be a result of the dif­
ferent genes involved in both animal and human hypertension.
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1.5 Alms of the present study
a) To perform association analysis using restriction fragment 
length polymorphisms in candidate genes in groups of offspring with 
contrasting predispositions to high blood pressure on the basis of 
personal and parental blood pressures, and in their parents
b) To perform sib pair analysis using restriction fragment length 
polymorphisms of candidate genes in affected and unaffected sibling 
pairs with contrasting predispositions to high blood pressure
c) To seek new restriction fragment length polymorphisms in candidate 
genes of interest on the basis of a) and b)
d) To perform mutational analysis in candidate genes of interest on 
the basis of a) and b)
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CHAPTER 2: PATIENTS AND METHODS
Chapter 2 PATIENTS AND METHODS
2-1 PATIENTS
2-1-1 Recruitment of subjects
In 1979, 6088 adults aged 35-64 years representing 76% of all indi­
viduals in this age group were selected from 24000 patients registered 
at the Ladywell Medical Centre, Edinburgh and screened to identify 
subjects for the Medical Research Council (MRC) Mild Hypertension 
Trial. All participants were identified via systematic selection from 
age/sex registers and patients on treatment for high blood pressure 
were included- 1809 husband/wife pairs were screened, with each 
person being given an age/sex adjusted blood pressure score. Parental 
blood pressure (Husband/wife) scores were combined to identify 
High/High and Low/Low families. Blood pressure was measured twice 
using a random zero sphygmomanometer and a standard adult cuff size. 
Diastolic blood pressure was recorded to the nearest 2mmHg after 
sitting for 10 minutes.
2.1.2 Phase 1
In 1986 the practice registers were reviewed. Of the original 1809 
couples, 1473 were still resident in the Ladywell catchment area. 
Letters were sent to each couple asking for dates of births and cur­
rent addresses of offspring. 2879 offspring were identified, of which 
1169 were natural offspring to both parents and were aged between 16- 
24 years on 31-5-1986. Offspring were invited to the medical centre 
where their blood pressure, pulse, height and weight were recorded. 
They were asked to complete a questionnaire requesting information on 
age, sex, marital status, educational attainment, place of residence.
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employment status, personal medical history, physical activity, ciga­
rette smoking, health knowledge and alcohol consumption. 864 individu­
als took part. To enable a comparison to be made between blood pres­
sures of parents and offspring a Z score was calculated by dividing 
an individuals blood pressure deviation from the mean of their age/sex 
blood pressure group by the standard deviation of blood pressure 
within the group. Individual scores and age/sex distribution were 
based on the arithmetic mean of all blood pressure data with a two 
year age groups for the offspring and a five year age groups for 
parents. The scores for women were based on roughly equal numbers of 
those taking or not taking the oral contraceptive pill. Parents on 
treatment for hypertension were given Z scores corresponding to the 
mean score of the top 5% of the distribution of scores in their 
age/sex group. Four groups of offspring were identified; Group A (122) 
Group B (118), Group C (122) and Group D (68) as shown in Figure 1.
2.1.3 Phase II
Random samples were taken from the three largest groups (A, B and C) 
in order to identify four groups of approximately 70 individuals. 
Statistical analysis allowed 238 offspring to be approached at the 
final stage, of which 201 participated. Height, weight and blood 
pressure were recorded, a non fasting blood sample was taken and a 24 
hour urine sample collected. The blood pressure characteristics of 
Phase II offspring are presented in Table 4.
2.1.4 Phase III
100 of the 200 offspring took part in detailed biochemical and physio­
logical studies as inpatients at the MRC Blood Pressure unit,
Glasgow..LSI
Figure 1: Diagrammatical representation of the four corner 
approach for the selection of offspring with contrasting 
predispostions to high blood pressure
HIGH
Offspring 
Blood Pressure 
Scores
LOW
LOW HIGH
Combined Parental 
Blood Pressure 
Scores
Group Personal BP Parental BP
A high low
B high high
C low low
D low high
32
\
Table 4: Blood pressure characteristics of Phase II offspring
Group A B C D
n 50 51 48 52
SBP 127.6+10.8 128.7+11.8 105.1+10.3 109.7+9.4
IBP 75.6+7.8 74.9+9.0 56.1+7.9 56.9+8.2
SBP(P) 112.3+6.8 137.3+9.7 112.6+7.1 135.7+11.8
DBP(P) 69.2+4.6 83.4+6.8 67.9+7.0 83.1+6.9
where BP is in nmHg and (P) refers to parental BP 
values are expressed as means ,+s.d.
SBP., systolic blood pressure 
DBP, diastolic blood pressure
Taken from Watt et al., (1992)
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2.1.5 Phase IV
Parents of all phase II participants were invited to return to the 
Ladywell clinic for height, weight, blood pressure and pulse rate 
measurements and to donate a blood sample.
2.1.6 Phase V
Phase II siblings who had been characterised in phase I but whom were 
not included in Phase II were approached for a blood sample to in­
crease the number of sibling pairs for stastistical analysis.
DMA extractions were carried out on all Phase II, Phase III 
and Phase V participants and lymphoblastoid cell lines (LCL) estab­
lished as a constant source of DMA.
The final study population consists of 4 groups of individuals;
Group A (high offspring, low parent blood pressure)= 50 
Group B (high offspring, high parent blood pressure)= 51 
Group C (low offspring, low parent blood pressure)= 49 
Group D (low offspring, high parent blood pressure)= 52
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2.2 METHODS
2.2.1 Materials
A list of materials and solutions are presented in Appendix I. All 
chemicals used were Analar Grade and purchased from BDH limited or 
Sigma. Restriction enzymes were purchased from Gibco BRL, New England 
Biolabs., NBL Limited and Boehringer Mannheim. The source of the re­
maining materials can be found in the text.
2.2.2 Plasmid techniques
DNA Probes were supplied either as glycerol stocks or as plasmid DNA 
samples and were grown up within the Duncan Guthrie Institute and 
stored as glycerol stocks. The features of the probes used in this 
study are presented in Table 5.
2.2.2.1 Preparation of Competent Cells
5mls of prewarmed L broth (Luria broth) was innoculated with lO^ il of 
glycerol stock and incubated overnight at 37*C in an orbital shaker. 
100ml of fresh L broth was inoculated with 1ml of the overnight cul­
ture and incubated at 37*C until the absorbance of the culture was 0.6 
(6x10® cells/ml). The culture was placed on ice and transferred to a 
chilled 30ml tube and spun at 4K for 5 minutes at 0*C The resulting 
pellet was resuspended in 12.5ml of ice cold lOmM magnesium sulphate 
and left on ice for 30 minutes. Cells were pelleted again and resus­
pended in 2m 1 of ice cold 50mM calcium chloride.
35
Table 5: Features of the DNA probes
Gene Probes Vector/insert size/ 
release enzyme
Source
Alpha-2-adrenerg ic 
receptor
puC18/5. 5kb/BnmHT ATTC
Beta-1-adrenerg i c 
Receptor
?/2.4kb/Ecorl ATTC
Beta-2-adrenerg i c 
Receptor
FMSG/2. 6kb/SnaI ATTC
Beta-f ibr inogen pFB5/1.4kb/PstI Humphries
Glucocorticoid
receptor
?/4.4kb/flamffI Evans
pMEG12/2.Skb/Notl Detera-Wad1e ig
Insulin pBR327/0.88kb /BnmHT ATTC
Renin PuC12/0.8kb/Ecorl 
Hindlll
Frossard
Humphries: Charing Cross Sunley Research Centre, Hammersmith,
London, UK.
Evans: Howard Hughes Medical Institute, Gene Expression Laboratory
Salt Lake Institute, La Jolla, CA, USA.
Detera-Wad 1 eigh: National Institute of Health, Bethesda, Maryland USA. 
Frossard:Calafornia Biotechnology Inc., Mountain View, Ca, USA.
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2.2.2.2 Transformations
100m 1 cold STET buffer was placed in a bijoux on ice. To this
IQpg of plasmid ENA was added and thoroughly mixed. 200^1 of competent 
cells were added and the bijoux placed on ice for 25 minutes. The 
cells were then subject to heat shock at 4*C for 2 minutes, followed 
by a 10 minute incubation at ET. 700pl of prewarmed L broth was added 
and the cells incubated in an orbital shaker for 1 hour. 200pl of the 
mixture was plated out onto X-Gal/ampicillin plates and left in a 37*C 
incubator overnight.
X-Gal/ampicillin plates were made as follows; 1.5% L-agar with ampi- 
cillin added to a final concentration of lOOpl/ml. When the plates 
were set, 40pl of X-Gal was spread over the surface. All probes used 
were ampicillin resistant.
2.2.2.3 Preparation of glycerol stocks
The agar plates were inspected and a single colony was removed and 
grown overnight in 15ml of L broth containing ampicillin at 37 *C.
After incubation the cultures were made 15% glycerol, and stored at 
-20 *C.
2.2.2.4 Steal 1 scale plasmid preparation
15ml of L broth media containing 0.01mg/ml Ampicillin was innoculated 
with 5jli1 of glycerol stock and incubated overnight at 3 7  C with vigor­
ous shaking. After incubation cultures were spun for 10 minutes at 
1.5K at 4*C in an IEC DPR-6000 centifuge, and the supernatant discard­
ed. The resulting pellet was resuspended in 400pl of ice cold STET 
buffer and transferred to a sarstedt tube. 25pl of fresh cold lysosyme
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(lOng/ml) was added and the tubes left on ice for 5 minutes, followed 
by a 1 minute incubation at 100 *C. The tubes were spun in a Scot lab 
Microcentaur centrifuge for 15 minutes and the supernatant transferred 
to a fresh tube. One tenth the volume of 3M sodium acetate was added 
together with an equal volume of phenol, and one sixth the volume of 
isopropanol. Ihbes were placed at -20*C for 30 minutes, and spun again 
for 10 minutes. The supernatant was discarded and the pellet washed 
dry with 1ml 95% ethanol. The pellet was resuspended in 8Qpl of TE 
buffer.
2.2.2.5 CIRCLEPREP plasmid preparation
CIRCLEPREP (BIO 101) kits were also used for the rapid isolation of 
plasmid DNA following the manufactures recommendations. 5ml cultures 
were grown overnight in Circlegrow medium provided in the kit and the 
cells pelleted in a centrifuge at 1.5K for 10 minutes at 4*C. The 
cells were then resuspended in 200pl of Pre-lysis buffer and lysed by 
the addition of 200pl of Alkaline lysis buffer. 200pl of neutralizing 
solution was added and the tubes mixed. After a 2 minute centrifuga­
tion the supernatent was transferred to a fresh tube by pipetting 
through a sieve, 400pl of isopropanol was added and the tubes centri­
fuged again. The resulting pellet was resuspended in 75jj1 of pre- 
lysis buffer. The tubes were then placed in a boiling water bath to 
denature linear cellular ENA and subsequently cooled on ice. 300pl of 
Lithium Chloride was added and left to incubate for 2 minutes to 
pellet rRNA and ssDNA precipitates. The supernatent was transferred to 
a fresh tube, 600pl of isopropanol added and centrifuged for 2 
minutes, the pellet was dissolved in 0.5 ml of SDW. Plasmid ENA was 
then purified by the addition of 75pl of circleprep Glassmilk and a 5
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minute incubation at RT. Tubes were spun for 10 seconds and the pellet 
was washed with binding buffer aixi then in wash solution, the 
pellet was then allowed to air dry. The plasmid ENA was resuspended 
in lOpl of TE buffer.
2.2.2.6 Releasing insert from plasmid
Plasmid concentrations were determined by measuring the optical densi­
ty (QD) of each sample at 260nm in a dual beam spectrophotometer with 
a Deuterium lamp CLKB Biochem Ultrospec 4050). An OD reading of 1 
corresponds to approximately 50pg/ml of DNA. lOug of plasmid DNA was 
measured into a 0.5ml eppendorf tube, to which 8pl of enzyme 
buffer,4pl of 0.1M spermidine and 4pl of the appropriate enzyme was 
added (Table 5 lists release enzymes for various probes).
The plasmid digests were incubated overnight at the manufactures 
recommended temperature for each enzyme. The released insert was 
resolved on a 1.2% low melting point Seakem agarose gel (FCM bio- 
products) along with 20pl of 1 kilobase marker (Boehringer Mannheim) 
at 120mA for 4 hours. The gel was visualised on a UV transilluminator 
(316nm), and the required band (released insert) was excised using a 
sterile scalpel blade and placed in a sarstedt tube. The weight of the 
insert was determined and a volume of SDW three times the weight of 
the insert was added. The probe was boiled for 10 minutes and stored 
at -20#C.
2.2.3 Preparation of cell cultures
Cell cultures were set up from previously established Lymphoblastoid 
cell lines (LCL) (Crouch M).
Since the culture media contains Epstein Barr Virus (EBV), and the
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risk of HIV/Hepatitis infection, cultures were prepared in a specially 
designated Class II fume hood with only plastic ware. Great care was 
taken in the handling of these samples and all necessary safety pre­
cautions were adhered too.
2.2.3.1 Feeding of cell cultures
Vials were removed from liquid nitrogen and rapidly thawed at 37*C. 
The cells were washed by transferring the contents of the vials to a 
fresh Sterilin universal and adding 25ml KPMI (10%FCS), universals 
were spun at 1400 rpm for 10 minutes. The supernatant was discarded 
and the cells resuspended in 3m 1 of fresh media and transferred to a 
50ml plastic culture bottle. The bottles were then left in a dry 37’C 
incubator overnight. The growth of the cells was assessed by the 
changing colour of the media. If the media changed colour, the cells 
were fed with 10ml KPMI (10%FCS) and left to grow for 3-4 days until 
the media colour changed again. When a volume of 30ml in the culture 
bottles was reached, the cells were resuspended and transferred to a 
260ml culture bottle. Cells were fed every 3-4 days until 100ml of 
media was present.
2.2.3.2 Harvesting lymphoblastoid cells
When cell growth was sufficient, 30ml of media was gently removed from 
the bottles taking great care not to disturb the cells and discarded. 
The cells were suspended by gentle shaking and 40ml of the culture 
transferred to a sterile Falcon tube. Falcon tubes were spun at 1.5K 
for 10 minutes at 4*C in a IEC DFR-6000 centrifuge and the supernatent 
discarded. Cells were then prepared for DNA/HNA extraction. In order 
to maximise the quantity of DNA/HNA. obtained the remaining cells in
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the 260ml bottles were repeatedly fed ever 3-4 days with 20ml RPMI 
(10%FCS) until a volume of between 80-100ml of media was present, 
allowing further DNA/HNA to be obtained.
2.2.4 Genomic DNA techniques
2.2.4.1 Genomic DNA extraction
Genomic DNA was extracted from peripheral blood samples (fresh and 
frozen) using a variation of the method described by Kunkel et al. 
(1977).
10ml of whole blood was placed in a Falcon tube and 40ml of lysis mix 
added. TXibes were left on ice for 10 minutes and then centrifuged at 
2.8K for 10 minutes at 4*C in a IEC DPR-6000 centrifuge. The resulting 
pellet was resuspended in 3m 1 of nuclei lysis mix, 20tyil 10% SDS and 
lOOpl proteinase K (10mg/ml). Thbes were incubated overnight at 37*C. 
After incubation 1ml of 6M sodium chloride was added with vigourous 
shaking,and tubes spun at 2.8K for a further 10 minutes at 4*C. The 
supernatent was then transferred to a fresh Falcon tube and 3m 1 of 
phenol/chloroform was added, and spun at 2.4K for 15 minutes. The 
upper aqueous phase was transferred to a fresh tube and DNA precipi­
tated out by the addition of two volumes of ethanol. DNA was spooled 
out, washed in ethanol, allowed to air dry and resuspended in 0.5ml 
of TE buffer. ENA samples were stored at 4*C.
For a large number of subjects, ENA stocks obtained from the blood 
samples became exhausted, thus it was necessary to extract DNA from 
lymphoblastoid cell lines. The method used was the same as for extrac­
tion from blood samples, however the initial lysis step was omitted 
since the starting material was solely nucleated cells.
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2.2.4.2 Optical densities of DNA
The concentration of each DNA sample was determined by measuring the 
optical density at 260nm in a dual beam spectrophotometer with a 
deuterium lamp. An QD reading of 1 corresponds to approximately 
50pg/ml of IMA.
2.2.4.3 Digestion of genomic DNA
To a lOpg aliquot of ENA, 3pl of a restriction enzyme, 4pl of appro­
priate buffer and 7^ i\ of 0.1M spermidine was added. Each digest was 
made up to a final volume of 40pl using SEW. Digests were incubated 
overnight at the suppliers recommended temperature for optimal enzyme 
activity.
2.2.4.4 Agarose Gel Electrophoresis
Digests were resolved on 0.8% EB Seakem agarose gels (FMC Bio­
products) containing 0.05% ethidium bromide (10mg/ml). Following 
addition of 4pl of loading mix, digests were loaded onto gels and run 
at 200mA for approximately 7 hours. The gels were visualised on a UV 
transilluminator (316nm) and photographed with a Polaroid type 667 
film in a Polaroid instant print camera fitted with a Kodak 22A Wrat- 
ten filter.
2.2.4.5 Southern Blotting
Southern blotting was carried out to transfer the digested DNA from 
the agarose gel to a Hybond N membrane (Amersham).
Gels were treated for 15 minutes with 0.25M hydrochloric acid with 
gentle agitation followed by a 30 minute wash in denaturation solution 
and a 30 minute wash in neutralisation solution. The gels were blotted
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for a minimum of 16 hours according to the standard Southern Blotting 
procedure (Southern 1975). A tank was filled with lOxSSC. Gels were 
placed on a glass plate covered with 2 sheets of Whatman 3MM paper 
soaked in lOxSSC. Both ends of the 3MM paper were sitting in the tank 
full of buffer. Bybond N (Amersham, UK) membrane was placed on top of 
the gel and two sheets of 3MM paper soaked in 2xSSC placed on top of 
the membrane. The remaining area of the glass plate was covered in 
plastic and a stack of paper towels placed on top of the gel together 
with a small weight. When blotting was completed, the filter was 
removed, rinsed in 2xSSC and baked in a hot air oven at 80*C for 3 
hours to fix the DNA to the filter.
2.2.4.6 Prehybridisation
This is necessary to prevent non specific binding of radiolabelled 
probe to the filter.
Filters were soaked in 2xSSC and placed on a mesh. The mesh was rolled 
up and placed in a hybridisation bottle (Hybaid), to which 5ml of 
2xSSC was added and the bottle gently rolled so that the filter and 
mesh adhered to the walls of the bottle. Excess 2xSSC was poured off 
and replaced by 10ml of prewarmed prehybridisation solution containing 
lOOpl of denatured salmon sperm DNA (10mg/ml). Bottles were placed in 
a Hybaid Hybridisation oven at 65*C overnight. Prior to purchasing a 
hybridisation oven, hybridisations were carried out in a water bath 
and filters were sealed in polythene bags.
43
2.2.4.7 Oligonucleotide Labelling Technique
Probes were labelled using random primed DNA labelling kits (Boehring- 
er Mannheim) according to the method of Feinberg & Volgenstein (1984). 
25|ul of probe was boiled for 10 minutes and incubated at 37*C for 2 
minutes. 2jj1 of the oligonucleotides dATP., dGTP, dTTP, 4pl of reaction
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mix, 1.5)il of Klenow enzyme and 50pCi (5pl) of P dCTP isotope (Amer 
sham International) were added. The mixture was incubated for a 
minimum of 1 hour, and the reaction stopped by the addition of 2pl 
0.5M EDTA.
2.2.4.8 Separation of labelled probe from unlabelled probe
A column packed with Sephadex G50 equilibrated with lxSSC/0.1%SDS was 
prepared. Once the column had settled excess lxSSC was removed from 
the surface and the probe added. The effluent from the base of the 
column was monitored using & Seris 900 mini moniter and the first peak 
(>200cpm) corresponding to the labeled probe was collected.
2.2.4.9 Hybridisation of filters
The collected probe was denatured by boiling for 10 minutes and placed 
on ice for 2 minutes. The prehybridisation solution from the bottle 
was poured into a universal and the probe added. The contents of the 
universal were mixed gently and transferred back into the bottle. 
Hybridisations were carried out in the hybridisation oven at 65*C for 
a minimum of 16 hours.
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2.2.4.10 Washing of Filters
Excess probe was removed by pouring off the solution in the bottles 
and washing in 2xSSC/0.1XSD6 for 20 minutes. Filters were monitored 
using a Seris 900 minimonitor, if a signal greater than lOcpms was 
seen, filters were washed at increased stringency.
Washing solutions used were; lxSSC/0.1% SDS, 0.5xSSC/0.1% SDS and 
0. lxSSC/0.1%SD6. All washes were carried out at 65*C.
2.2.4.11 Autoradiography
Once filters were washed, they were placed between plastic and placed 
in light tight autoradiography cassettes with intensifying screens and 
exposed to Kodak Diagnostic AR imaging film. Cassettes were stored at 
-70*C for an average of 7 days. Films were developed in a Agfa Curix 
60 X-Ctoat.
2.2.4.12 Stripping of filters
Filters were "stripped” by rinsing in 0.4M sodium hydroxide for 30 
minutes followed by a 30 minute wash in neutralisation solution at BT. 
This removes hybridised probe and therefore allows for further prob­
ing.
2.2.5 HNA techniques
2.2.5.1 HNA extraction from lymphocytes
The Acid Guanidium Thiocynate Chloroform method.
This method is a variation of the procedure described by Chomczynski 
and Sacchi (1987).
All neccessary precautions were taken to avoid contamination by 
HNAses. Glassware and plasticware used for the preparation and storage
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of HNA were soaked in 0.1% diethylpyrocarbonate (DEPC) in SDW for 14- 
16 hours and rinsed in SEW and autoclaved for 20 minutes at 151b/sq 
in. All solutions used for HNA handling were also DEPC treated and 
autoclaved.
HNA was extracted from lymphoblastoid cell lines. Cells were initially 
washed in 10ml PBS and spun for 10 minutes at 1200 rpm. After this 
another wash was given and the supernatant discarded. The cell pellet 
was then dissolved in 1ml of Solution D (denaturing solution) and 
transferred into 2 sarstedt tubes. To each tube the following were 
added: 150pls of 2M sodium acetate, 500yls of phenol, 300pls of chlo­
roform. Samples were mixed and left on ice for 15 minutes and then
centrifuged at lOOOOg for 20 minutes at 4*C. The aqueous phase was
transferred to a fresh tube and 1.5ml of isopropanol added. Tubes were
mixed and placed at -20*C for at least 1 hour or at 4*C overnight. The 
tubes were then spun at lOOOQg for 20 minutes at 4*C and the superna­
tant discarded. The resulting pellet was dissolved in 0.6ml of Solu­
tion D and transferred to a fresh eppendorf to which 0.6ml isopropanol 
was added and the samples chilled at -20*C for 1 hour. The eppendorf 
tubes were spun in a microcentrifuge for 10 minutes at 4*C, the pellet 
was then washed in 75% ethanol twice, dried and dissolved in lOOpl of 
SDW at 65*C for 10 minutes. HNA samples were stored at -20*C.
2.2.5.2 Optical densities of HNA
The concentration of each HNA sample was determined by measuring the 
optical density at 260nm in a dual beam spectrophotometer with a 
deuterium lamp. An CD reading of 1 corresponds to approximately 
40pg/ml of HNA. Optical densities were measured at 260nm and 280nm to
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determine the purity of the HNA sample. For a pure HNA sample the 
ratio of OD reading (260nm:280nm) is 2.
2.2.5.3 Visualisation of extracted HNA
A checker gel was run to determine if the HNA extraction was success­
ful . A 30ml 1% agarose gel was prepared containing 5mIs of formalde­
hyde and 3m 1 of lOxMOPS. The HNA sample was prepared as follows: 5uls
formamide, 1.65pls formaldehyde, lpl lOxMOPS, 1.3jil H20, lpg HNA 
sample.
The preparation was heated to 55*C for 10 minutes and then placed on 
ice. 2pl of gel juice was added to the sample and loaded immediately. 
Gels were run in lxMOPS at 75V. On completion of electrophoresis, gels 
were soaked in SDW for 1 hour to remove the formaldehyde, stained in 
ethidium bromide for 10 minutes destained in water overnight, visua­
lised on a uv transilluminator (316nm) and photographed with a Pola­
roid type 667 film in a Polaroid Instant print camera fitted with a 
Kodak 22A Wratten filter.
An E. coli ribosomal HNA molecular weight marker (Boehringer Mannheim) 
was used to determine if HNA extraction was successful.
2.2.6 Reverse Transcription-Polmerase Chain Reaction amplif ication
of the glucocorticoid receptor cDNA
2.2.6.1 Primer Design for amplification
Primers were designed with the aid of the OLIGO computer programme 
(Rychlich & Rhodes 1989) to determine the "best" primers for amplifi­
cation of the human glucocorticoid receptor (HGR) cDNA. Three sets of 
primers were designed such that the cDNA including part of the 3*and 
5* untranslated regions were amplified. The features of the oligonu­
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cleotide primers are presented in Table 6.
Synthetic oligonucleotide primers were initially prepared by Oswell 
DNA sevices, Department of biochemistry, University of Edinburgh, aixi 
then within the Duncan Guthrie Institute using a Biosystems 380B DNA 
synthesiser using cyanoethyl phosphoramidites (E O'Hare). Figures 2 
shows a diagrammatical representation of the regions amplified.
2.2.6.2 Deprotection of synthetic oligonucleotides
Primers prepared within the department required a deprotection stage,
to remove the oligonucleotide from the columns.
Using a 1ml syringe 0.3mls of ammonia solution was pushed into the 
column and left for 10 minutes. This was repeated several times until 
all the solution was in the column. A second syringe placed at the 
opposite end of the column was used to collect the solution containing 
the oligonucleotide. This was then placed in a Nunc tube and a further 
lml of ammonia solution was added. The tubes were incubated overnight 
at 55*C, and the ammonia allowed to evaporate off in a fume hood. The 
remaining oligonucleotide solution was made up to lml using SDW and 
the optical density determined (See section 2.2.4.2) and the concen­
tration determined (Appendix II).
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Table 6: Features of the primer sets used for the amplification of 
the glucocorticoid cDNA
Primer Primer Sequence Size of 
product
236R F GOG TTC ACA AGC TAA GTT GT
240R R AGA GGC TIG CAG TCC TCA TT 835bp
239R F GGA GAA GAC GAT TCA TTC CT
238R R ACA GAG CTA TCA TAT CCT GC 968bp
241R F GTG TCA CIG TIG GAG GTT AT
237R R AGT GAT GAC GAC TCA ACT GC 934bp
Sequence of the primers are shown in the 5‘-- 3* orientation
F: forward primer 
R: reverse primer
49
Figure 2: Diagrammatic Representation of the relative positions of the 
amplified fragments of the glucocorticoid receptor cENA
236R 239R 241R
3'
240R 238R 237R
835bp
968bp
934bp
Primers 236R/240R amplify exon 1, 756bp of exon 2
Primers 239R/238R amplify 497bp of exon 2t exon 3 & 4, 188bp of exon 5
Primers 241R/237R amplify 151bp exon 5, exon 6, 7 & 8, 3349 bp exon 9
2.2.6.3 Purification of oligonucleotides
In some instances it was necessary to purify synthetic oligonucleo­
tides after deprotection. This was carried out according to (Sawadogo 
1991). lOOpl of the deprotected oligonucleotide was placed in a 1ml 
microcentrifuge tube and vortexed together with 1ml of n-butanol for 
15seconds. The tubes were then spun at 12,000rpm for 4 minutes. The 
n-butanol phase was removed using a sterile pipette tip and the pellet 
air dried and resuspended in lOOpl of SDW.
2.2.6.4 Reverse Transcription-PCR
l|ug of HNA, in a sterile 0.5pl microcentrifuge tube, was heated to 
95*C for 5 minutes and snap chilled on ice. The HNA template was then 
reverse transcribed for 1 hour at 42*C in a 20pl reaction mixture 
containing 200pM of each dNTP (dTTP, dGTP, dCTP, dATP), lOmM DDT, 75mM 
KC1, 50mM Tris HC1 (pH 8.4), 3mg MgCl, 100pg/pl Bovine serum albumen, 
0.5pM of forward primer and 200 units of Murine Maloney Leukemia Virus 
(MMLV).
At the end of the transcription reaction, the reaction components were 
heated to 95’C for 5 minutes and placed on ice, and prepared for PCR. 
The reverse primer was added to a final concentration of 0.5pM and the 
volume adjusted to 50pls. After the addition of 2.5 units of Taq ENA 
polymerase, the reaction components were overlaid with 50pl of mineral 
oil and the cDNA PCR amplified for 30 cycles.
PCR reactions were carried out on a automated Cetus Perkin Elmer 
Thermo-cyc1er.
For oligonucleotide set 236R/240R the optimised thermo-cycler condi­
tions were: 72*C for 10 minutes for 1 cycle, 94*C for 3 minutes, 60*C
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for 1 minute, 72*C for 2 minutes for 1 cycle, 94*C for 1 minute, 60*C
for 1 minute, 72’C for 2 minutes for 30 cycles followed by a final
extension step of 72*C for 5 minutes. Hie optimised conditions for 
oligonucleotide set 238R/239R and 241R/237R were the same except for 
the annealing temperature, which were 58*C and 57’C respectively.
2.2.6.5 Identification of PCR products
Amplified PCR products were resolved on 1.4% Seakem agarose mini-gels 
containing 0.5pg/ml of ethidium bromide in lxTBE buffer with the
addition of loading mix. A lkb molecular weight marker was used to 
determine the sizes of amplified products, and gels were visualised on 
a uv transilluminator (316nm) and photographed.
2.2.6.6 Precipitation of DNA from PCR product
The PCR product "band" was excised from the gel using a sterile blade 
and the ENA extracted by overnight elution in lOQpl of TE buffer. The 
DNA was then precipitated by the addition of an equal volume of 4M 
ammonium acetate (pH 5.2) and 2 volumes of isopropanol and left at RT 
for 10 minutes, followed by a 10 minute spin at 12,000g. The resulting 
pellet was washed in 70% ethanol and allowed to air dry and resuspend­
ed in lOOpls of SEW.
2.2.6.7 Generation of single stranded ENA templates 
Asymmetric PCRs were performed for the generation of single stranded 
DNA for chain termination sequencing using precipitated ENA samples 
from standard PCR reactions by the method described by Mgone (personal 
communication) using an unequal ratio of 100:1 of the two oligonucleo­
tide primers.
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Asymmetric PCRs were set up as follows; to a 0.5ml epperadorf tube the 
following reagents were added: lOpls of Taq polymerase buffer, 10}j1s 
of 2.5mM dNlF mix, 5pg of forward primer and 500ng of reverse prim­
er, or 500ngs of forward primer, 5ngs of reverse primer, lpg of DNA, 
and a volume of SEW to give a total volume of lOOpls. PCR reactions 
were then performed using the conditions described in section 2.2.6.4. 
The number of cycles was increased from 30 too 40, since the first 
20-25 cycles results in double stranded DNA, but as the limiting 
primer is depleted, single stranded templates are produced.
2.2.6.8 Visulisation of Single stranded DNA
5jils of each PCR product was resolved on a 50ml 1% agarose TBE mini­
gel containing 10% ethidium bromide with 5pls of loading mix, and the 
products viewed on a uv transil luminator. Single stranded DNA migrates 
slower through agarose gels than double stranded ENA and also shows 
less fluorescene. The single stranded DNA was then precipitated to 
remove primers and dNTPS prior to sequencing, using the same protocol 
described in section 2.2.6.6, but dissolving the DNA in 14juls of SEW.
2.2.7 PCR amplification of the Human Angiotensinogen gene
The angiotensinogen gene consists of five exons and four introns and 
spans a region of approximately 13kb (Gaillard 1989). Nine sets of 
synthetic oligonucleotides were manufactured within the department for 
the amplification of the five exons and the 5* region of the gene.
Primer sequences were taken from Jeunemaitre et al., (1992), and are
listed in Table 7.
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Table 7: Features of the primers used for the amplification of the 
angiotensinogen gene
Primer Primer sequence size of 
product
5’al F ACC ATT TGC AAT TTG TAC AGO 255bp
5*a2 R GCC CGC TCA GGG ATG TG
5'bl F AAG ACT CTC CCC TGC CCC TCT
5’b2 R GAA GTC TTA GTG ATC GAT GCA G 282bp
5‘cl F AGA GGT CCC AGO GIG AGT GT
5*c2 R AGA CCA GAA GGA GCT GAG GG 238bp
2a 1 F GTT AAT AAC CAC CIT TCA CCC TT
2a2 R GCA GGT ATG AAG GIG GGG TC 252bp
2b 1 F AAG CCA ATG COG GGA AGC CC
2b2 R ATC AGC CIG CCC TGG GCC A 381bp
2c 1 F GAT GCG CAC AAG TCC TGT C
2c2 R GCC AGC GAG AGG TIT GCCT 344bp
3a 1 F TCC CTC CCT GTC TCC TGT CT
3a2 R TCA GGA GAG TGT GGC TCC CA 335bp
4a 1 F TGG AGC CTT CCT AAC TGT GC
4a2 R AGA CAC AGG CTC ACA CAT AC 275bp
5a 1 F GTC ACC CAT GOG CCC TCA GA
5a2 R GTG TIC TGG GGC CCT GGC CT 260bp
Primer sequences are shown in the 5’-- 3* orientation
F: Forward primer 
R: Reverse primer
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PCR reactions were performed by adding lpg of DNA to a 50pl reaction 
mix containing 50mM KC1, lOmM Tris HC1 (Fh 8.4), 1.5mM MgCl, lOOyg/ml 
gelatin and 200pM of each dNTP (dTIP, dCTP, dGTP, dATP) and 0.5pM of 
each primer. To this 2.5 units of Taq DNA polymerase was added the 
reaction mixture overlaid with 5Qpl of mineral oil. Prior to the 
addition of DNA and enzyme the reaction components were uv irradiated 
for 5 minutes, and the DNA denatured by heating to 95*C for 5 minutes. 
The PCR conditions used were, denaturation for 1 minute at 94*C, 
annealing at 62*C for 1 minute and extension for 2 minutes at 72*C for 
primer sets 5cl/5c2, 2al/2al, 2bl/2b2, 2cl/2c2, 4al/4a2, and 5al/5a2. 
For primer sets 5al/5a2, 5bl/5b2, and 3al/3a2 the annealing tempera­
ture was alter to 56*C. Once PCR was complete, samples were resolved 
on 1.4% agarose gels as described previously.
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2.2.8 Chain termination sequencing
All sequencing reactions were carried out using Sequenase Version 2.0 
(United States Biochemical Corporation). Sequencing reactions were 
carried out in sterile 0.5ml eppendorf tubes with sterile pipette 
tips.
2.2.8.1 Single strand sequencing-Annealing template and primer
To an eppendorf tube lpg of ssDNA was added together with lpmol of 
the limiting primer and 2pl of reaction buffer. The final volume was 
made up to lOpls using SOW. The tube containing the sample was heated 
to 65*C for a minimum of 2 minutes and then allowed to cool slowly to 
room temperature (<35’C) over a period of approximately 30 minutes. 
Once the temperature was below 35*C annealing reaction was complete 
and the tubes were snap chilled on ice.
2.2.8.2 Labelling reaction
Labelling mix was diluted five fold and the sequenase version 2.0 
enzyme diluted 8 fold with enzyme dilution buffer. To the annealed
temp late—primer the following reagents were added; l.Opls of 0.1 M
iS
DDT.. l.Opls of diluted labelling mix., 0.5pl of S dATP and 2.0pls of 
diluted sequenase enzyme. The contents of the tube were mixed thor­
oughly and incubated at RT for 2-3 minutes.
2.2.8.3 Termination reaction
Four eppendorf tubes were prewarmed to 37*C and labelled G,A.,T and C, 
2.5pl of ddGTP termination mix was added to tube G, 2.5pl of ddATP 
termination mix was added to tube A etc. Once the labelling incubation 
was complete 3.5pl was transferred to each tube and the incubation
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reaction continued for a further 5 minutes at 37 *C. Reactions were 
terminated by the addition of 4pl of stop solution. Prior to loading 
of the samples, tubes were heated to 75*C for 2 minutes and placed on 
ice and loaded immediately.
2.2.8.4 Sequencing gel electrophoresis
8% polyacrylamide gels were used and prepared as follows: An original 
stock solution of 60mls was prepared with SDW containing 12mls of 40% 
bis acrylamide, 6mls of 10 x TBE and 25g of urea. The solution was 
thoroughly mixed to dissolve the urea. A Sequi-Gen nucleic acid se­
quencing cell (Biorad) was used for electrophoresis of sequencing 
reactions. The glass plates were thoroughly cleaned with soapy water 
and rinsed in distilled water. The glass plates were then dried and 
cleaned with ethanol. The bound glass plate was siliconised in a fume 
hood and allowed to dry. Once dry spacers were placed between the two 
glass plates and held together by side clamps. The bottom of the 
sequencing cell was sealed by pouring 10ml of the gel solution con­
taining 50p1 of 25% ammonium persulphate and 50pl of TEMED onto a 
paper strip and the sequencing cell placed on top and held in place 
until the gel solution had polymerised. To the remaining gel solution, 
lOOpl of TEMED and 150pl of fresh ammonium persulphate were added and 
the gel poured immediately taking care to prevent bubbles from form­
ing. Once poured the gel comb was positioned and the gel allowed to 
polymerise. Once the gel had polymerised, the comb was removed and the 
wells washed with lxTBE. Gels were pre-run at 2000V for approximately 
1-2 hours to stabilise the temperature of the gel (55*C). Prior to 
loading of samples, the samples were heated to 70*C for 5 minutes and
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placed on ice. 1.5pl of the sample was immediately loaded onto the 
gel. Polyacyl amide sequencing gels were electrophoresed in 1 x TBE at 
of 50*C for 2-4 hours depending on the size of the DNA fragment to be 
sequenced. On completion of electrophoresis, the gel plates were 
gently prised apart and the gel stuck to the outer plate were treated 
in methanol/acetic acid (3:1) for 15 minutes, then gently blotted and 
placed on a sheet of 3MM paper. A layer of Saranwrap was placed over 
the gel and the gel dryed for 45 minutes at 80’C.
2.2.8.5 Autoradiography
Dryed gels were placed in light tight autoradiography cassettes and 
exposed to Kodak Diagnostic AR imaging film. Cassettes were stored at 
-70*C overnight. Films were developed in a Agfa Curix 60X-0mat, if the 
signal was not very strong the gels were exposed for longer.
2.2.9 ljydrolink Gel Electrophoresis
Hydrolink Gel Electrophoresis was carried out using a variation of the 
method described by Keen (1991).
2.2.9.1 Generat ion of Heteroduplexes
PCR was performed as described in Section 2.2.6.4 and 2.2.7. After the 
final extension PCR cycles, the PCR products were heated to 90*C for 5 
minutes and incubated at 70*C for a minimum of 1 hour for the genera­
tion of heteroduplexes.
2.2.9.2 Hydolink Gel Electrophoresis
Gels were prepared as follows; 40mls of Hydrolink (AT Biochem), 5mls 
lOxTBE, 750pls of fresh 10% ammonium persulphate, 70pls of TEMED. The 
gel solution was poured in between freshly cleaned glass plates (20cm
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x 20cm) separated by a 2mm spacer. A 50ml syringe was used to pour 
the gel solution into the mould. Once the gel was poured a gel comb 
was positioned in the gel, and clamped securely in place. Gels were 
allowed to set for a minimum of 30 minutes, and then place on a 
vertical gel apparatus. The comb was then removed, and the wells 
washed thourougly with 1 X TBE buffer. 4pls of loading mix was added 
to 16pl of the PCR product and added to the wells. Gels were electro- 
phoresed in 1 X TBE buffer at approximatley 200v for 3-4 hours. Gels 
were stained in ethidium bromide for 10 minutes and destained in SDW 
for several hours and visualised on a uv transilluminator, and photo­
graphed .
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2.3 Statistical methods
2.3.1 Chi-square analysis
Genotype frequencies were determined from the collected genotype data 
and the allele frequencies calculated. Chi-square analysis was per­
formed on the observed genotype data to test the significance of the 
recorded data, using the following equation;
2
chi-square (X)= (observed no. - expected no)
expected no.
In some instance Yates Correction Thereom was applied when the expect­
ed counts were less than one, using the following equation;
2
Chi-square (X)= (observed no. - expected number - 0.5)
expected no.
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CHAPTER 3: RESULTS
Chapter 3 RESULTS
3.1 HFLP analysis in offspring with contrasting predispositions 
to the development of high blood pressure.
Six polymorphisms of six candidate genes were analysed in four groups 
of offspring with contrasting predispositions to high blood pressure; 
Group A (high offspring/low parental blood pressure), Group B (high 
offspring/high parental blood pressure), Group C (low offspring/low 
parental blood pressure) and Group D (low offspring/high parental 
blood pressure. The observed genotypes for all offspring studied are 
presented in Appendix III.
Genotype and allele frequencies for each HFLP were calculated and 
analysis of the data was carried out by chi-square analysis using 
Yates correction theorem where indicated.
3.1.1 Renin Gene Polymorphism
Using a 0.8kb cDNA probe of the renin gene 192 offspring of the Lady- 
well study were genotyped for the Hind III HFLP of the renin gene 
(Frossard et al., 1987). Homozygote individuals for the polymorphism 
have either a 9.0kb or a 6.2kb band, and heterozygotes have both the 
9.0kb and 6.2kb bands, identified by Southern blotting.
The genotype and deduced allele frequencies for the whole population 
and the four individual groups are presented in Table 8. The genotypes 
have been abbreviated AA, Aa and aa, where the 9.0kb allele of the 
Hindlll polymorphism has been designated (A) and the 6.2kb allele 
(a). The Hindlll polymorphism allele frequencies for the whole popula­
tion were 0.67 for the 9.0kb allele (A), and 0.33 for the 6.2kb allele 
(a), similar to those reported previously (Frossard et al., 1987). The
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overall genotype frequencies were compared with those predicted from 
the Hardy-Weinberg equilibrium by chi-square analysis. No statistical­
ly significant difference was noted such that the genotype frequen­
cies satisfied the Bardy-Veinberg proportions (X^=4.38 p=0.1-0.2).
A comparison of the genotype distribution was carried out between the 
four different groups in the ladywell study, and no statistically 
significant difference between the genotype distribution of the four 
groups of offspring was found (X^=12.34 p=0.01-0.05).
The two groups of offspring with maximum genetic predisposition to 
high blood pressure ie. Groups B (high/high) and C (low/low), were 
then tested for a difference in genotype distribution as presented in 
Table 9. However, a statistically significance difference was not 
found (X^  =5.77 p=0.01-0.05).
A comparison of the genotype distribution was also performed between 
offspring with low blood pressure and offspring with high blood pres­
sure irrespective of parental blood pressures ie. (Group A and B) 
versus (Group C and D). Again no significant difference was found 
Otj =0.89 p=0.5-0.8).
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Table 8:Genotype and allele frequencies for the A (9.0kb) and a 
(6.2kb) alleles of the Hindlll/renin gene RFLP in the four groups of 
offspring;
Group A (high offspring BP/low parental BP)
Group B (high offspring BP/high parental BP)
Group C (low offspring BP/low parental BP)
Group D (low offspring BP/high parental BP)
Frequencies
Group Genotype Al 1 e 1 es
n AA Aa aa A a
A 49 21 23 5 0.66 0.34
B 45 14 30 1 0.65 0.35
C 48 20 22 6 0.65 0.35
D 50 23 27 0 0.73 0.27
Total 192 78 102 12 0.67 0.33
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Table 9:Comparison of the Hindlll/renin gene RFLP distribution between 
the two groups of offspripg with polarised predisposition to high 
blood pressure: Group B (high offspring/high parental BP) and Group C 
(low offspring/low parental BP).
Genotype Number of offspring
Group B Group C
Observed
9.0 14 20
9.0/6.2 30 22
6.2 1 6
Expected
9.0 16.45 17.55
9.0/6.2 25.16 26.84
6.2 3.39 3.61
x2, 5.77
0.01-0.05CNS)
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3.1.2 Beta-2-adrenergic receptor gene polymorphism 
Using a 2.6kb genomic DNA probe of the beta-2-adrenergic receptor gene 
182 offspring were genotyped for the BanI RFLP of this gene (Lentes et 
al., 1988). Homozygote individuals for the BanI polymorphism have 
either a 3.7kb allele or a 3.4kb allele, and heterozygotes have both 
the 3.7kb and 3.4kb bands, detected by Southern blotting*
Genotypes and deduced allele frequencies for the whole population and 
for the four individual groups are presented in Table 10. The geno­
types have been abbreviated to BB, Bb and bb, where the 3.7kb allele 
of the BanI polymorphism has been designated (B), and the 3.4kb 
allele (b). The allele frequencies for the whole offspring population 
were 0.25 for the the 3.7 kb allele (B) and 0.75 for the 3.4kb allele 
(b). These allele frequencies are similar to those reported previously 
(Lentes et al., 1988). The overall genotype frequencies were compared 
with those predicted from the Hardy-Weinberg equilibrium by chi-square 
analysis. No significant difference between observed and expected 
numbers was seen, such that the genotype frequencies satisfied the 
Hardy-Weinberg proportions (X^  =0.05 p=0.98).
A comparison of the BanI RFLP genotypes was performed between the four 
groups of offspring of the Ladywell Study and no significant differ­
ence was found (X^=8.76 p=0.20-0.50).
The two groups of offspring with contrasting predispositions to high 
blood pressure ie Groups B (high/high) and C (low/low), were then 
tested for a difference in genotype distribution (Table 11). Chi- 
square analysis revealed no statistically significant difference 
between the two groups (X^=4.43 p=0.10-0.20).
A comparison of the genotype distribution between offspring with high 
blood pressure and offsprirjg with low blood pressure, irrespective of 
parental blood pressure levels was also performed ie. Group (A and 8) 
versus Group (C and D). Again, no statistically significant difference 
was detected (X^=1.84 p=0.20-0.50).
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Table 10:Genotype and allele frequencies for the B (3.7kb) and b 
(3.4kb) alleles of the Binl/beta-2-adrenergic receptor gene RFLP in 
the four groups of offspring;
Group A (high offspring BP/low parental BP)
Group B (high offspring BP/high parental BP)
Group C (low offspring BP/low parental BP)
Group D (low offspring BP/high parental BP)
Frequencies
Group Genotypes Al 1 e 1 es
n BB Bb bb B b
A 45 51 13 27 0.26 0.74
B 43 3 17 23 0.27 0.73
C 47 0 15 32 0.16 0.84
D 47 4 21 22 0.31 0.69
Total 182 12 66 104 0.25 0.75
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Table 11:Comparison of the ifanI/beta-2-adrenergic receptor gene RFLP 
distribution between groups with polarised predisposition to high 
blood pressure; Group B (high offspring/high parental BP), Group C 
(Low of spring/low parental HP).
Genotype Number of offspring 
Group B Group C
Observed
3.7 3 0
3.7/3.4 17 15
3.4 23 32
Expected
3.7 1.43 1.57
3.7/3.4 15.29 16.71
3.4 26.28 28.72
x22 4.429
P 0.10-0.20(NS)
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3.1.3 Beta-l-adrenergic receptor gene polymorphism 
Using a 2.4kb genomic DNA probe of the beta-1-adrenergic receptor gene 
173 offspring of the Ladywell study were genotyped for the Bgll RFLP 
of this gene (Frielle et al., 1987). Homozygote individuals for the 
EglI polymorphism have either a 6.2kb band or a 4.7kb band, and heter­
ozygotes have both the 6.2kb and the 4.7kb band, detected by Southern 
blotting*
Genotype and deduced allele frequencies for the whole population and 
the four individual groups are presented in Table 12. The genotypes 
have been abbreviated to CC, Cc and cc, where the 6.2kb allele of the 
EgII polymorphism has been designated (C) and the 4.7kb allele (c). 
The EglI polymorphism allele frequencies were found to be 0.78 for the 
6.2kb allele (D) and 0.22 for the 4.7kb allele (d), similar to those 
reported previously (Frielle et al., 1987). Overall genotype frequen­
cies were compared with those predicted from the Hardy-Weinberg equi­
librium by chi-square analysis. No statistically significant differ­
ence between the observed and expected numbers was seen, such that the 
genotype frequencies satisify the Hardy-Weinberg proportions (X^  =0.98 
p=0.50-0.80).
A comparison of the EglI polymorphism was carried between the four 
groups of the Ladywell Study, however no statistically significant 
difference in the genotype distribution was observed (X^=7.02 p=0.20-
0.50).
Chi-square analysis was also performed between the two groups of 
offspring with maximum genetic predisposition ie. Groups B (high/high) 
and C (low/low) (Table 13). A significant difference between the two
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groups was not detected (X^  =0.22 p=0.80-0.90).
A comparison of the genotype distribution between offspring with high 
blood pressure and offspring with low blood pressure irrespective of 
parental blood pressures was also performed ie. Group CA and B) versus 
Group (C and D). Again no statistically significant difference was 
found (X2=0.29 p=0.80-0.90).
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Table 12:Genotype and allele frequencies for the C (6.2kb) are! c
(4.7kb) alleles of the ffefJ I/beta-1-adrenergic receptor gene RFLP in
the four groups of offspring;
Group A (high offspring BP/low parental BP)
Group B (high offspring BP/high parental BP)
Group C (low offspring BP/low parental BP)
Group D (low offspring BP/high parental BP)
Frequencies
Groups Genotype Alleles
n CC Cc cc C c
A 41 28 13 0 0.84 0.16
B 42 26 11 5 0.75 0.25
C 45 29 12 4 0.78 0.22
D 45 26 17 2 0.77 0.23
Total 173 109 53 11 0.78 0.22
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Table 13:Comparison of the BglJ/beta— 1 -adrenergic receptor gene RFLP 
distribution between groups of offspripg with polarised predisposi­
tion to high blood pressure; Group B (high offspring/high parent BP), 
Group C (low offspripg/low parent BP)
Genotype Number of offspring 
Group B Group C
Observed
6.2 26 29
6.2/4.7 11 12
4.7 5 4
Expected
6.2 26.55 28.45
6.2/4.7 11.10 11.90
4.7 4.34 4.66
A 0.215
p 0.80-0.90 (NS)
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3.1.4 Alpha-2-adrenergic receptor gene polymorphism 
Using a 5.5kb genomic DNA probe of the a 1 pha-2-adrenergic receptor 
gene 151 offspring of the Ladywell Study were genotyped for the Dra.1 
RFLP of this gene (Hoehe et al., 1988). Homozygote individuals for the 
Dra.1 polymorphism have either a 6.7kb band or a 6.3kb band, and heter­
ozygotes have both a 6.7kb and 6.3kb band, detected by Southern blot­
ting.
The genotypes and deduced allele frequencies for the whole population 
and the four individual groups are presented in Table 14. The geno­
types have been abbreviated to DD, Dd and dd, where the 6.7kb allele 
has been designated (D) and the 6.3kb allele (d). The allele frequen­
cies were found to be 0.86 for the 6.7kb allele (D), and 0.14 for 
the 6.3kb allele (d), similar to those reported previously (Hoehe et 
al., 1988). The overall genotype frequencies were compared with those 
predicted from the Hardy-Weinberg equilibrium by chi-square analysis. 
No statistically significant difference between the observed and 
expected numbers was seen, such that the genotype frequencies satisi- 
fied the Hardy-Weinberg proportions (X^  =0.34 p=0.80-0.90).
A comparison of the Dral polymorphism was carried between the four 
groups of the Ladywell Study. No statistically significant difference 
in the genotype distribution was observed between the four groups 
=7.51 p=0.20-0.50 using Yates correction theorem).
Chi-square analysis was also performed between the two groups of 
offspring with maximum genetic predisposition ie. Groups B 
(high/high) and C (low/low) (Table 15). A statistically significant 
difference between the genotype distribution of the two groups was not
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detected (X^  =4.36 p=0.10-0.20).
A comparison of the genotype distribution between offspring with high 
blood pressure and offspring with low blood pressure, irrespective of 
parental blood pressures was also performed ie. Group (A and B) versus 
Group (C and D). Again no statistically significant difference was 
found (X^=3.33 p=0.10-0.20 using Yates correction theorem).
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Table 14:Genotype and allele frequencies of the D (6.7kb) and d 
(6.3kb) alleles of the Dral/b. 1pha-2-adrenergic receptor gene RFLP in 
the four groups of offspring;
Group A (high offspring BP/low parental BP)
Group B (high offspring BP/high parental BP)
Group C (low offspring BP/low parental BP)
Group D (low offspring BP/high parental BP)
Frequencies
Groups Genotype A1leles
n DD Dd dd D d
A 38 30 7 1 0.88 0.12
B 39 31 8 0 0.90 0.10
C 40 25 14 1 0.80 0.20
D 34 24 10 0 0.85 0.25
Total 151 110 39 2 0.86 0.14
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Table 15.'Comparison of Dral/alpha-2-adrenergic receptor gene HFLP 
distribution between the two groups with polarised predisposition to 
high blood pressure: Group B (high of spring/high parental BP), Group C 
(low offspring/low parental BP)
Genotype Number of offspring 
Group B Group C
Observed
6.7 31 25
6.7/6.3 8 14
6.3 0 1
Expected
6.7 27.65 28.35
6.7/6.3 10.86 11.14
6.3 0.49 0.51
A 4.36 *
P 0.10-0.20 (NS)
* Yates Correction theorem applied since chi-square approximation 
probably invalid since 2 cells with expected counts less than 1.00
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3.1.5 Insulin gene polymorphism
Using a 0.88kb DNA probe of the insulin gene 174 offspring of the 
Ladywel 1 study were genotyped for the S a d  RFLP of the insulin gene 
(Bell et al., 1982). Homozygote individuals for the S a d  polymorphism 
have either a 7.5kb band or a 6.0kb band and heterozygotes have both 
the 7.5kb and 6.0 kb band, detected by Southern Blotting*
Genotypes and deduced allele frequencies for the whole population and 
the four individual groups are presented in Table 16. The genotypes 
have been abbreviated to E, Ee and ee, where the 7.5kb allele of the 
S a d  polymorphism has been designated (E) and the 6.0kb allele (e). 
The S a d  polymorphism allele frequencies for the whole population were 
0.37 for the 7.5kb allele and 0.63 for the 6.0kb allele, similar to 
those reported previously (Bell et al., 1982). The overall genotype 
frequencies were compared with those predicted from the Hardy-Weinberg 
equilibrium by chi-square analysis. No statistically significant 
difference between observed and expected numbers was seen, such that 
the genotype frequencies satisfied the Hardy-Weinberg proportions (X^  
=1.523 p=0.20-0.50).
A comparison of the S a d  polymorphism distribution was carried out for 
all four groups and a significant difference was not detected
(X2=4.95 p=0.50-0.80).
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A comparison of the genotype distribution was also carried out between 
the two groups of offspring with maximum predisposition to the devel­
opment of high blood pressure ie. Groups B (high/high) and C (low/low) 
(Table 17). However, no significant difference was detected (X2 =1.76 
p=0.20-0.50).
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A comparison of the genotype distribution between offspring with high 
blood pressure and low blood pressure, irrespective of parental blood 
pressures was also performed ie. group (A and B) versus group (C and 
D). Again, no statistically significant difference was found =0.066 
p>0.95).
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Table 16:Genotype and allele frequencies of the E (7.5kb) and e 
(6.0kb) alleles of the Sacl/insulin gene HFLP in the four groups of 
offspring;
Group A (high offspring BP/low parental BP)
Group B (high offspring BP/high parental BP)
Group C (low offspring BP/low parental BP)
Group D (low offspring BP/high parental BP)
Group
n EE
Frequencies 
Genotype Allel
Ee ee E
es
e
A 45 6 18 21 0.33 0.67
B 35 7 15 13 0.41 0.59
C 50 10 15 25 0.35 0.65
D 44 6 22 16 0.39 0.61
Total 174 29 70 75 0.37 0.63
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Table 17.-Comparison of the SelcI/insulin gene HFLP genotype 
tion between the two groups with polarised predisposition 
blood pressure; Group B (high offspring/high parental BP) 
(low offspring/low parental BP).
Genotype Number of offspring 
Group B Group C
Observed
7.0 7 10
7.0/6.5 15 15
6.5 13 25
Expected
7.0 7.0 10.0
7.0/6.5 12.35 17.65
6.5 15.65 22.35
1.762
p 0.20-0.50 (NS)
distribu­
te high 
Group C
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3.1.6 Glucocorticoid receptor gene polymorphism 
Using a 4.4kb genomic ENA probe of the glucocorticoid receptor gene 
117 offspring of the Ladywell study were genotyped for the Tthlll RFLP 
of this gene CDetera-Wadleigh et al., 1991). Homozygote individuals 
for the Tthlll polymorphism have either a 3.8kb or a 3.4kb band, and 
heterozygotes have both the 3.8kb and 3.4kb bands, detected by South­
ern blotting.
The genotype and deduced allele frequencies for the whole population 
and the four individual groups are presented in Table 18. The geno­
types have been abbreviated to FF, Ff and ff, where 3.8kb allele of 
the Tthlll polymorphism has deen designated (F) and the 3.4 kb (f). 
The Tthlll polymorphism allele frequencies were 0.21 for the 3.8kb 
allele (G), and 0.79 for the 3.4kb allele (g), in close agreement with 
those reported previously (Detera-Wadleigh et al., 1991). The overall 
genotype frequencies were compared with those predicted from from the 
Hardy-Weinberg equilibrium by chi-square analysis. A statistically 
significant difference between the observed and expected numbers was 
not seen, such that the genotype frequencies satisfied the Hardy- 
We inberg proportions (X^=3.71 p=0.02-0.05).
A comparison of the polymorphism was carried out between the four 
groups of offspring of the Ladywell study. No statistically signifi­
cant difference in the genotype distribution was observed between the 
four groups (X*=4.68 p=0.50-0.80).
Chi-square analysis was also performed between the two groups of 
offspring with maximum genetic prediposition ie. Group B (high/high) 
and Group C (low/low) (Table 19), however no significant difference
was found (X2=2.18 p=0.20-0.50).
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A comparison of the genotype distribution was also performed between 
offspring with high blood pressure and offspring with low blood pres­
sure, irrespective of parental blood pressures ie. Group (A and B) 
versus Group (C and D). Again, no statistically significant difference 
was found (X^=0.40 p=0.50-0.80).
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Table 18.’Genotype and allele frequencies of the F (3.8kb) and f 
(3.4kb) alleles of the Tthlll/g 1 ucocorticoid receptor gene RFLP in the 
four groups of offspring;
Group A (high offspring BP/low parental BP)
Group B (high offspring BP/high parental BP)
Group C (low offspring BP/low parental BP)
Group D (low offspring BP/high parental BP)
Frequencies
Group Genotype Alleles
FF Ff ff F f
A 28 2 7 19 0.20 0.80
B 30 2 7 21 0.18 0.82
c 25 4 8 13 0.32 0.68
D 34 2 6 26 0.15 0.85
Total 117 10 28 79 0.21 0.79
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Table 19:Comparison of the Tthlll/g\ucocorticoid receptor gene RFLP 
genotype distribution between the two groups with polarised predispo­
sitions to high blood pressure; Group B (high offspring/high parental 
BP), Group C (low ofspring/low parental BP)
Genotype Number of offspring 
Group B Group C
Observed
3.8 2 4
3.8/3.4 7 8
3.4 21 13
Expected
3.8 3.27 2.73
3.8/3.4 8.18 6.82
3.4 18.55 15.45
A 2.179
p 0.20-0.50 (NS)
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3.2 RFLP analysis in parents with high blood pressure and low
blood pressure.
The genotype data of the HFLPs examined in the parent popluation is 
presented in Appendix III.
3.2.1 Renin Gene polymorphism
91 parents of the high/high and low/low groups of offspring were 
genotyped for the renin Hindlll polymorphism. 44 parents were classi­
fied as having high blood pressure and 47 parents as having low blood 
pressure. Genotype and allele frequencies of the two groups are pre­
sented in Table 20. The allele frequencies from all subjects examined 
are 0.67 for the 9.0kb allele (A) and 0.33 for the 6.2kb allele (a). 
These frequencies are similar to those reported previously (Frossard 
et al., 1987). Chi-square analysis was performed to determine if a 
difference between the genotype distribution in the two parental 
groups exists, however no statistically significant difference was
observed (X2 =0.53 p=0.50-0.80) (Table 21).
2
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Table 20:Genotype and allele freqencies for the A (d.Okb) and a
(6.2kb) alleles of the Hindlll/renin gene RFLP in parents with high
(HBP) and low (LBP) blood pressure.
Frequencies
Group Genotype Alleles
n AA Aa aa A a
HBP 44 22 18 4 0.70 0.30
LBP 47 27 16 4 0.74 0.26
Total 91 49 24 8 0.67 0.33
Table 21 .’Comparison of the Hindlll/renin gene RFLP distribution in 
parental groups with high blood pressure (HBP) and low blood pressure 
(LBP).
Genotype Number of subjects
HBP LBP
Observed
9.0 22 27
9.0/6.2 18 16
6.2 4 4
Expected
9.0 23.69 25.31
9.0/6.2 16.44 17.56
6.2 3.87 4.13
x2
2 0.53
P 0.50-0.80 (NS)
3.2.2 Beta-2-Adrenergic receptor Gene polymorphism 
97 parents of the high/high and low/low groups of offspring were 
genotyped for the beta-2-adrenergic receptor/flanl polymorphism. 49 
parents were classified as having high blood pressure and 48 parents 
as having low blood pressure. Genotype and allele frequencies of the 
two parental groups are presented in Table 22. The allele frequencies 
from all subjects examined are 0.22 for the 3.7kb allele (B) and 0.78 
for the 3.4kb allele (b), similar to those reported previously (Lentes 
et al., 1988). Chi-square analysis was performed to determine if a 
difference between the genotype distribution in the two parental 
groups exists (Table 23). No statistically significant difference was 
observed (X2=2.88 p=0.20-0.50).
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Table 22:Genotype and allele frequencies for the B (3.7kb) and b
(3.4kb) alleles of the BEUiZVbeta-2-adrenergic receptor gene RFLP in
parents with high (HBP) and low blood pressure (LBP).
Frequencies
Group Genotype Allele
n BB Bb bb B b
HBP 49 2 18 29 0.22 0.78
LBP 48 0 21 27 0.22 0.78
Total 97 2 39 56 0.22 0.78
Table 23:Comparison of the BanJ/beta-2-adrenergic receptor gene RFLP 
distribution in parental groups with high blood pressure (HBP) and low 
blood pressure (LBP).
Genotype Number of subjects
HBP LBP
Observed
3.7 2 0
3.7/3.4 18 21
3.4 29 27
Expected
3.7 1.10 0.99
3.7/3.4 19.70 19.30
3.4 28.29 27.17
x2 2.88 ♦
p 0.20-0.50 (NS)
♦Yates Correction theorem applied since chi-square approximation 
probably invalid since one cell with expected counts less than 1.00
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3.2.3 Beta-1 -Adrenergic receptor gene polymorphism
93 parents of the high/high and low/low groups of offspring were 
genotyped for the beta-1-adrenergic receptor/£Jg7I polymorphism. 44 
parents were classified as having high blood pressure and 47 parents 
as having low blood pressure. Genotype and allele frequencies of the 
two groups are presented in Table 24. The allele frequencies from all 
subjects examined are 0.81 for the 6.2kb allele (C) and 0.19 for the 
4.7kb allele (c), similar to those reported previously (Frielle et 
al., 1987). Chi-square analysis was performed to detect a difference
between the genotype distribution of the two groups (Table 25). No
2
statistically significant difference was detected (X2 =0.46 p=0.50- 
0.80).
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Table 24:Genotype and allele frequencies for the C (6.2kb) and c
(4.7kb) alleles of the BglI/beta-1-adrenergic receptor gene RFLP in
parents with high (HBP) and low blood pressure (LBP).
Frequencies
Group Genotypes Alleles
n CC Cc cc C c
HBP 47 30 16 1 0.81 0.19
LBP 46 30 14 2 0.80 0.20
Total 93 60 30 3 0.81 0.19
Table 25:Comparison of the BglJ/beta-1-adrenergic receptor gene RFLP 
distribution in parental groups with high blood pressure (HBP) and low 
blood pressure (LBP).
Genotype Number of subjects 
HBP LBP
Observed
6.2 30 30
6.2/4.7 16 14
4.7 1 2
Expected
6.2 30.32 29.68
6.2/4.7 15.16 14.84
4.7 1.52 1.48
A 0.456
p 0.50-0.80 (NS)
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3.2.4 A1 pha-2-Adrenergic receptor Gene polymorphism
90 parents of the high/high and low/low groups of offspring were 
genotyped for the a 1 pha-2-adrenergic receptor/Dral polymorphism. 45 
parents were classified as having high blood pressure and 45 parents 
as having low blood pressure. Genotype and allele frequencies of the 
two groups are presented in Table 26. The overall genotype frequencies 
from all subjects examined are 0.81 for the 6.7kb allele CD) and 0.19 
for the 6.3kb allele (d), similar to those reported previously (Hoehe 
et al., 1988). Chi-square analysis was performed to detect a differ­
ence between the genotype distribution of the two groups (Table 27). 
However, no statistically significant difference was observed (X^=0.22 
p=0.90).
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Table 26:Genotype and allele frequencies for the D (6.7kb) and d
(6.3kb) alleles for the 23naJ/alpha-2—adrenergic receptor gene RFLP in
parents with high (HBP) and low blood pressure (LBP).
Frequencies
Group Genotypes Alleles
n DD Dd dd D d
HBP 45 31 12 2 0.82 0.18
LBP 45 30 12 3 0.80 0.20
Total 90 61 24 5 0.81 0.19
Table 27:Comparison of the Z)naI/alpha-2-adrenergic receptor gene RFLP 
distribution in parental groups with high blood pressure (HBP) and low 
blood pressure (LBP).
Genotype Nimber of subjects 
HBP LBP
Observed
7.6 31 30
7.6/7.4 12 12
7.4 2 3
Expected
7.6 30.50 30.50
7.6/7.4 12.00 12.00
7.4 2.50 2.50
x22 0.216
,
P 0.90 (NS)
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3.2.5 Insulin Gene polymorphism
54 parents of the high/high and low/low groups of offspring were 
geno typed for the insul in/Sac I polymorphism. 28 parents were classi­
fied as having high blood pressure and 26 parents as having low blood 
pressure. The genotype and allele frequencies of the two groups are 
presented in Table 28. The allele frequencies of all subjects examined 
are 0.36 for the 7.5kb allele and 0.64 for the 6.0kb allele., similar 
to those reported previously (Bell et al., 1982). Chi-square analysis 
was performed to determine if a difference between the genotype dis­
tribution in the two parental groups exists (Table 29). However, no
2
statistically significant difference was observed (X2 =2.94 p=0.20- 
0.50).
93
Table 28:Genotype and allele frequencies for the E (7.0kb) and e
(6.5kb) alleles for the jSacJ/insulin gene EFLP in parents with high
(HBP) and low blood pressure (LBP).
Frequencies
Group Genotypes Alleles
n EE Ee ee E e
HBP 28 5 10 13 0.36 0.64
LBP 26 2 15 9 0.37 0.63
Total 54 7 25 22 0.36 0.64
Table 29:Comparison of the <SacJ/insulin gene RFLP distribution in 
parental groups with high blood pressure (HBP) and low blood pressure 
(LHP).
Genotype Number of subjects
HBP LBP
Observed
7.0 5 2
7.0/6.5 10 15
6.5 13 9
Expected
7.0 3.63 3.37
7.0/6.5 12.96 12.04
6.5 11.41 10.59
x22 2.943
P 0.20-0.50 (NS)
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3.2.6 Glucocorticoid receptor gene polymorphism
3.2.6.1 Tthlll RFLP
55 parents of the high/high and low/low group of offspring were 
genotyped for the Tth Ill/glucocorticoid receptor gene polymorphism 
(Detera Wadleigh et al ., 1991). 27 parents were classified as having 
high blood pressure and 28 els having low blood pressure. Genotype and 
allele frequencies of the two parental groups are presented in Table 
30. The allele frequencies of all subjects examined are 0.21 for the 
3.8kb allele (F), and 0.79 for the 3.4kb allele (f). These allele 
frequencies are similar to those previously reported (Detera-Wadleigh 
et al., 1991). Chi-square analysis was performed to determine if a 
difference between the genotype distribution in the two parental
groups exists (Table 31). However, no statistically significant dif-
2
ference was observed (X2=0.58 p=0.98).
3.2.6.2 B ell HFLP
Using a 4.4kb cDNA probe 76 parents were genotyped for the Bell poly­
morphism of the glucocorticoid receptor (Murray et al., 1987). 42
parents were classified as having high blood pressure and 34 parents 
as having low blood pressure. Homozygotes for the Bell polymorphism 
have either a 5.3kb band or a 4.2kb band, and heterozygotes have the 
5.3kb and 4.2kb band. Genotype and allele frequencies of the two 
groups are presented in Table 32. The genotypes have been abreviated 
to GG, Gg and gg, where the 5.3kb allele has been designated (G) and 
the 4.3kb allele (g). The allele frequencies of all subjects examined 
are 0.40 for the 4.5kb allele (G) and 0.60 for the 2.3kb allele (g), 
similar to those reported previously (Murray et al., 1987). Chi-square
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analysis was performed to determine if a difference between the geno­
type distribution in the two parental groups exists (Table 34). No
2
statistically significant difference was observed (X2 =0.56
P=0.50=0.80).
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Table 30: Genotype and allele frequencies for the G (3.8kb) and g
(3.4kb) alleles for the Tthlll/glucocorticoid receptor gene RFLP in
parents with high (HBP) and low blood pressure (LBP).
Frequencies
Group Genotypes Alleles
n FF Ff ff F f
HBP 27 1 9 17 0.20 0.80
LBP 28 1 10 17 0.21 0.79
Total 55 2 19 34 0.21 0.79
Table 31: Comparison of the Tthlll/g 1 ucocorticoid receptor gene RFLP 
distribution in parental groups with high blood pressure (HBP) and low 
blood pressure (LBP).
Genotype Number of subjects
HBP LBP
Observed
3.8 1 1
3 .8 /3 .4 9 10
3.4 17 17
Expected
3.8 0.98 1.02
3 .8 /3 .4 9.33 9.67
3.4 16.69 17.31
x 22 0.58 *
P 0.98-0.99
* Yates Correction Theorem applied since chi-square approximation
probably invalid since 1 cell with counts less than 1.0
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Table 32: Genotype and allele frequencies for the G (5.3kb) and g
(4.2kb) alleles for the Bel I/glucocorticoid receptor gene RFLP in
parents with high (HBP) and low blood pressure (LBP).
Frequencies
Group Genotypes Alleles
n GG Gg gg G g
HBP 42 6 19 17 0.25 0.75
LBP 34 6 17 11 0.43 0.57
Total 76 12 36 28 0.40 0.60
Table 33: Comparison of the Bel I/glucocorticoid receptor gene RFLP 
distribution in parental groups with high blood pressure (HBP) and low 
blood pressure (LBP).
Genotype Number of subjects 
HBP LBP
Observed
4.5 6 6
4.5/2.3 19 17
2.3 17 11
Expected
4.5 6.63 5.37
4.5/2.3 19.89 16.11
2.3 15.47 12.53
x2
2
P
0.561
0.50-0.80 (NS)
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3.2.7 Beta-f ibrinogen Gene polymorphism
Using a 1.4kb genomic probe of the be ta-f ibri nogen gene 73 parents 
were genotyped for the Bell polymorphism of this gene (Cook et al., 
1988). 40 were classified as havipg high blood pressure and 33 parents 
as havipg low blood pressure. Homozygotes for the Boll polymorphism 
have either a 5.3kb or a 4.2kb band., and heterozygotes have both the 
5.3kb and 4.2kb bands. Genotypes and allele frequencies of the two 
parental groups are present in Table 34. The genotypes have been 
abbreviated to HH, Hh and hh, where the 5.3kb allele has been desig­
nated (H) and the 4.2kb allele (h). The allele frequencies of all 
subjects examined are 0.82 for the 5.3kb allele (H) and 0.18 for the 
4.2kb allele (h), similar to those reported previously (Cooke et al., 
1988). Chi-square analysis was performed to determine if a difference 
between the genotype distribution in the two parental groups exists 
(Table 35). However, no statistically significant difference was 
observed (X2=2.61 p=0.20-0.50).
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Table 34: Genotype and allele frequencies for the H (5.3kb) and h
(4.2kb) alleles for the Bci J/beta-fibrinogen gene HFLP in parents with
high (HBP) and low blood pressure (LBP).
Frequencies
Group Genotypes Alleles
n HH Hh hh H h
HBP 40 24 15 1 0.79 0.21
LBP 33 23 10 0 0.85 0.15
Total 73 47 25 1 0.82 0.18
Table 35: Comparison of the JBbJI/beta-f ibrinogen gene HFLP distribu­
tion in parental groups with high blood pressure (HBP) and low blood 
pressure (LHP).
Genotype Number of subjects
HBP LBP
Observed
5.3 24 23
5.3/4.2 15 10
4.2 1 0
Expected
5.3 25.75 21.25
5.3/4.2 13.70 11.30
4.2 0.55 0.45
x22 2.61 *
P 0.20-0.50 (NS)
* Yates Correction Theorem applied since chi-square approximation
probably invalid since 2 cells with expected counts less than 1.00
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3.3 Sib-Rair HFLP Analysis
The 200 offspring identified in Phase II of the the Ladywel 1 Study 
included 20 sib-pairs. Phase V of the study identified an additional 
17 sib-pairs, thus increasing the number of sib-pairs to give a total 
of 37. DNA from these offspring was isolated and genotyped for seven
HFLPs, for sib-pair analysis. Ihe sib-pairs were divided into two
groups ie. like sib-pairs, where both sibs have either high blood 
pressure or low blood pressure, and unlike sib-pairs where one sib has
high blood pressure and the other has low blood pressure. 19 of the
sib-pairs were classified as like-sibs and 18 as unlike-sibs. The 
sib-pairs were then classified as marker concordant if they share the 
same allele, marker discordant if the marker genotype share no common 
alleles, and marker half concordant if neither concordant or discon- 
cordant. The number of observed and expected sib-pairs falling into 
each of the catergories was then tested by chi-square analysis. The 
expected probabilites are a function of the allele frequencies, and 
are calculated from mating type probabilites.
3.3.1 Benin gene polymorphism
A total of 33 sib-pairs were genotyped for the Hindlll/renin gene 
HFLP. 19 of the sib-pairs were classified as like sib-pairs and 14 as 
unlike sib-pairs. The number of like and unlike sibs-pairs sharing 2 
alleles (marker concordant), 1 allele (marker half concordant) and 0 
alleles (marker disconcordant) are presented in Table 36. The allele 
frequencies for the offspring population were 0.67 for the 9.0kb 
allele (A) and 0.33 for the 6.2kb allele (a) as calculated in section 
3.1.1. These frequencies were used to calculate the expected number of
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sib-pairs falling into the three categories. The expected proportions 
of sib-pairs sharing 2, 1 and 0 alleles are 0.60, 0.35 and 0.05 re­
spectively.
The observed and expected number of sib-pairs (like and unlike) for 
the three catergories are presented in Table 37. Chi-square analysis 
was performed between the observed and expected numbers and showed a 
statistically significant lack of allele sharing in like sibs-pairs 
0^=9.48 p<0.01).
102
Table 36.’Number of marker concordant, discordant and half concordant
like and unlike sib-pairs for the alleles of the Hindlll/renin gene
HFLP.
Category
Like
Sib-Pairs
Uni ike
Discordant 0 0
Half concordant 11 3
Concordant 8 11
Total 19 14
Table 37:Comparison of the observed and expected number of like and 
unlike sib-pairs sharing 2, 1 or 0 alleles of the Hindlll/renin gene 
HFLP.
Shared Alleles
Sib-pairs
Like Uni ike
Observed
0 0 0
1 11 3
2 8 11
Expected
0 0.95 0.70
1 6.65 4.90
2 11.40 8.40
x22 9.48 *
P <0.01 (S)
* Yates correction theorem applied, since chi-square approximation
probably invalid since two cells with expected counts less than 1.00
3.3.2 Beta-2-adrenergic receptor gene HFLP
A total of 33 sib-pairs were genotyped for the BanI/beta-2-adrenergic 
receptor gene polymorphism. 18 of the sib-pairs were classified as 
like and 15 as unlike sib-pairs. The number of like and unlike sib- 
pairs sharing 2 alleles (marker concordant), 1 allele (marker half 
concordant) and 0 alleles (marker disconcordant) are presented in 
Table 38. The allele frequencies for the offspring population were 
0.25 for the 3.4kb allele (B) and 0.75 for the 3.7kb allele (b) as 
calculated in Section 3.1.2. These frequencies were used to calculate 
the expected number of sib-pairs falling into the three categories. 
The expected proportions of sib-pairs sharing 2, 1 and 0 alleles are 
0.66, 0.30 and 0.04 respectively.
The observed and expected number of sib-pairs (like and unlike) for 
the three catergories are presented in Table 39. Chi-square analysis
was performed between the observed and expected numbers, however no
2
statistically significant difference was found (X2=4.65 p=0.1-0.05).
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Table 38: Number of Barker concordant, discordant and half concordant
like and unlike sib-pairs for the alleles of the BajiI/beta-2-adrener-
gic receptor gene HFLP.
Category Sib-Fairs
Like Uni ike
Discordant 0 1
Half concordant 4 4
Concordant 14 10
Total 18 15
Table 39: Comparison of the observed and expected number of like and 
unlike sib-pairs sharing 2,1 or 0 alleles for the BanJbeta—2—adrener­
gic receptor gene HFLP.
Shared Alleles
Sib-pairs
Like Unlike
Observed
0 0 1
1 4 4
2 14 10
Expected
0 0.72 0.60
1 5.40 4.50
2 11.88 9.90
X2 4.65 *
P 0.1-0.05 (NS)
* Yates correction theorem applied since chi-square approximation
probably invalid since two cells with expected counts less than 1.00
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3.3.3 Beta-1-adrenergic receptor gene HFLP
A total of 24 sib-pairs were genotyped for the BglI/beta-1 -adrenergic 
receptor gene polymorphism. 10 of the sib-pairs were classified as 
like and 14 as unlike sib-pairs. The number of like and unlike sib- 
pairs sharipg 2 alleles (marker concordant), 1 allele (marker half 
concordant) and 0 alleles (marker disconcordant) are presented in 
Table 40. The allele frequencies for the offspring population were 
0.78 for the 6.2kb allele (C) and 0.22 for the 4.7kb allele (c) as 
calculated in Section 3.1.3. These frequencies were used to calculate 
the expected number of sib-pairs falling into the three categories. 
The expected proportions of sib-pairs sharing 2, 1 and 0 alleles are 
0.68, 0.29 and 0.03 respectively.
The observed and expected number of sib-pairs (like and unlike) for 
the three catergories are presented in Table 41. Chi-square analysis 
was performed between the observed and expected numbers, and no sta­
tistically significant difference was found of2=5.79 p=0.1-0.05).
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Table 40: Number of marker concordant, discordant and half concordant
like and unlike sib-pairs for the alleles of the BglI/beta-1-adre­
nergic receptor gene HFLP.
Category
Like
Sib Pairs
Uni ike
Discordant 0 0
Half concordant 2 6
Concordant 8 8
Total 10 14
Table 41: Comparison of the observed and expected number of like and 
unlike sib-pairs sharing 2, 1 or 0 alleles for the I/beta-1-adre­
nergic receptor gene HFLP.
Shared Alleles
Sib-pairs 
Like Uni ike
Observed
Expected
0.30
2.90
6.80
0.42
4.06
9.38
5.79 *
0.1-0.05 (NS)
* Yates correction theorem applied since chi-square approximation
probably invalid since two cells with expected counts less than 1.00
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3.3.4 A1 pha-2-adrenergic receptor gene HFLP
A total of 16 sib-pairs were genotyped for the Dral/a 1 pha-2-adrenergic 
receptor gene polymorphism. 8 of the sib-pairs were classified as like 
and 8 as unlike sib-pairs. The number of like and unlike sib-pairs 
sharing 2 alleles (marker concordant), 1 allele (marker half concord­
ant) and 0 alleles (marker disconcordant) are presented in Table 42. 
The allele frequencies for the offspring population were 0.86 for the 
6.7kb allele (D) and 0.14 for the 6.3kb allele (d) as calculated in 
Section 3.1.4. These frequencies were used to calculate the expected 
number of sib-pairs falling into the three categories. The expected 
proportions of sib-pairs sharing 2A 1 and 0 alleles are 0.86* 0.14 and 
0.01 respectively.
The observed and expected number of sib-pairs (like and unlike) for 
the three catergories are presented in Table 43. Chi-square analysis
was perfomed between the observed and expected numbers and no statis-
2
tically significant difference was found (X2=1.40 p=0.5-0.8).
108
Table 42: Number of marker concordant, discordant arxi half concordant
like and unlike sib-pairs for the alleles of the Ural/alpha-2-adre-
nergic receptor gene HFLP.
Category
Like
Sib-Ifeirs
Uni ike
Discordant 0 0
Half concordant 2 1
Concordant 6 7
Total 8 8
Table 43: Comparison of the observed and expected number of like and 
unlike sib-pairs sharing 2,1 or 0 alleles for the DraI/alpha-2-adre- 
nergic receptor gene HFLP.
Shared Alleles
Sib-pairs
like unlike
Observed
0 0 0
1 2 1
2 6 7
Expected
0 0.08 0.08
1 1.68 1.68
2 6.24 6.24
x22 1.40 *
P 0.5-0.8 (NS)
* Yates correction theorem applied since chi-square approximation
probably invalid since two cells with expected counts less than 1.00
3.3.5 Insulin gene HFLP
A total of 19 sib-pairs were genotyped for the SacJ/insulin gene 
polymorphism. 11 of the sib-pairs were classified as like and 8 as 
unlike sib-pairs. The number of like and unlike sibs pairs sharing 2 
alleles (marker concordant), 1 allele (marker half concordant) and 0 
alleles (marker disconcordant) are presented in Table 44. The allele 
frequencies for the offspring population were 0.37 for the 7.5kb 
allele (E) and 0.63 for the 6.0kb allele (e) as calculated in Section 
3.1.5. These frequencies were used to calculate the expected number of 
sib-pairs falling into the three categories. The expected proportions 
of sib-pairs sharing 2, 1 and 0 alleles are 0.60, 0.35 and 0.05 re­
spectively.
The observed and expected number of sib-pairs (like and unlike) for 
the three catergories are presented in Table 45. Chi-square analysis 
was performed between the observed and expected numbers., and no sta­
tistically significant difference was found (X^=1.97 p=0.20-0.50).
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Table 44: Number of marker concordant, discordant and half concordant
like and unlike sib-pairs for the alleles of the SacI/insulin gene
HFLP.
Category
like
sib-pairs
uni ike
Disconcordant 0 1
Half concordant 5 2
Concordant 6 5
Total 11 8
Table 45: Comparison of the observed and expected number of like and 
unlike sib-pairs sharing 2,1 or 0 alleles for the SacI/insulin gene 
HFLP.
Shared Alleles
Sib-pairs
Like Uni ike
Observed
0 1 1
1 5 2
2 6 5
Expected
0 0.60 0.40
1 4.20 2.80
2 7.2 4.80
*2 1.97 *
P 0.20-0.50 (NS)
* Yates correction theorem applied since chi-square approximation
probably invalid since two cells with expected counts less than 1.00
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3.3.6 Glucocorticoid receptor gene HFLPs
3.3.6.1 Tth III HFLP
A total of 15 sib-pairs were genotyped for the Tthlll/g 1 ucocorticoid 
receptor gene polymorphism. 10 of the sib-pairs were classified as 
like and 5 as unlike sib-pairs. The number of like and unlike sib- 
pairs sharing 2 alleles (marker concordant), 1 allele (half concond- 
ant) and 0 alleles (marker discordant) are presented in Table 46. The 
allele frequencies for the offspring population were 0.21 for the 
3.8kb allele (F) and 0.79 for the 3.4kb allele (f), as calculated in 
section 3.1.6. These frequencies were used to calculate the expected 
number of sib-pairs falling into the three catergories. The expected 
proportions of sib-pairs sharing 2, 1 and 0 alleles are 0.68 0.29
0.03 respectively.
The observed and expected numbers of sib-pairs (like and unlike) for 
the three catergories are presented in Table 47. Chi-square analysis 
was performed between the observed and expected numbers., and no sta­
tistically significant difference was found 
(Xj =2.94 p=0.20-0.50).
3.3.6.2 Ball HFLP
A total of 27 sib-pairs were genotyped for the Bel I/glucocorti­
coid receptor gene polymorphism. 16 of the sitr-pairs were classified 
as like and 11 as unlike sib-pairs. The number of like and unlike sibs 
pairs sharing 2 alleles (marker concordant), 1 allele (marker half 
concordant) and 0 alleles (marker disconcordant) are presented in 
Table 48. The allele frequencies for the offspring population were 
0.40kb for the 5.4kb allele (G) and 0.60 for the 2.3kb allele (g)
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(Vatt 1992). These frequencies were used to calculate the expected 
number of sib-pairs fallipg into the three categories. The expected 
proportions of sib-pairs sharing 2, 1 and 0 alleles are 0.58 , 0.37 and 
0.05 respectively.
The observed and expected number of sib-pairs (like and unlike) for 
the three catergories are presented in Table 49. Chi-square analysis 
was performed between the observed and expected numbers, and a statis­
tically significant difference was not found (X2=3.21 p=0.20).
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Table 46: Number of marker concordant, discordant and half concordant
like and unlike sib-pairs for the alleles of the 7YhIII/glucocorti-
coid receptor gene HFLP.
Category
Like
Sib-Pairs
Uni ike
Discordant 1 1
Half concordant 3 1
Concordant 6 3
Total 10 5
Table 47: Comparison of the observed and expected number of like and 
unlike sib-pairs sharing 2,1 or 0 alleles for the Tf/iTJJ/glucocorti— 
coid receptor gene HFLP.
Sib-pairs
Shared Alleles Like Uni ike
Observed
0 1 1
1 3 1
2 6 3
Expected
0 0.30 0.15
1 2.90 1.45
2 6.80 3.40
x2 2.94 ♦2
P 0.2-0.50 (NS)
♦Yates correction theorem applied since chi-square approximation
probably invalid since two cells with expected counts less than 1.00
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Table 48: Number of marker concordant, discordant and half concordant
like and unlike sib-pairs for the alleles of theficlJ/glucocorticoid
receptor gene HFLP.
Oatergory
Like
Sib Ifeirs
Unlike
Discordant 0 1
Half concordant 5 5
Concordant 11 5
Total 16 11
Table 49: Comparison of the observed and expected number of like and 
unlike sib-pairs sharing 2,1 or 0 alleles for the BelJ/glucocorticoid 
receptor gene HFLP.
Shared Alleles
Sib-pairs
Like Uni ike
Observed
0 0 1
1 5 5
2 11 5
Expected
0 0.88 0.55
1 5.92 4.07
2 9.28 6.38
x2 3.21 *
P 0.20
* Yates correction theorem applied since chi-square approximation
probably invalid since two cells with expected counts less than 1.00
cl 15
3.3.7 Beta-f ibrinogen gene HFLP
A total of 30 sib-pairs were genotyped for the Bel I/beta-f ibr inogen 
gene polymorphism. 16 of the sib-pairs were classified as like and 14 
as unlike sib-pairs. The number of like and unlike sib-pairs sharing 2 
alleles (marker concordant), 1 allele (marker half concordant) and 0 
alleles (marker disconcordant) are presented in Table 50. Ihe allele 
frequencies for the offspring population were 0.84 for the 5.3kb 
allele (G) and 0.16 for the 4.2kb allele (g) (Wood 1990). These fre­
quencies were used to calculate the expected number of sib-pairs 
falling into the three categories. The expected proportions of sib- 
pairs sharing 2, 1 and 0 alleles are 0.74, 0.24 and 0.02 respectively. 
The observed and expected number of sib-pairs (like and unlike) for 
the three catergories are presented in Table 51. Chi-square analysis 
was performed between the observed and expected numbers, and showed a 
statistically significant lack of allele sharing in like sibs (X2=6.46 
p<0.05).
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Table 50: Number of marker concordant, discordant and half concordant
like and unlike sib-pairs for the alleles of the £b 7 I/beta-f ibr inogen
gene HFLP.
Category Sib-Pairs
Like Uni ike
Discordant 1 1
Half concordant 8 3
Concordant 7 10
Total 16 14
Table 51: Comparison of the observed and expected number of like and 
unlike sib-pairs sharing 2,1 or 0 alleles for the Bel I/beta-f ibr inogen 
gene HFLP.
Shared Alleles
Sib-pairs
Like Uni ike
Observed
0 1 1
1 8 3
2 7 10
Expected
0 0.32 0.28
1 3.84 3.36
2 11.84 10.36
x22 6.46 *
P <0.05 (S)
* Yates correction theorem applied since chi-square approximation
probably invalid since two cells with expected counts less than 1.00
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3.4 Restriction Fragment Length polymorphism screening
3.4.1 Beta-2-adrenergic receptor gene
A 2.6kb genomic ENA probe of the beta-2-adrenergic receptor gene, was 
used to detect polymorphisms by hybridisation to a series of Southern 
blot filters containing genomic IMA from 10-20 unrelated irxiividuals 
digested with a series of restriction enzymes.
The restriction enzymes tested were;
Alulj, Apal, Aval. Avail,,Bam HI, Bell, Bgll, Bglll, Bst NI, Cfol, Ddel, 
Dral, EcoRI, HaeIII,HgiIA, HinDIII, Hint I, Hpal, Kpnl, MspI, Neil, 
Not I, PstI, PvuII, fisaJ, &cl. Sail, TaqI, Xbal
For all the above enzymes, no polymorphic band pattern was observed on 
autorad iography.
3.4.2 Glucocorticoid receptor gene
A 4.4kb cDNA probe of the glucocorticoid receptor gene was used to 
detect polymorphisms. The restriction enzymes used are listed in 
section 3.4.1. For the enzymes tested, with the exception of the 
enzyme HgilA, no polymorphic band patterns were observed. However, 
HgilA digested ENA on hybridisation to a radiolabelled glucocorticoid 
receptor probe identified a two allele polymorphism with band sizes of 
3.5kb and 2.0kb. From the total of 20 individuals tested the frequency 
of the alleles were 0.75 for the 3.5kb allele and 0.25 for the 2.0kb 
allele.
Fig. 3 shows the polymorphic band pattern observed.
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Figure 3: Polymorphic band pattern on hybridisation of radiolabelled 
glucocorticoid receptor gene probe to Southern blots of HgilA digested 
BNA.
3.5 Baplotype analysis and linkage disequilibrium
The Bell HFLP of the glucocorticoid receptor gene has previously been 
examined in the offspring population (Watt et al., 1992). The allele 
frequencies were found to be 0.40 for the 5.3kb allele (G) and 0.60 
for the 3.2kb allele (g). The Tth III polymorphism was analysed in the 
offspring population (See Section 3.1.6), with allele frequencies of 
0.23 for the 3.8kb allele (F) and 0.77 for the 3.4kb allele (f). 119
offspring have thus been genotyped for both HFLPS and nine different 
hap lo types have been recorded, as shown in Table 52.
The number of, FG (++), Fg (■•— ), fG (-+) and fg (— ) gametic haplotyes 
were calculated, and chi-square analysis was performed to test the 
hypothesis that no difference between the observed and expected ga­
metic haplotype distribution exists (Table 53). No statistically 
significant difference was found such that the observed gametic haplo­
type distribution is similar to the expected distribution for random
2
association, and are therefore in linkage equilibrium (X =2.04
p=0.10-0.20).
In order to confirm the linkage equlilibrium between the two markers 
of the glucocorticoid receptor, the gametic frequencies were calculat­
ed from observed numbers of garnetic haplotypes, and the frequencies 
were PG=0.09, Fg=0.108, fG=0.302 and fg=0.50. These frequencies were 
then used to estimate the linkage disequilibrium parameter (D) as 
follows according to Hart (1988);
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Linkage disequilibrium (D) = (a x b)- (c x d)
where a= frequency of FG hap lo type 
b= frequency of fg haplotype 
c= frequency of Fg haplotype 
d= frequency of fG haplotype
D=0 corresponds to linkage equi 1 ibrium
For the allele frequencies F, f, G, g the smallest (Rain) and tte 
largest (Emax) possible values of D are as follows;
Emin = -FG or -fg (whichever is largest)
Emax = Fg or fG (whichever is smallest)
The estimated value of D is therefore 0.012. The Emax value from the 
allele frequencies was calculated as 0.138, such that the amount of 
disequilibrium is 8.7% of its theoretical maximum. Therefore, linkage 
equl ibrium exists between the Bell and the Tthlll restriction site 
polymorphisms.
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Table 52: The nine different h&lotypes of the two HFLPS of the gluco­
corticoid receptor and their distribution between the four groups of 
offspring* and in the whole popuation.
Group 
Haplotype A B C D Total
1 (FFGG) 2 0 1 0 3
2 (FfGG) 2 2 0 2 6
3 CffGG) 1 5 2 1 9
4 (FPGg) 0 2 5 0 7
5 (FfGg) 4 5 5 2 13
6 CffGg) 8 11 9 12 40
7 (FFgg) 1 0 1 1 3
8 (Ffgg) 1 1 6 2 10
9 (ffgg) 9 4 2 13 28
Table 53: Comparison of observed and expected lumbers of the four
different gametic haplotypes (++/+-/-+/— )* for the two restriction 
sites.
Haplotype No. chromosomes
Observed
FG (++) 19
Fg (+-) 23
fG (-+) 64
fg (— ) 106
Expected
FG C++) 19.50
Fg (+-) 29.26
fG (-+) 65.30
fg (— ) 97.94
2.042
p 0.10-0.20 (NS)
Where F and f are the alleles of the Tthlll HFLP 
where G and g are the alleles of the Bell HFLP
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3.6 Mutational Screening of the Glucocorticoid receptor cENA
3.6.1 ENA extraction and quantitation
Total cellular ENA was extracted from lymphoblastoid cell lines from 
10 offspring of the Ladywell study. Five of the subjects were assigned 
to Group 8 (high personal and high parental blood pressure) and five 
to Group C (low personal and low parental blood pressure). The acid 
guanidium thiocynate chloroform method was used for the preparation of 
HNA samples (Chomczynski & Sacchi, 1989). The concentration of the ENA 
samples were determined by spectrophotometry at 260nm and the purity 
of the sample determined by the value of GD (260nm)/0D (280nm). The
mean total cellular ENA concentration was 700ug/ml. HNA samples were 
electrophoresed on checker gels to assess the integrity of the ENA 
preparation. Results of fractionation of HNA samples are shown in fig. 
4.
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Figure 4:HNA electrophoresis
mm
The upper band represents the 28S rRNA and the lower band the 18S 
rHNA, and the smear represents the presence of ENA
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3.6.2 Reverse transcription-PCR Optimisation
Three sets of synthetic oligonucleotide primers were designed for 
amplification of the glucocorticoid receptor (HGR) cDNA with the aid 
of the Oligo computer program (Rychilk & Rhoads, 1989). For amplifica­
tion it was necessary to transcribe the HNA template to produce cDNA. 
Reverse transcription (RT) was performed using the most upstream 
primer to initiate transcription.
Optimisation of RT-PCR (Polymerase Chain Reaction) was first performed 
on control HNA samples, and once optimised, RT-PCR was performed on 
total cellular HNA from 10 offspring of the Ladywell study, such that 
the cDNA of the HGR was amplified. A series of RT-PCR optimisation 
experiments were performed to determine the optimal annealing tempera­
ture for each PCR cycle, such that only the PCR product of interest 
was amplified and non-specific amplification was eliminated. The 
initial annealing temperature used was the average Tta (melting temper­
ature) of each primer pair. Once the PCR product of interest was 
amplified, additional PCR products were minimised by increasing the 
annealing temperature. Fig. 5 shows a series of optimisation experi­
ments performed for primers 238R/239R.
For all subjects examined the correct sized fragments were amplified 
for all three sets of primers, thus excluding any major gene deletions 
or truncated mKNA products.
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Figure 5: PCR optimisation
5a: Lane 1, lkb marker., lanes 2-3, RT-PCR amplification with primers 
238R/239R, at an annealing temperature of 54*C
5b: lane 1, lkb marker, lane 2, RT-PCR amplification with primers
238R/239R, at an annealing temperature of 56*C
5c: lane 1, lkb marker, lane 2 RT-PCR with primers 238R/239R, at an
annealing temperature of 57*C
5d: Lane 1, lkb ladder, lane 2-3, RT-PCR with primers 238R/239R at an
annealing temperature of 58*C.
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3.6.3 Hydro 1 ink Gel Electrophoresis
Hie three PCR amplified regions of the HGR cDNA of the 10 Ladywel 1 
offspring examined, were subjected to Hydrolink gel electrophoresis. 
PCR products were denatured at 95*C for 5 minutes and allowed to 
anneal over a period of two hours at 70*C, and electrophoresed 
through Hydrolink gel matrixes. Ethidium bromide staining of the gels 
showed no evidence of heteroduplex formation for regions amplified by 
primers 236R/241R and 237R/240R. This suggests no DNA sequence differ­
ences exist in these regions of the HGR cENA for the offspring stud­
ied. However, electrophoresis of the region amplified by primers 
238R/239R, showed four of the ten offspring to have a second band 
migrating closely above the first band, representing the formation of 
a heteroduplex between a normal and mutant ENA strand. This additional 
band was not visible after agarose gel electrophoresis of the PCR 
products. TVrc> of these offspring were assigned to Group B (high/high) 
(subject A and B) and two to group C (low/low) (Subject C and D). To 
ensure the validity of these results, each sample was run on several 
different gels, using different PCR products.
These results are presented in fig. 6.
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Figure 6: Hydro 1 ink gel electrophoresis
6: Lanes 1-2, ethidium bromide staining of a Hydrolink gel showing
homoduplex formation in the region of the HGR cDNA amplified by prim­
ers 238R/239R, lane 3, ethidium bromide staining of a Hydrolink gel 
showing the presence of a second band above the homoduplex band ie. 
heteroduplex formation.
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3.6.4 Asymmetric reaapli float ion
In attempts to characterise the additional band identified by Hydro— 
link gel electrophoresis in four of the offspring, asymmetric PCR were 
performed on dsDNA PCR products for the generation of ssDNA, for 
direct sequencing. In some instances RT-PCR resulted in non specific 
amplification products in addition to the expected PCR product, even 
after optimisation of the PCR parameters. Fig. 7 shows an example of 
the spurious PCR products seen after PCR. The PCS products were 
therefore fractionated on agarose gels and the cDNA eluted from aga­
rose, for asymmetric PCR.
A series of asymmetric PCR optimisation experiments were performed for 
each region to be amplified, using differing ratios of the two syn­
thetic oligonucleotides ie. 1:100, 1:75 and 1:50. Asymmetric PCR were 
performed using both primers limiting* such that both cENA strands 
could be amplified. Asymme ic PCR using primer 239R as the limiting 
factor was unsuccessful at generating ssENA, even when differing 
ratios of the two primers were used. However, asymmetric PCR was 
successful using primer 238R as the limiting primer. Fig.8 shows 
results from asymmetric PCR optimisation experiments.
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Figure 7: Spurious PCR products
1 2  3 4
7: Lanes 1-3, RT-PCR using primers 238R/239R, the upper band repre­
sents the PCR product of interest, lanes 1 & 2 show spurious PCR 
products as a result of primer annealing to a non-target sequence.
Lane 4, lkb marker
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Figure 8: Asymmetric PCR optimisation
1 2  3 4
8: Lane 1, lkb marker, lane 2, asymmetric PCR usipg a ratio of 1:50 of 
primers 238R/239R, Lane 3, asymmetric PCR using a ration of 1:75 of 
primers 238R/239R, Lane 4, asymmetric PCR using a ratio of 1:50 of 
primers 238R/239R
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3.6.5 Direct sequencing of ssPCR amplified ENA templates 
Single strand PCR products generated through asymmetric PCR, were 
sequenced. The PCR products were purified by selective precipitation 
in 2M ammonium acetate and isopropanol. Sequencing was performed with 
Sequenase enzyme using 100% of the purified PCR product and lpmol of 
the limiting primer els a sequencing primer.
Several problems were encountered in attempts to perform direct se­
quencing of ssDNA products. Asymmetric PCR performed with primer 239R 
els the limiting primer was unsuccessful at generating ssDNA, however, 
when primer 238R was the limiting primer asymmetric PCR was success­
ful, and a sequence was obtained. Fig.9 shows the sequence ladder 
produce from a Group B (subject A) and Group C (subject C) ladywell 
offspring using 238R els the sequencing primer. 400 bp of the 3* region 
of the PCR segment amplified by primers 238R/239R was sequenced in 
subjects A and C. No sequence difference was observed between these 
individuals, such that no molecular variants exist in the region 
sequenced in the subjects examined.
It was also found that although the asymmettic PCR was successful, 
sequencing was problematic due to the presence of ambiguous sequencing 
ladders caused by the presence of the same sequencing band in all four 
lanes.
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Figure 9: Partial sequence of the glucocorticoid receptor cDNA
a b
T C G  A T C  G A
9a: Partial sequence of the HGR cDNA from HNA of subject A, using
primer 238R as the limiting primer for sequencing
9b: Partial sequence of the HGRc DNA from HNA of subject B, using
primer 238R as the limiting primer for sequencing
3.7 Mutational Screening of the angiotensinogen gone
3.7.1 Polymerase Chain Reaction
12 Ladywell subjects were identified with polarised predispositions to 
the development of high blood pressure ie. 6 from Group B (high/high) 
and 6 from Group C (low/low). All five exons and the 5* region of the 
angiotensinogen gene for all subjects were PCR amplified using nine 
sets of primers. Fig 10, shows an example of the PCR product generated 
using primers 2al/2a2. All subjects examined for the nine sets of 
primers resulted in amplification of the correct sized fragments, thus 
excluding any major gene length mutations in these offspring.
1 3 4
Figure 10: PCR of a region of exon II of the angiotensinogen gene
10 11
10: Lanes 1-10, PCR amplified DNA of Ladywell offspring using primers 
2cl/2c2, Lane 11, lkb marker
- „ 3.7.2  BydrolinkjfeL electrophoresis
The amplified products for each primer pair in all 12 offspring were 
subjected to hydrolink gel electrophoresis. No evidence for heterodu­
plex formation was seen for PCR products amplified by primer sets; 
5al/5a2, 5bl/5b2, 5cl/5c2, 2al/2a2, 2bl/2b2, 3-1/3-2, 4-1/4-2 and 5-
1/5-2. However, Hydrolink gel electrophoresis of the region amplified 
by primers 2c-1 and 2c-2 showed 4 out of the 12 offspring to show 
heteroduplex formation. Fig. 11 shows the heteroduplexes identified 
by Hydrolink gel electrophoresis. As can be seen from fig. 11, two 
additional bands are present above the homoduplex band, suggesting the 
presence of two molecular variants. This double heteroduplex band was 
seen in all four of the offspring.
Three of the four offspring exhibiting heteroduplex formation were 
assigned to Group C, and only 1 to Group B. Additional offspring from 
Group B, and Group C, were then analysed for heteroduplex formation. 
Thirty-five Group B subjects were studied, and six heteroduplexes 
detected, whereas in Group C, fourty subjects were studied and 10 
heteroduplexes identified. Chi-square analysis was performed to deter­
mine if the distribution of offspring with heteroduplexes amongst the 
two groups was statistically significant. However, no statistically 
significant difference was observed (Table 54).
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Figure 11: Hydrolink gel electrophoresis
11: Lanes 1 , ethidium bromide staining of a hydrolink gel, showing
the presence of a homoduplex band, in the region of the angiotensino­
gen gene amplified by primers 2al/2a2, lane 2. , shows the formation of 
two additional bands above the homoduplex band, representing 
heteroduplex formation.
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Table 54: Comparison of the distribution of offspring showing hetero- 
duplex formation between Group B (high offspring and high parental 
blood pressure) and Group C (low offspring and low parent blood pres­
sure).
Heteroduplex
Formation
Group B Group C Total
Observed
Positive 6 10 16
Negative 29 30 59
Expected
Positive 7.47 8.53
Negative 27.53 31.47
X’ 0.687
p 0.20-0.50 (NS)
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3.8 Analysis of the T174M and the M235T molecular variants in
exon II of the angiotensinogen gene
TYvo molecular variants in exon II of the angiotensinogen gene previ­
ously identifed by Juenemaitre et al., (1992b), by direct sequencing, 
were analysed in the high/high and low/low offspring by Soubrier et 
al., (Personal Comnunication 1992). The frequency of the variants in 
the two groups was compared by Qhi-square analysis as presented in 
Tables 55 & 56, and no statistically significant difference was found.
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Table 55: A comparison of the genotype distribution of the T174M
molecular variant in group B (high/high) offspring and group C 
(low/low) ofspring.
No of offspring 
Genotype Group B Group C
Observed
ww 30 32
WM 7 5
MM 0 1
Expected
WW 30.59 31.49
WM 5.92 6.08
MM 0.49 0.51
A 1.385
P 0.20-0.50 (NS)
Table 56:A comparison of the genotype distribution of the M235T molec­
ular variant in group B (high/high) offspring and group C (low/low) 
offspring*
Genotype Group B Group C
Observed
WW 17 13
WM 17 16
MM 4 7
Expected
WW 15.41 14.59
WM 16.95 16.05
MM 5.65 5.35
x22 1.329
P 0.20-0.50 (NS)
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CHAPTER 4: DISCUSSION
Chapter 4 DISCUSSION
The present study has utilised three different approaches to identify 
genetic determinants of high blood pressure; association analysis in 
subjects with polarised predispositions, sib-pair analysis and muta­
tional analysis of candidate genes.
4.1 Genetic association studies
This form of genetic analysis is based on the determination of the
prevalence of specif ic markers in groups of hypertensive and normoten-
sive subjects and aims to identify an association between a DNA marker 
and hypertension. The present study has employed the candidate gene
approach, where the frequency of HFLPs of candidate genes are com­
pared, and may allow the demonstration of an association between the 
candidate gene or a closely linked locus and hypertension. For the 
majority of hypertension candidate genes, HFLPs have been reported and 
due to the ease of their identification have been used in many associ­
ation studies.
There are several disadvantages encountered in association studies. 
The number of subjects studied must be large enough to demonstrate the 
smaller effects of some alleles. Association studies assume genetic 
homogeneity and hypertension itself is a highly heterogenous disorder, 
therefore absence of an association between a particular polymorphism 
and hypertension does not rule out the effect of some genes in subsets 
of hypertensive patients. Association studies assume linkage disequi­
librium between the marker and a mutation at the disease locus, and if 
an association between a polymorphism and hypertension is found, then 
a second series of experiments are necessary using an additional
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marker of the gene to determine if the association still holds. 
Association studies do not provide a definite causal link between a 
particular gene and hypertension, and further studies are necessary to 
confirm the precise genetic abnormality.
Another problem seen in association studies is in the definition of 
high blood pressure, and therefore in the interpretation of data. The 
majority of association studies in hypertension have examined patients 
with or without a family history, based on medical family history 
questionnaires. A review of the sampling methods by Watt (1986), has 
shown that only 3 of 31 studies verified reported family histories, 
therefore resulting in a large number of false positive and negative 
results. Negative family histories were usually defined as neither 
parent on treatment, and such individuals lie in the lower 75-80% of 
the blood pressure distribution, therefore individuals from the upper 
15-20% of the distribution are compared to individuals from the lower 
75-80% of the distribution. Based on such observations Watt (1986) has 
proposed the four corner approach for the identification of high/high 
offspring whose parents both have blood pressures in the upper part of 
the distribution and low/low offspring whose parents both have blood 
pressure in the lower part of the distribution.
The present study has employed the four corner approach for the selec­
tion of offspring with contrasting predispositions to high blood 
pressure. Ttie unique design of the study has allowed the identifica­
tion of individuals with high blood pressure and a strong genetic 
predisposition based on both parents having high blood pressure 
(high/high), and individuals with low blood pressure and a weak genet­
ic predisposition based on both parents having low blood pressure
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(low/low). The use of these groups allows for the most potentially 
informative comparisons to be made. In addition* parents with low 
blood pressure and parents with high blood pressure identified from 
opposite ends of the blood pressure distribution can be compared.
The number of studies to date on the RFLP analysis of candidate genes 
for hypertension has been limited. The renin gene HFUPs are the most 
widely studied. Several studies concerning renin gene polymorphisms in 
human hypertensive subjects have been reported. Morris & Griffiths 
(1988) were the first to compare the distribution of the renin Hindlll 
RFLP genotypes in 29 hypertensive subjects and 202 adult normoten- 
sives. No association between the RFLP and hypertension was evident. 
Similarly* Naftilan et al., (1989) performed linkage analysis on 9 
hypertensive relatives and 59 normotensives from a large Utah pedigree 
using three RFLPs of the renin gene (HindlllThql, Bgll)* and failed 
to demonstrate an association. Haplotype analysis was also performed 
by Soubrier et al.* (1990) on 102 hypertensives and 120 normotensives 
using three RFLPs of the renin gene (TaqI, HinflHindlll)* and again 
no association was demonstrated. The study by Barley et al. * (1991)
examined four renin RFLPs (Bgll., Bglll, TaqI., Hindlll) in hyperten­
sives and normotensives from two different populations; Afro—Carribean 
and European. An association between blood pressure and the Bgll RFLP 
was demonstrated in the Afro—Carr ibean population, but no association 
was observed for any of the other polymorphisms. The Bgll RFLP of the 
renin gene was not examined in the present study* since it has previ­
ously been studied in the Ladywell offspring population and no associ­
ation with hypertension was demonstrated (0 Hare Personal Communica­
tion 1988).
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The Hindlll RFLP of the renin gene was analysed in the present study 
in 192 offspring, including 45 high/high offspring and 48 low/low 
offspring, and in 44 parents with high blood pressure and 47 parents 
with low blood pressure. However, no statistically significant asso­
ciation between the Hindlll polymorphism of the renin gene and hyper­
tension was demonstrated.
The present study based on the analysis of offspring with contrasting 
predispositions to high blood pressure and parents with high and low 
blood pressures confirm previous findings of no association between 
Hindlll alleles of the renin gene and hypertension.
A recent association study performed by Terhal (1992 personal communi­
cation) examined the Bgll RFLP of the beta-1-adrenergic receptor gene, 
the BanI RFLP of the beta-2-adrenergic receptor gene and the Dral RFLP 
of the a 1 pha-2-adrenergic receptor gene and hypertension in the Dutch 
Hypertension Study. Parents identified from the upper (P75) and the 
lower (P25) quintiles of the age/sex specific blood pressure distribu­
tion were genotyped for the three polymorphisms, and no significant 
difference in the genotype distribution was found. Similarly, the 
analysis of offspring with either high or low blood pressure, with 
either both parents as hypertensive, both parents as normotensive or 
one parent hypertensive and one parent normotensive showed no signifi­
cant differences in the RFLP pattern. These three polymorphisms have 
been analysed in the present study, in four groups of offspring with 
contrasting predispositions to high blood pressure and in parents with 
high and low blood pressures. However, no association with hyperten 
sion was demonstrated. The design of the Dutch Hyper tens ion Study, is 
similar to the approach used in the present study, where offspring
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are identified from parents from opposite end of the blood pressure 
distribution, for maximal contrast in predisposition. However, in the 
present study a greater number of subjects were examined. Therefore 
the analysis of the three polymorphisms in the present study confirms 
the finding by Terhal (1992).
Several other RFLP association studies have been performed on hyper­
tension candidate genes. Ying et al., (1991) analysed a Bglll RFLP of 
the insulin gene in 68 hypertensives and 75 normotensives adults and 
failed to demonstrate an association between specific alleles and 
hypertension. An association between the alleles of a Rsa.1 RFLP of the 
insulin receptor gene and hypertension was however determined (Ying 
et al., 1991). The Rsal RFLP of the insulin receptor gene was not
examined in the present study because of problems associated with 
probe availability, however analysis of this polymorphism in the off 
spring population of the Ladywel 1 study should be initiated. The 
present study has analysed the Sa.cl RFLP of the insulin gene and 
demonstrated no association. This is the first study to perform RFLP 
analysis of the insulin gene in offspring with polarised predisposi­
tions to high blood pressure, and in parents with high and low blood 
pressures.
Association analysis by Watt et al., (1992) of the Bell RFLP of the 
glucocorticoid receptor gene in the offspring population of the Lady- 
well study, has previously shown a significant association between the 
larger allele of the RFLP and a predisposition to high blood pressure. 
However, the present study has demonstrated no such association be­
tween a second polymorphism of the gene ie. the Tthlll RFLP and hyper 
tension. The present study is the first to perform association analy-
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sis of the Tthlll polymorphism of the glucocorticoid receptor gene and 
hypertension. Haplotype analysis of the two HFLPs of the glucocorti­
coid receptor gene showed no significant difference between the ob­
served and expected haplotype distribution, and linkage equilibria was 
demonstrated between the two restriction site polymorphisms (RSPs) 
with an estimated linkage disequilibrium parameter (D) of 0.012. 
Therefore the present finding of linkage equilibria between the two 
RSPs is in agreement with the lack of association observed between the 
Tthlll RFLP of the glucocorticoid receptor gene and hypertension. If 
the two RSPs were in linkage disequilibrium then the analysis of the 
Tthlll RFLP would be expected to show a similar association as ob­
served with the Bell RFLP. This suggests that analysis of additional 
polymorphisms of the glucocorticoid receptor gene are necessary to 
confirm the original finding. To date no additional HFLPs of the 
glucocorticoid receptor gene have been identified. In the present 
study, RFLP screening of the glucocorticoid receptor gene using 30 
different restriction enzymes was performed, and a polymorphism with 
the restriction enzyme HgilA was found, with allele sizes of 3.5kb and 
2.0kb. From a total 12 individuals tested the frequency of the alleles 
were 0.75 for the 3.5kb allele and 0.25 for the 2.0kb allele. However, 
due to the manufactures costly price of the enzyme, analysis of this 
polymorphism was not possible in the offspring population of the 
Ladywel1 study.
In the present study, analysis of parents with high and low blood 
pressure showed no association between the Bell RFLP of the gluco­
corticoid receptor and hypertension. These results are in contrast to
the results obtained in the offspring population, by Watt et al.,
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(1992) where the larger allele was associated with a predisposition to 
high blood pressure. This may reflect the two different approaches 
used ie. the four corner approach versus analysis of individuals with 
high blood pressure and low blood pressure. In the four corner ap­
proach 50 high/high offspripg were compared to 50 low/low offspring., 
and in the latter study 44 parents with high blood pressure were 
compared to 33 with low blood pressure. Although slightly higher 
number of subject were studied in the four corner approach, if the 
association between the Boll RFLP and hypertension is true, then this 
provides evidence for the four corner approach as a more effective 
method of identifying genetic factors associated with hypertension 
compared to the more common approach of analysing parents with high 
and low blood pressure levels. However, before this can be estab­
lished, the association between the Boll RFLP and predisposition to 
hypertension must be confirmed. The Boll RFLP of the glucocorticoid 
receptor gene has recently been examined in the Dutch Hypertension 
study (Terhal 1992), aixi no association was found. The lack of associ­
ation demonstrated in the present study between the Tthlll RFLP of 
this gene, suggests that the original findings of the Ladywell study 
may represents a chance finding and not a true association. If this is 
the case, then this highlights one of the pitfalls of association 
studies, were reported associations do not stand the test of time.
The Bell RFLP of the beta-f ibrinogen gene has also been previously 
examined in the offspring population of the Ladywell study (Wood 1991 
personal communication), and no association between the polymorphism 
and predisposition to hypertension was demonstrated. The present study 
has analysed this polymorphism in parents with high and low blood
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pressures from opposite ends of the blood pressure distribution and 
again no association has been found. These two studies are the first 
to perform association analysis of the Bell RFLP of the beta- 
fibrinogen gene and hypertension.
The Atrial Natriuretic Factor (ANF) gene has also been the subject of 
investigation in association studies, and RFLP analysis of the Bgl 
polymorphism in 32 normotensives and 51 hypertensives from two differ­
ent ethnic populations, failed to demonstrate an association (Barley 
et al., 1991). The Bgll RFLP of the ANF gene has previously been 
examined in the adywell offspring population, and no association was 
demonstrated (Personal Communication 0  Hare).
A recent cross-sectional association study of 80 hypertensives and 93 
normotensives has shown an association between hypertension and a 
287bp insertion/deletion polymorphism of the Angiotensin Converting 
Enzyme (ACE) gene, suggesting the ACE locus or a gene closely linked 
to the ACE gene is implicated in hypertension (Zee et al., 1992).
However, this polymorphism has also been previously examined in the 
Ladywell offspring population and no association was demonstrated 
(personal communication S°u brier et al,.)
Therefore the present analysis of offspring with contrasting predispo­
sitions to high blood pressure, suggests that allelic variations 
associated with the renin, the alpha-1, the beta-1, the beta-2-adre- 
nergic receptors, glucocorticoid receptor and insulin genes identified 
by Hindlll, Dral, Bgl, BanI, Tthlll and SacI RFLP respectively are 
not associated with human essential hypertension. The present study 
is the first to carry analysis of several RFLPs of candidate genes in
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offspring with markedly contrasting predispositions to high blood 
pressure. In addition analysis of parents from opposite ends of the 
blood pressure distribution shows no association between the Hindlll 
RFLP of the renin gene, Dral HFLP of the alpha-2-adrenergic receptor, 
Bgl RFLP of the beta-1-adrenergic receptor, BanI RFLP of the beta-2- 
adrenergic receptor, Tthlll and the Bell RFLP of the glucocorticoid 
receptor and the Bell RFLP of the beta-f ibrinogen gene and hyperten­
sion. For all the polymorphisms studied, the allele frequencies ob­
served in the offspring and parent populations were in close agreement 
with previously reported allele frequencies. The main limiting factor 
however, in the present study was the small number of offspring iden­
tified using the four corner approach, despite a total original popu­
lation of 24,000.
The power of an association study may be increased by using more 
polymorphic markers. The majority of HFLPs are usually simple 2-allele 
site polymorphisms, and the strength of studies can be screening for 
additional polymorphisms at the marker locus. However, the majority of 
additional markers are usually in linkage equilibrium with the origi­
nal and therefore no further additional information is gained. An 
alternative, is to identify new highly polymorphic markers at candi­
date genes. Simple tandem repeats have been shown to be very common in 
the human genome and are highly polymorphic with multiple alleles 
(Weber et al., 1989). The genetic heterogeneity of hypertension is 
another problem factor in association studies. One way to attempt to 
overcome this is to identify subsets of hypertensive patients where 
the same genes are more likely to operate.
149
In conclusion, the majority of association studies have been performed 
in case—control studies of hypertensive and normotensives. The present 
study has analysed offspring with polarised predispositions to high 
blood pressure in addition to parents with high and low blood pressures 
from opposite ends of the distribution. Several polymorphisms have 
been examined in the present study and no association between specific 
markers and hypertension has been demonstrated.
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4.2 Sib pair analysis.
This form of analysis is based on Mendel ian principles* where sib- 
pairs are typed for a number of genetic marker loci* and the lumber of 
marker alleles shared by affected sib-pairs is compared with the 
expected number assuming independent assortment of the marker and 
disease. At genetic loci contributing to the disease* siblings who 
both have the disease are expected to inherit the same alleles at the 
locus than would be expected from random segregation ie. 25% of sib- 
pairs would be expected to share identical alleles* 50% would be 
expected to share one haplotype and 25% would be expected to be non­
identical. If a distortion of these ratios is seen* then this suggests 
the possible involvement of the locus in the aetiology of the disease. 
The method of sib-pair analysis is well established (Motro & Thomson 
1985, Galton & Alcolado 1991), and has several advantages. It only 
requires the analysis of affected sibs* therefore if diagnosis is in 
doubt* the individual can be rejected from calculations. In addition* 
no assumptions are needed on the mode of transmission of the disease* 
which is essential for linkage analysis* and is therefore suited to 
diseases of polygenic inheritance. Sib-pair analysis requires no 
control group since the results are based on concordance of shared 
haplotypes. This is advantageous over association studies* where care 
fully matched control groups are necessary. It also overcomes to some 
extent the problem of genetic heterogeneity* since sib-pairs are more 
likely to be genetically homogeneous. The main disadvantage of this 
method is that a large number of affected sib-pairs are required* and 
the number has been suggested to be approximately 200, to detect
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linkage (Lifton 1991).
In the present study sib-pair analysis was initiated in a limited 
number of affected sib-pairs ie. siblings who both have high blood 
pressure, for the identification of candidate loci involved in the 
development of hypertension.
Analysis of the Hindlll RFLP of the renin gene in 19 affected sibs- 
pairs, showed a statistically significant lack of allele sharing. 
Similarly, a lack of allele sharing in 16 affected sib-pairs was also 
observed for the alleles of the beta-fibrinogen Bell RFLP. This 
suggests that the Hindlll RFLP of the renin gene and the Bell RFLP of 
the beta-f ibrinogen gene are not associated with hypertension. These 
results are in agreement with the analysis of the Hindlll RFLP pre­
formed in the present study in the offspring and parent population, 
demonstrating no association with high blood pressure. The Bell RFLP 
of the beta-f ibrinogen gene has also previously been studied in the 
Ladywell offspring population (Wood 1992 Personal Communication), and 
demonstrated no association with hypertension, and in the present 
study in parents with high and low blood pressures again demonstrating 
no association.
A lack of allele sharing was evident for the alleles of the Tthlll 
RFLP of the glucocorticoid receptor gene in 10 affected sib-pairs, 
however this was not statistically significant. Increased allele 
sharing was observed in 18 affected sib-pairs for the alleles of the 
BanI RFLP of the beta-2-adrenergic receptor gene polymorphism, in 10 
affected sibs-pairs for the alleles of the Bgll RFLP of the beta-1- 
adrenergic receptor gene , and in 16 affected sib-pairs for the 
alleles of the Bell RFLP of the glucocorticoid receptor gene. However,
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the increased allele concordance for the three polymorphisms, was not 
statistically significant.
Although a significant lack of association between hypertension and 
the renin and beta-fibrinogen RFLPs has been observed, the number of 
sib-pairs studied is small, and therefore further studies are neces­
sary on a larger number of affected sib-pairs to confirm or refute 
these findipg. Similarly the lack of allele sharipg in affected sib^ 
pairs for the Tthlll RFLP, requires to be confirmed in a larger number 
of affected sib-pairs. However, our preliminary analysis of the Tthlll 
polymorphism in a limited number of sib-pairs is in agreement with no 
association, as demonstrated in the offspring and parent populations 
in the present study.
The increased allele sharing for the Bell RFLP of the glucocorticoid 
receptor gene, is also in agreement with the original findings of an 
association between the larger allele of the RFLP and hypertension as 
shown by Watt et al., (1992). Analysis of this polymorphism in a 
larger number of sib-pairs is again necessary to determine if a sig­
nificant association can be demonstrated. The increased allele sharing 
observed in affected sib-pairs for the beta-1 and beta-2-adrenergic 
receptors gene RFLPs, however, is in contrast to the association 
analysis of these polymorphisms in offspring with contrasting predis­
positions to high blood pressure, and in parents with high and low 
blood pressures, where no significant association was demonstrated. 
Therefore, ana lysis of these two polymorphism in a greater number of 
subjects is necessary to confirm or refute our findings.
The sib-pair analysis performed has shown increased allele concordance 
in affected sib-pairs for three loci, suggesting the involvement of
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these loci in the aetiology of hypertension. However, only one of 
these loci ie. the Bell RFLP of the glucocorticoid receptor gene, has 
been shown to be associated with hypertension, by studying offspring 
with differing risks of hypertension (Watt et al., 1992). If this is 
the case, then it points to sib-pair analysis as a more robust method 
of identifying genetic factors associated with hypertension compared 
to the four corner approach, however this needs to be confirmed by 
analysing a larger number of sib-pairs.
A number of recent studies have employed sib-pair linkage analysis in 
human hypertensives. Jeunemaitre et al.,(1992b), analysed 237 sib-pairs 
and provide evidence for absence of 1 inkage between the Angiotensino- 
gen Converting Enzyme and hypertension. However, a recent case-control 
association study performed by Zee et al.,(1992), has shown an associa­
tion between a 287bp deletion/insert ion polymorphism of the ACE gene, 
suggesting ACE or a locus closely linked to ACE may be implicated in 
the development of raised arterial pressure.
Another study has employed sib-pair analysis and has demonstrated
linkage between the angiotensinogen gene and hypertension (Jeunemaitre 
1992a). In this study, 215 sibships in two distinct geographical
populations were analysed for the highly polymorphic VNTR of the AGT 
gene. Soubrier et al (1992 Personal Communication), have previously 
analysed this polymorphism in the four groups of offspring of the 
Ladywel 1 Study, and no association between specific alleles and hyper­
tension was demonstrated. Therefore linkage has been demonstrated
using sib-pair analysis, yet no association has been identified in the 
association analysis using the four corner approach. This again sug­
gests that sib-pair analysis provides a more robust method of identi­
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fying genes of aetiological significance in hypertension compared to 
the Four Corner Approach.
The present sib-pair study is the first to analyse polymorphisms of 
the renin, beta-1, beta-2, alpha-2 adrenergic receptors, insulin, 
beta-f ibrinogen and glucocorticoid receptor genes. The numbers studied 
are small and these results need to be confirmed in a larger number of 
subjects. The identification of more highly polymorphic markers for 
candidate genes, and their use in sibling pair analysis may improve 
the strength of the study. The strength of sib-pair studies can also 
be improved by identifying subsets of more severely hypertensives. 
Tbus, in conclusion, the present sib-pair analysis although only in a 
small number of sib-pairs seems to be suitable for identifying genetic 
factors associated with hypertension compared to the association 
studies performed in groups of offspring with contrasting predisposi­
tions to high blood pressure.
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4.3 Mutational Screening
The ability to detect polymorphisms and mutations in individuals has 
become increasingly important for the characterisation of genes re­
sponsible for inherited disease and in DMA linkage studies. In the 
past, the detection of mutations was carried out by gene cloning and 
ENA sequencing. Although this provides 100% detection it is labour 
intensive and not rapid enough for routine diagnosis. Over recent 
years several techniques for mutation detection have been identified 
with the development of the Polymerase Chain Reaction (PCR) (Saiki et 
al., 1988), with the potential to provide simple, sensitive and rapid 
detection. The methods employed include Denaturing Gradient Gel Elec­
trophoresis (DGGE) (Fischer et al., 1983), Single Strand Conformation­
al Polymorphism Analysis (SSCP) (Orita et al., 1989), Chemical Cleav­
age of Mismatches (CCM) (Cotton et al., 1988) Hydrolink gel electro­
phoresis (Keen et al., 1991), and direct sequencing of asymmetric PCR 
products.
Denaturing Gradient gel electrophoresis (DGGE) involves the electro­
phoresis of heteroduplexes formed between mutant and normal DMA 
through denaturing gels. Heteroduplexes with regions of mismatches 
show altered migration pattern, therefore identifying mutations. The 
main disadvantage of this technique is the tendency of the heterodu­
plex ends to denature prematurely, such that mutations in these re­
gions are not detected. The addition of GC clamps to the ends of 
heteroduplexes can overcome this (Myers et al., 1985), however this 
makes the procedure more time consuming.
Single strand conformation polymorphism analysis (SSCP), involves the
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electrophoresis of single stranded BNA through non-denaturing gels. 
Mutations are identified as mobility shifts, due to conformational 
changes of single stranded ENA. However, the ability of SSCP to iden­
tify all mutations is unclear.
Chemical cleavage of mismatches (CCM) is a more recent developed 
technique. Regions of mismatches in heteroduplexes, showed enhanced 
sensitivity towards chemical cleavage at T by osmium tetraoxide and at 
C by hydroxyl amine. Piperidine recognises these modified bases and 
cleaves these regions resulting in differing size fragment that can be 
resolved by electrophoresis. This method therefore allows for the 
detection of 100% of imitations, and also provide some information on 
the nature of the mutation. However, the chemicals used are highly 
toxic, making this procedure highly hazardous, and is also labour 
intensive.
Hydrolink Gel Electrophoresis is a very recent technique involving the 
electrophoresis of heteroduplexes through hydrolink gel matrices, and 
mutations are detected as mobility shifts, on ethidium bromide stain­
ing of gels. This is the simplest of all techniques to use, however, 
since it is a relatively new mutation detection method, its ability to 
detect all mutations is unclear, although some authors have suggested 
100% of mutations can be identified (Boyd et al., 1992).
Whichever of the methods are used, confirmation and characterisation 
of mutations is necessary by sequencing. Sequencing has in recent 
years become simplified by the development of PCR. Asymmetric PCR, 
where the two oligonucleotide primers are used in differing ratios, 
results in single stranded DNA templates, which can then be directly 
sequenced, this method allows the detection of 100% of mutations.
157
The main advantages of these approaches is that mutations in candidate 
genes in hypertensive subjects can be directly identified. However, 
the inference that a mutation identified is causal to the development 
of hypertension, requires further analyses. In addition the detection 
of no mutations does not rule out the possibility that mutation 
involved in the development of hypertension is in an unscreened por­
tion of the gene, such as introns or 5’-3* flanking regions.
Sequencing is the most powerful tool for the identification of molecu­
lar variants in hypertension candidate genes. The glucocorticoid 
receptor gene consists of 10 exons with a cDNA in the region of 3kb, 
and the angiotensinogen gene consists of five exons, therefore se­
quencing of such genes is a labour intensive process and time consum­
ing. Hydrolink gel electrophoresis of PCR products has been successful 
at identifying several single base pair substitutions, both known and 
unknown ( Boyd et al., 1992, Inglehearn et al., 1992, White et al., 
1992).
In the present study, hydrolink gel electrophoresis and direct se­
quencing of the angiotensinogen gene and the glucocorticoid receptor 
cDNA, was employed to identify molecular variants in these genes, in 
offspring of the Ladywell study with contrasting predispositions to 
high blood pressure.
4.3.1 Mutational Screening of the Glucocorticoid receptor
cDNA
Analysis of the Bell RFLP of the glucocorticoid receptor gene by Watt 
et al., (1992) demonstrated an association between the larger allele 
of the RFLP and hypertension. However, the present studied analysed a 
second polymorphism, the Tthlll RFLP of this gene, and showed no
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association. In order to identify additional DNA variation of the HGR 
gene, mutational screening of the HGR gene was initiated.
Using three sets of oligonucleotide primers the cDNA of the HGR gene 
was reverse transcription (RT)-PCR amplified in five high/high off­
spring and five low/low offspring. For all subjects examined, the
correct size products were amplified, thus excluding any major gene 
deletions and truncated mKNA products.
Optimisation of the RT-PCR was necessary for successful amplifica­
tion. Denaturation of the HNA sample followed by quenching on ice was 
found to be crucial for successful amplifeation since it allows for
cDNA priming by reducing secondary structures in the HNA molecules
(Kawasaki et al., 1990). Similarly, denaturation of the cDNA was also
found to be necessary, since it inactivates the reverse transcriptase 
enzyme and denatures HNA-DNA hybrids (Kawasaki & Vang 1989). Once 
amplification was evident, the annealing temperature were optimised to 
reduce non-specific amplification, due to priming of a non-target 
sequence during the first few cycles of PCR. However, in some in­
stances, non-specific amplification was seen, even at optimal anneal­
ing temperature.
Hydrolink gel electrophoresis of the three RT-PCR amplified regions of 
the HGR cDNA in 5 high/high and 5 low/low offspring showed no evidence 
of heteroduplex formation in the regions amplified by primers 
237R/240R, and 236/241R, suggesting no molecular variants in these 
regions exist. However, two high/high offspring and 2 low/low off­
spring showed a mobility shift in the region amplified by primers 
238R/239R, suggesting the presence of a mutation in this region in 
these individuals. Asymmetric PCR for the generation of single strand­
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ed ENA, using primer 238R as the limiting primer allowed sequencing 
of 400bp of the 968bp PCR product in 1 high/high offspring and 1 
low/low offspring showing the mobility shift, and no sequence varia­
tion was identified. Asymmetric PCRs were unsuccessful at generating 
single strand ENA when primer 239R was limiting, using ratios of 
1:100, 1:75 and 1:50, and resulted in only the generation of dsDNA and 
no ssDNA. This was found to be the case in all subjects examined and 
not only one indiviual. The reason for this is not fully understood. 
One obvious way to overcome this would be to use alternative primers, 
however due to limited resources we were unable to attempt this.
For a mutation to be involved in the development of raised arterial 
pressure, then its frequency would be expected to be greater in 
high/high offspring compared to low/low offspring. The present variant 
identifed, however, showed an equal frequency in both groups of off­
spring, and is therefore unlikely to be associated with high blood 
pressure, and more likely a polymorphism.
Therefore we have screened the coding region of the cDNA of the HGR 
cDNA in 5 offspring with greatest genetic risk and 5 offspring with 
weakest genetic risk of hypertension by hydrolink gel electrophoresis. 
A molecular variant was identified in 4 offspring, with an equal 
frequency in both the high/high and low/low offspring. However char­
acterisation of the variant was unsuccessful.
The present study is the first to inititate mutational screening of 
the glucocorticoid receptor cDNA in offspring with contrasting predis­
positions to high blood pressure. A study performed by Hurley et al., 
(1991), identifed a point mutation by direct sequencing of PCR 
products in the HGR cDNA in three family memebers with Familial gluco­
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corticoid resistance (PGR). PGR is a hypertensive disorder, and the 
authors suggests that the point mutation which results in a single 
aminoacid substitution is the cause of PGR in this family. No previous 
mutations have been reported in the HGR cDNA in hypertensives sub­
jects.
4.3.2 Mutational screening of the Apgiotensinpgen gene 
Mutational analysis of angiotensinogen (AGT) gene has recently been 
performed by Jeunmaitre et al., (1992). Direct sequencing identified 
15 molecular variants in the AGT gene, 5 of which were nucleotide 
substitutions in the 5‘ region, and the remaining 10, silent muta­
tions. TWo of these variants M235T and T174M, were significantly more 
frequent in hypertensives compared to controls, and in linkage dise­
quilibrium. Haplotype analysis showed the haplotype carrying M235T, 
with or without T174M, was observed more frequently in hypertensives. 
In the present study mutational screening of the AGT gene in off­
spring with contrasting predispostions to high blood pressure was 
performed using Hydro1 ink gel electrophoresis (Keen et al., 1991).
PCR amplification of the five exons and the 5’ region of the AGT in 
six high/high and six low/low offspring of the Ladywell Study, result­
ed in amplification of the correct sized PCR products, thus excluding 
any major gene mutations. Primer sequences were taken from Jeunemaitre 
et al., (1992b), and no optimisation was necessary.
Hydrolink gel electrophoresis of the PCR products showed no evidence 
for heteroduplex formation in the PCR products from primers 5al/5a2, 
5bl/5b2, 5cl/5c2, 2al/2a2, 2bl/2b2, 3-1/3-2, 4-1/4-2 and 5-1.5-2. This 
suggests that no molecular variants are present in exon I, III, TV, V,
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and 600bp of exon II and the 5‘ region of the gene, in the twelve 
subjects examined.
Hydro1 ink gel electrophoresis however, identified heteroduplex forma­
tion in the PCR products from primers 2cl/2c2, in one high/high off- 
spring and three low/low offspring. Inspection of the gels, showed the 
presence of two additional bands above the homoduplex band in all four 
offspring, as shown in Fig. 11. The frequency of the molecular vari­
ants was determined in 40 low/low offspring and 35 high/high off­
spring, with frequencies of 25% (n=10) and 17% (n=6) respectively.
However, the distribution of the molecular variant in the two groups 
of offspring was not statistically significant. The frequencies of the 
two molecular variants M235T and T174M identified by Jeuemaitre et 
al., (1992b), were previously analysed in the high/high and low/low 
offspring of the Ladywell study (Soubrier 1992 Personal 
Communication), and no statistically significant difference between 
the genotype distribution of the variants in the two groups was found, 
as shown in Tables 55 & 56. Therefore although the number of offspring 
examined in the Ladywell study were smaller, the results do not sup­
port the original findings of Jeunemaitre et al., (1992b), and further 
analyses are on a larger number of subjects are needed to confirm or 
refute the involvement of the AGT locus in the aetiology of hyperten­
sion.
Two of the molecular variants identified by Jeunemaitre et al., 
(1992b) , M235T and T174M, were present in the same PCR region of the
AGT gene as the double variant identifed in the present study. A 
comparison of the offspring possessing the double molecular variant 
with the genotype of the variants M235T and T174M deduced by Soubrier
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et al., showed that all offspring who scored positive for heteroduplex 
formation (possess the double molecular variant) without exception 
were double heterozygotes for the M235T and the T174M variants ie. 
have the genotype wildtype/M235T wildtype/T174M. Those scored as 
negative were either wild type homozygotes for both variants or 
homozygote wild type for the T174M variant and heterozygotes for the 
M235T variant (wild type/M235T wild type/wild type) (Appendix IV). 
Therefore it is evident that the molecular variant we have identified 
is a double variant identifying both the M235T and the T174M molecular 
variants, and shows no association with hypertension.
The present study, and the previous studies performed in the Ladywell 
offspring population on the AGT gene suggest, that the AGT locus is 
not implicated in the aetiology of hypertension in the individuals 
studies. However, the number of subjects we have examined is small in 
comparison to other studies and therefore our results should be treat­
ed with caution and analysis of a larger number of subjects is re­
quired to confirm the original results of Jeunemaitre et al., (1992).
In conclusion, the present study has utilised three different ap­
proaches for the determination of genetic factors associated with 
hypertension; association study, sib-pair analysis and mutational 
screening. In the association analysis of several polymorphisms of 
several candidate genes in offspring with contrasting predispositions 
to high blood pressure and in parents with high and low blood pres­
sures, no allelic association with hypertension was found. Where an 
association was previously demonstrated between hypertension and the 
Bell RFLP of the glucocorticoid receptor gene, analysis of an addi­
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tional polymorphism of the same gene has failed to establish the same 
association. The sib-pair analysis in a limited number of sib-pairs 
has proved to be more advantageous, in this study, compared to the 
four corner approach, and has suggested an association between the 
Bgll RFLP of the beta-1-adrenergic receptor gene, the BanI RFLP of the 
beta-2-adrenergic receptor gene and the Bell RFLP of the glucocorto- 
coid receptor gene and hypertension. Mutational analysis of the gluco­
corticoid receptor cDNA. identified a molecular variant, with an equal 
frequency in high/high and low/low offspring. Similarly mutational 
analysis of the aqgiotensinogen gene identified a double molecular 
variant in exon II of the gene. Analysis of this double variant in 
high/high and low/low offspring showed no statistically significant 
difference in the distribution.
The present study therefore suggests, sib-pair analysis in conjunction 
with direct mutational screening of candidate genes is the most prom­
ising way forward in identifying genetic factors of etiological sig­
nificance.
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APPENDIX I 
Solutions 
Plasmid solutions 
Luria BrothC 1000mls)
Magnesium Sulphate 
Calcium Chloride 
STET Buffer
Glycerol 
Lysosyme 
Sodium Acetate 
Phenol
Ethanol 
Ampicill in
Genomic ENA solutions 
Lysis Mix
Nuclei Lysis Mix
lOg Bactotryptone 
5g Bacto yeast extract 
5g NaCl 
pH 7.5
lOmM-ice cold
50mM-ice cold
50nM Tris 
50mM EDTA 
8% Sucrose 
5% Triton X-100
15%
10n*g/ml-ice cold-fresh 
3M
water saturated 
protected from light 
stored at 4*C
95%
0.1mg/ml
0.32M Sucrose 
lOmM Tris
5mM Magnesium chloride 
1% Triton X-100 
pH 7.5
lOmM Tris
0.4M Sodium chloride 
2mM EDTA 
pH 2.8
TE Buffer lOmM Tris 
lOmM EDTA 
pH 7.5
Loading Mix 
20 X SSC
Denaturation Solution 
Neutralisation Solution
Depurination Solution 
Sephadex
Prehybridisation Solution
Salmon Sperm ENA 
SDS
Proteinase K
Sodium chloride solution
Pheno1/chioroform
Ethanol 
Spermidine 
Ethidium Bromide
30% Glycerol
0.25% Bromohpenol Blue
3M Sodium chloride 
0.3M Sodium citrate 
pH 7
0.5M Sodium hydroxide 
1.5M Sodium chloride
0.5M Tris Hydrochloric Acid 
3M Sodium chloride 
pH 7.5
0.25M Hydrochloric Acid
30g Sephadex 
500mIs 2XSSC
50% Formamide 
5 X Denharts 
5 X SSC 
2% SDS
lOqg/ml
sonicated
10%
lOtyg/ml
6M
50:50 
pH 7.5
0.1% Eydroxyqinoline 
95%
0.1M
lOmg/ml
RNA extraction solutions 
PBS Buffer 0.14M Sodium chloride
3mM Potassium chloride
O.lnM sodium hydrogen phosphate
lmM potassium dihydrogen phosphate
Stored at 4*C
pH 7.2
Solution D
Sodium acetate 
Phenol
Chloroform/ isoaiqylal cohol 
SDS
ethanol
isopropanol
formaldehyde
lOxMOPS
Formamide 
Gel juice
Ethidium bromide
Reverse transcription solutions
Reverse transcription buffer 
(lOx concentrate)
DIT (Ditheriothiol)
Reverse transcriptase
4M Guanidium thiocynate 
25oM sodium citrate 
0. ImM mercaptoethanol 
0.5% sarkosyl
3M pH 4
water saturated 
protected from light 
Stored at 4*C
49:1
0.5%
75%
37%
0.2M MOPS (Sodium salt) 
80mM Sodium acetate 
lOmM EDTA 
pH 7.0
protect from light 
deionised 
2g Ficoll
lml 2.5% Bromophenol blue 
lml 2.5% Xylene Cyanol 
0.2ml 0.5M EDTA 
8ml water
lOiqg/ml
250mM Tris Hydrochloric acid (pH 8) 
375mM Potassium chloride 
15mM Magnesium chloride
0.1M
200units/ul
Rnase inhibitor 40units/ul
dNTPs (dATP,dTrP,dCIP,dGTP) 2.5mM
TBE 4.0M Tris Base
4.4M Boric Acid 
1.3M EDTA
PCR solutions
lOOmM Tris Hydrochloric acid 
15oM Magnesium chloride 
500mM potassium chloride 
liqg/ml gelatine 
pH 8.3
dNTPs 2.5mM
Taq polymerase 5 units/ul
PCR Buffer
(10 X concentrate)
Sequencing Reaction Solutions
Sequenase Buffer 
(5x concentrate) 200mM Tris.HCl pH 7.5 
lOOmM Magnesium chloride 
250mM Sodium chloride
Dithiotheiol (BIT) 0.1M
Labelling Mix (dGTP) 
(5x concentrate)
Labelling mix (dlTP) 
(5x concentrate)
ddG termination mix
7.5uM dGTP 
7.5pM dCTP 
7.5jjM dTIP
15jjM dlTP 
7.5pM dCIP 
7.5pM dTIP
80pM dGTP 
80uM dATP 
80pM dCIP 
8oJjM dTIP 
8pM ddGTP 
50mM NaCl
ddA termination mix 80pM dGTP 
80jjM dATP 
80]pM dCIP 
8 OuM dTIP 
8pM ddATP 
50mM NaCl
ddT termination mix
ddC termination mix
Enzyme Dilution buffer
Stop solution
80pM dGTP 
80pM dATP 
80jjM dCIP 
80pM dTIP 
8pM ddTTP 
50mM NaCl
80pM dGTP 
80pM dATP 
80pM dCIP 
80pM dTIP 
8pM ddCTP 
50mM NaCl
lOmM Tris.HCl pH 7.5 
5mM BIT 
0.5mg/ml BSA
95% formamide 
20mM EBTA
0.05% Bromophenol blue 
0.05% Xylene Cyanol FF
APPENDIX II
Calculation of oligonucleotide primer concentrations
The concentration of an oligonucleotide of known sequence can be 
calculated when the molecular weight (MW) of the oligonucleotide and 
the quantity synthesised is determined.
MW= [ (AX 312.2) +(G X 328.2) + (C X 288.2) + (T X 303.2)1 -61.0
Where A,G,T and C are the number of each base in the sequence 
The quantity synthesised is determined by the optical density (0D) 
reading. OD is the amount synthesised in lml volume. An 0D reading of 
1.00, corresponds to approximately 37ug/ml of oligonucleotide.
Concentration = (N x 0.037/MW x 106 
Where N is the number of OD units
APPENDIX III
Ladywel 1 offspring results
Ladywell
Number
BanI 
$ j-adreno 
receptor
RFLP data
Hindlll
Renin
Bgll
(5,-adreno
receptor
SacI
Insulin
10082B 
10083B 
10121C 
10173A 
10252B 
1037IB 
10502A 
1053ID 
10592B 
1062ID 
10622B 
10892A 
1092ID 
10943B 
10952D 
10953B 
11001C 
11002C 
11062A 
11232B 
11252C 
11291D 
11352B 
11362D 
11453D 
11543A 
11611C 
11722D 
11842A 
11914D 
11924A 
11951B 
11952D 
12062B 
12063D 
12111C 
12112C 
12132B 
12203D 
12251B 
12252B 
1228ID
3.7/3.4 
3.7/3.4 
3.7/3.7 
3.7/3.4 
3.7/3.4 
3.7/3.4 
3.7/3.4 
3.7/3.4 
3.4/3.4 
3.7/3.4 
3.7/3.4 
3.7/3.7 
3.7/3.4 
3.7/3.4 
3.4/3.4 
3.4/3.4 
3.4/3.4 
3.4/3.4 
3.7/3.4 
3.4/3.4 
3.7/3.4 
3.4/3.4 
3.7/3.4 
3.4/3.4 
3.7/3.4 
3.4/3.4 
3.4/3.4 
3.7/3.4 
3.4/3.4 
3.7/3.7 
3.7/3.7 
3.7/3.7 
3.4/3.4 
3.4/3.4 
3.7/3.4 
3.4/3.4 
3.4/3.4 
3.7/3.4 
3.7/3.7 
3.4/3.4 
3.4/3.4 
3.7/3.4
9.0/6.2 
9.0/6.2 
9.0/9.0 
6.2/6.2 
6.2/6.2 
9.0/6.2 
9.0/6.2 
9.0/9.0 
9.0/6.2 
9.0/6.2 
9.0/9.0 
9.0/6.2 
9.0/6.2 
9.0/6.2 
9.0/9.0 
9.0/6.2 
9.0/9.0 
9.0/6.2 
9.0/9.0 
9.0/9.0 
9.0/9.0 
9.0/9.0 
9.0/6.2 
9.0/9.0 
9.0/6.2 
9.0/6.2 
9.0/6.2 
9.0/9.0 
9.0/6.2 
9.0/9.0 
9.0/9.0 
9.0/9.0 
9.0/9.0 
9.0/9.0 
9.0/9.0 
9.0/9.0 
9.0/6.2 
9.0/9.0 
9.0/6.2 
9.0/6.2 
9.0/6.2 
9.0/6.2
6.2/6.2 
6.2.6.2 
4.7/4.7 
6.2/4.7 
6.2/4.7 
6.2/6.2 
6.2/4.7 
4.7/4.7 
6.2/6.2 
6.2/4.7 
6.2/6.2 
6.2/6.2 
6.2/6.2 
6.2/4.7 
6.2/6.2 
6.2/4.7 
6.2/6.2 
6.2/6.2
6.2/6.2 
4.7/4.7 
6.2/6.2 
4.7/4.7 
6.2/6.2
6.2/6.2 
6.2/6.2 
6.2/4.7
6.2/4.7 
6.2/6.2 
6.2/6.2 
6.2/4.7 
6.2/6.2 
6.2/6.2 
6.2/6.2 
6.2/6.2 
6.2/4.7 
6.2/4.7 
6.2/6.2 
6.2/6.2
6.0/6.0 
6.0/6.0 
6.0/6.0 
6.0/6.0 
6.0/6.0 
6.0/6.0 
7.5/6.0 
7.5/6.0 
7.5/6.0 
7.5/6.0 
6.0/1,8
6.0/6.0 
6.0/6.0
6.0/6.0 
7.5.6/0 
6.0/6.0 
7.5/6.0
7.5/6.0 
7.5/7.5 
7.5/7.5
7.5/6.0 
6.0/6.0 
6.0/6.0 
6.0/6.0
7.5/6.0
6.0/6.0 
6.0/6.0 
6.0/6.0 
6.0/6.0 
6.0/6.0 
6.0/6.0 
6.0/6.0 
7.5/6.0 
7.5/6.0 
6.0/6.0 
6.0/6.0
12513A 3.7/3.7 9.0/6.2 6.2/6.2 6.0/6.0
12594A 3.7/3.4 9.0/9.0 6.2/6.2 6.0/6.0
12792D 9.0/6.2 6.0/6.0
12902C 3.4/3.4 9.0/9.0 6.2/6.2 7.5/6.0
12922A 3.7/3.4 9.0/9.0 6.2/6.2 7.5/6.0
12942C 3.4/3.4 9.0/9.0 6.2/4.7 7.5/7.5
12982C 3.7/3.4 9.0/6.2 6.2/6.2 6.0/6.0
12983A 3.4/3.4 9.0/6.2 6.2/6.2 7.5/7.5
13003B 3.4/3.4 9.0/6.2 6.2/6.2 7.5/6.0
13101D 3.7/3.4 9.0/9.0 6.2/6.2 6.0/6.0
13102B 3.7/3.4 9.0/9.0 6.2/6.2 6.0/6.0
13123C 3.4/3.4 9.0/9.0 6.2/6.2 7.5/6.0
13222D
13241C 3.7/3.4 9.0/9.0 6.2/4.7 7.5/6.0
13421A 3.4/3.4 9.0/6.2 6.2/6.2 6.0/6.0
13423A t3.4/3.4 6.2/6.2 6.2/6.2 6.0/6.0
13642D 9.0/6.2 6.2/6.2
13654D 3.7/3.4 9.0/9.0 6.2/4.7 6.0/6.0
13684A 3.4/3.4 9.0/6.2 6.2/6.2 7.5/6.0
13802D 3.4/3.4 9.0/9.0 6.2/6.2 6.0/6.0
13862C 3.4/3.4 6.2/6.2 6.2/6.2 6.0/6.0
13911A 3.7/3.4 9.0/9.0 6.2/6.2 7.5/6.0
14013B 3.7/3.4 9.0/6.2 6.2/4.7 7.5/6.0
14024C 3.4/3.4 9.0/9.0 6.2/4.7 7.5/6.0
14051A 9.0/6.2 7.5/7.5
14241A 3.4/3.4 6.2/6.2 6.2/4.7 6.0/6.0
14242A 3.7/3.4 9.0/6.2 6.2/6.2 6.0/6.0
14323C 3.4/3.4 9.0/9.0 6.2/6.2 6.0/6.0
14332D 3.4/3.4 9.0/6.2 6.2/4.7 6.0/6.0
14542A 3.4/3.4 9.0/9.0 6.2/4.7 7.5/6.0
14582B 3.7/3.7 9.0/6.2 6.2/4.7 7.5/6.0
14622B 3.7/3.4 9.0/6.2 6.2/6.2 6.0/6.0
14642A 3.4/3.4 9.0/6.2 6.2/6.2 7.5/6.0
14672B 3.4/3.4 9.0/9.0 6.2/6.2 7.5/7.5
14763C 3.7/3.4 6.2/6.2 6.2/6.2 7.5/6.0
14792C 3.4/3.4 9.0/6.2 6.2/6.2 7.5/7.5
14882D 3.7/3.7 9.0/6.2 6.2/6.2 6.0/6.0
1491ID 3.4/3.4 9.0/9.0 6.2/6.2 7.5/7.5
14974D 3.4/3.4 9.0/9.0 6.2/6.2 7.5/6.0
15082B 6.0/6.0
15282D 3.4/3.4 9.0/6.2 6.2/6.2 7.5/6.0
15502B 7.5/6.0
15601B 3.4/3.4 9.0/6.2 6.2/6.2 6.0.6/0
15691C 3.7/3.4 9.0/9.0 6.2/4.7
15723D 3.4/3.4 9.0/9.0 6.2/4.7 7.5/6.0
1577IB 3.4/3.4 9.0/9.0 6.2/4.7 6.0/6.0
15833A 3.7/3.4 7.5/7.5
15932A 3.4/3.4 9.0/9.0 7.5/6.0
1611IB 3.7/3.4 9.0/9.0 6.2/6.2 6.0/6.0
16182C 3.4/3.4 6.2/6.2 6.2/6.2 7.5/6.0
16301A 9.0/6.2 6.2/6.2 6.0/6.0
16332A 3.4/3.4 9.0/9.0 6.2/6.2
16382C 3.7/3.4 9.0/6.2 6.2/6.2 6.0/6.0
16531B 3.4/3.4 9.0/6.2 6.2/6.2 7.5/7.5
16621A 9.0/9.0 7.5/7.5
16701D 3.4/3.4 9.0/9.0 6.2/4.7 6.0/6.0
16702D 3.4/3.4 9.0/6.2 6.2/4.7 7.5/6.0
1677ID 3.7/3.4 9.0/6.2 6.2/4.7 7.5/6.0
16841A 3.4/3.4 9.0/9.0 6.2/6.2 7.5/6.0
17052D
17161A 3.7/3.4 9.0/6.2 6.2/6.2 6.0/6.0
17321A 3.4/3.4 9.0/9.0 6.2/6.2 6.0/6.0
17371A 3.4/3.4 9.0/9.0 6.2/6.2 7.5/6.0
17551B 3.4/3.4 9.0/9.0 6.2/4.7 6.0/6.0
1767IB 3.4/3.4 9.0/6.2 6.2/6.2 6.0/6.0
17672D 3.7/3.4 9.0/9.0 6.2/4.7 6.0/6.0
17892A 3.4/3.4 9.0/6.2 6.2/6.2 6.0/6.0
20072D 3.7/3.4 9.0/6.2 6.2/6.2 7.5/7.5
20091C 3.7/3.4 9.0/6.2 6.2/6.2 6.0/6.0
20131B 3.4/3.4 9.0/6.2 6.2/4.7 6.0/6.0
20142A 3.4/3.4 9.0/9.0 6.2/4.7
20152C 3.7/3.4 9.0/9.0 6.2/4.7 7.5/6.0
20252C 3.4/3.4 9.0/6.2 6.2/6.2 6.0/6.0
20253C 3.7/3.4 9.0/9.0 6.2/6.2 7.5/6.0
20351C 3.7/3.4 9.0/6.2 6.2/4.7 7.5/6.0
20422D 3.4/3.4 9.0/9.0 6.2/6.2 7.5/7.5
20423D 3.4/3.4 9.0/6.2 6.2/6.2 7.5/6.0
20472A 3.4/3.4 9.0/6.2 6.2/6.2 6.0/6.0
20553A 3.4/3.4 9.0/6.2 6.2/6.2
20561C 3.4/3.4 9.0/6.2 6.2/6.2 7.5/6.0
20682C 3.4/3.4 9.0/9.0 6.2/6.2 7.5/6.0
20741D 3.4/3.4 9.0/6.2 6.2/6.2 6.0/6.0
21052C 3.7/3.4 9.0/9.0 6.2/4.7 6.0/6.0
21192D 3.7/3.4 9.0/6.2 6.2/6.2 7.5/6.0
21222B 3.7/3.4 9.0/9.0 6.2/6.2 7.5/6.0
21272A 3.4/3.4 9.0/6.2 6.2/4.7 6.0/6.0
21332C 3.4/3.4 9.0/9.0 6.2/6.2 7.5/6.0
21451C 3.7/3.4 9.0/6.2
21522B 3.7/3.7 9.0/6.2 6.2/6.2 6.0/6.0
21702A 3.7/3.7 9.0/6.2 6.2/6.2 6.0/6.0
21714A 3.4/3.4 9.0/9.0 6.2/4.7 7.5/6.0
21722A 3.7/3. 9.0/9.0 6.2/6.2 7.5/6.0
21843B 3.7/3.4 9.0/6.2 6.2/6.2 6.0/6.0
22023B 9.0/6.2 7.5/6.0
22024D 3.7/3.7 9.0/6.2 6.2/6.2 7.5/6.0
22112B
22381C 3.4/3.4 9.0/9.0 6.2/4.7 7.5/6.0
22752A 3.4/3.4 6.2/6.2 6.2/4.7 7.5/6.0
22762A 3.7/3.4 9.0/9.0 6.2/4.7 7.5/6.0
22942D 3.7/3.4 9.0/9.0 6.2/6.2 7.5/6.0
23061A 3.7/3.4 9.0/6.2 6.2/6.2 7.5/6.0
23082D 3.7/3.4 9.0/6.2 6.2/6.2 7.5/6.0
23256D 3.7/3.4 9.0/6.2 6.2/4.7 7.5/7.5
23293A 3.7/3.4 9.0/6.2 6.2/4.7 7.5/6.0
23393A 3.7/3.4 9.0/9.0 6.2/6.2 7.5/6.0
23403D 3.7/3.4 9.0/6.2 6.2/6.2 7.5/6.0
23452D 9.0/6.2
23523B 3.4/3.4 6.2/6.2 7.5/6.0
23583C 6.2/6.2
23662C 3.4/3.4 9.0/9.0 6.2/6.2 6.0/6.0
2369ID 3.7/3.4 9.0/6.2 6.2/4.7 6.0/6.0
23793 C 3.4/3.4 9.0/6.2 6.2/6.2 6.0/6.0
23892A 3.4/3.4 9.0/6.2 6.2/6.2 6.0/6.0
23952B 3.4/3.4 9.0/6.2 6.2/4.7 7.5/6.0
24011C 3.7/3.4 9.0/9.0 6.2/4.7 7.5/7.5
24113D 3.4/3.4 9.0/9.0 6.2/6.2 7.5/6.0
24261A 9.0/9.0 6.0/6.0
24262A 3.4/3.4 9.0/9.0 6.2/4.7 6.0/6.0
2430IB 3.4/3.4 9.0/6.2 6.2/6.2 7.5/7.5
24302D 3.4/3.4 9.0/6.2 6.2/6.2
24363A 3.4/3.4 9.0/6.2 6.2/4.7 7.5/7.5
24372C 3.4/3.4 9.0/6.2 6.2/6.2
24492A 3.4/3.4 9.0/6.2 7.5/6.0
24516B 3.7/3.4 9.0/6.2 6.2/6.2
24521C 3.4/3.4 9.0/6.2
24531C 3.4/3.4 9.0/6.2 6.2/6.2 7.5/7.5
24682B
2472IB 3.4/3.4 9.0/6.2 6.2/6.2 7.5/7.5
24751C 3.4/3.4 9.0/6.2 4.7/4.7
24752C 3.4/3.4 9.0/9.0 6.2/4.7 7.5/6.0
24762C 3.4/3.4 6.2/6.2 6.2/6.2
2482IB 3.7/3.4 9.0/6.2 6.2/6.2 6.0/6.0
2493ID 3.4/3.4 9.0/6.2 6.2/4.7 7.5/6.0
25142D 3.4/3.4 9.0/6.2 6.2/6.2 7.5/6.0
25143B 3.4/3.4 9.0/6.2 6.2/6.2 7.5/7.5
25202D 3.7/3.4 9.0/6.2 6.2/4.7 6.0/6.0
25203C 3.4/3.4 9.0/6.2 6.2/6.2 6.0/6.0
25311C 3.4/3.4 9.0/6.2 6.2/4.7 7.5/6.0
25331A 3.4/3.4 9.0/9.0 6.0/6.0
25361C 3.4/3.4 9.0/6.2 6.2/6.2 7.5/6.0
2537IB 3.7/3.4 9.0/6.2 6.2/6.2 6.0/6.0
25544C 3.4/3.4 9.0/9.0 6.2/6.2 6.0/6.0
25553B 9.0/9.0 6.0/6.0
25684D 3.4/3.4 9.0/9.0 6.2/6.2 7.5/6.0
25685D 3.4/3.4 9.0/9.0 6.2/6.2 7.5/6.0
25751A 3.4/3.4 9.0/9.0 6.2/4.7 7.5/7.5
25814A 6.2/6.2 6.0/6.0
25852C 3.4/3.4 9.0/6.2 6.2/4.7 7.5/7.5
25863B 3.4/3.4
25864D 3.7/3.4 9.0/9.0 6.2/6.2 7.5/6.0
25942B 3.4/3.4 9.0/6.2 6.2/4.7 7.5/7.5
25962B 9.0/9.0 7.5/6.0
26093C 3.7/3.4 9.0/6.2 6.2/6.2 7.5/7.5
26132B 3.4/3.4 9.0/6.2
26191D 3.4/3.4 9.0/9.0 7.5/7.5
2624IB 3.4/3.4 9.0/9.0 6.2/6.2 6.0/6.0
26262D 3.7/3.4 9.0/6.2 6.2/4.7 7.5/6.0
26331C
26372C 3.4/3.4 6.2/6.2 6.2/6.2
2652IB 9.0/6.2
24011C 6.7/6.3 3.4/3.4
24113D 6.7/6.3 3.4/3.4
24261A
24262A 6.7/6.3 3.8/3.4
2430IB 6.7/6.7
24302D 3.4/3.4
24363A 6.7/6.3 3.8/3.4
24372C
24492A
24516B
24521 C 3.8/3.4
24531C 6.7/6.7 3.4/3.4
24682B
24721B 6.7/6.3 3.4/3.4
24751C 6.7/6.7 3.8/3.8
24752C 3.8/3.4
24762C 6.7/6.7 3.8/3.8
2482IB 6.7/6.7 3.4/3.4
2493ID 6.7/6.3 3.4/3.4
25142D 6.7/6.7 3.4/3.4
25143B 6.7/6.7 3.8/3.4
25202D
25203C 6.7/6.7
25311C 6.7/6.7 3.8/3.4
25331A
25361C 6.7/6.7
2537IB 6.7/6.3
25544C 6.7/6.7
25553B
25684D
25685D
25751A 6.7/6.7
25814A
25852C 6.7/6.3 3.4/3.4
25863B
25864D 3.4/3.4
25942B 3.8/3.8
25962B
26093C
26132B 3.8/3.8
26191D 3.8/3.8
2624IB 6.7/6.7
26262D
26331C
26372C 6.7/6.7
2652IB
Genotypes are given in allele sizes (kb)
The letters after the 5 digit numbers refers to groups;
A;high offspring/low parent blood presure Bjhigh offspring/high parent 
blood pressure C;low offspring/low parent blood pressure 
D;low offspring/high parent blood pressure
Ladywel 1 Dral Tthlll
number oC^ndreno glucocorticoid
receptor receptor
10082B 6.7/6.7 3.4/3.4
10083B 6.7/6.7 3.4/3.4
10121C 6.7/6.7
10173A 6.7/6.3 3.8/3.4
10252B 6.7/6.7 3.8/3.4
1037IB 6.7/6.3 3.4/3.4
10502A 6.7/6.3 3.4/3.4
1053ID 6.7/6.7 3.4/3.4
10592B 6.7/6.7 3.4/3.4
10621D 6.7/6.7 3.4/3.4
10622B 6.7/6.7 3.4/3.4
10892A 6.7/6.7 3.4/3.4
10921D 6.7/6.3 3.4/3.4
10943B 6.7/6.7
10952D
10953B 6.7/6.7 3.8/3.8
11001C 3.8/3.8
11002C 6.7/6.7 3.8/3.8
11062A 3.8/3.8
11232B 6.7/6.7
11252C 6.7/6.7 3.8/3.4
11291D 6.7/6.3 3.8/3.4
11352B 6.7/6.7 3.8/3.4
11362D 6.7/6.7 3.4/3.4
11453D 3.4/3.4
11543A 6.7/6.7 3.4/3.4
11611C 6.7/6.7 3.4/3.4
11722D 6.7/6.7 3.4/3.4
11842A 6.7/6.7
11914D 6.7/6.3
11924A 6.7/6.7
11951B 6.7/6.7 3.8/3.4
11952D 6.7/6.7 3.8/3.4
12062B 6.7/6.7 3.8/3.4
12063D 6.7/6.7
12111C 6.7/6.7
12112C
12132B 6.7/6.7 3.4/3.4
12203D 6.7/6.3 3.4/3.4
1225IB 6.7/6.7 3.4/3.4
12252B 6.7/6.7 3.8/3.4
1228ID
12513A 6.7/6.7 3.4/3.4
12594A 6.7/6.7
12792D
12902C 6.7/6.7 3.8/3.4
12922A 6.7/6.7
12942C 6.7/6.3 3.8/3.8
12982C 6.7/6.7 3.8/3.8
12983A 6.7/6.3 3.4/3.4
13003B 6.7/6.7
13101D 6.7/6.7
13102B 6.7/6.3
13123C 6.7/6.7
13222D
13241C 6.7/6.7 3.4/3.4
13421A
13423A 6.7/6.7 3.4/3.4
13642D 3.4/3.4
13654D 6.7/6.7 3.4/3.4
13684A 6.7/6.7 3.4/3.4
13802D 6.7/6.3 3.4/3.4
13862C 6.7/6.3
13911A 6.7/6.3 3.8/3.8
14013B 6.7/6.7 3.4/3.4
14024C
14051A 3.8/3.4
14241A 6.7/6.3 3.4/3.4
14242A 3.4/3.4
14323C 6.7/6.7 3.4/3.4
14332D 6.7/6.7 3.4/3.4
14542A 6.7/6.7 3.8/3.4
14582B 6.7/6.3
14622B 6.7/6.7 3.4/3.4
14642A 6.7/6.7 3.4/3.4
14672B 6.7/6.7 3.8/3.4
14763C 6.7/6.7 3.8/3.4
14792C 3.8/3.8
14882D 6.7/6.3
1491ID 6.7/6.7
14974D 6.7/6.7 3.4/3.4
15082B 6.7/6.7
15282D 6.7/6.7 3.4/3.4
15502B
15601B 6.7/6.7 3.4/3.4
15691C 6.3/6.3 3.4/3.4
15723D 6.7/6.7 3.4/3.4
15771B 6.7/6.7 3.4/3.4
15833A
15932A 6.7/6.7
16111B 6.7/6.3 3.4/3.4
16182C 6.7/6.3 3.8/3.4
16301A
16332A
16382C 6.7/6.3 3.4/3.4
16531B 6.7/6.7 3.4/3.4
16621A 3.8/3.4
16701D 3.8/3.4
16702D 6.7/6.7 3.8/3.4
1677ID 6.7/6.7 3.4/3.4
16841A 6.7/6.7 3.4/3.4
17052D
17161A 6.7/6.7 3.4/3.4
17321A 6.7/6.7
17371A 6.7/6.7 3.8/3.4
17551B 6.7/6.3 3.8/3.4
17671B 6.7/6.7 3.4/3.4
17672D 6.7/6.7 3.4/3.4
17892A 6.7/6.7 3.4/3.4
20072D 3.4/3.4
20091C 6.7/6.7 3.4/3.4
20131B 6.7/6.7 3.4/3.4
20142A 6.7/6.7 3.4/3.4
20152C 6.7/6.3
20252C 6.7/6.3 3.4/3.4
20253C 6.7/6.7 3.4/3.4
20351C 6.7/6.7 3.4/3.4
20422D 3.4/3.4
20423D 6.7/6.3
20472A 6.7/6.7 3.4/3.4
20553A 6.7/6.7
20561C 6.7/6.7 3.4/3.4
20682C 6.7/6.7 3.4/3.4
20741D 6.7/6.7 3.4/3.4
21052C 6.7/6.3 3.4/3.4
21192D 3.8/3.8
21222B 6.7/6.3 3.4/3.4
21272A 6.7/6.7 3.4/3.4
21332C 6.7/6.7
21451C
21522B 6.7/6.7 3.4/3.4
21702A 6.7/6.7
21714A 6.7/6.7 3.8/3.8
21722A 6.7/6.7
21843B 6.7/6.7 3.4/3.4
22023B
22024D 6.7/6.7 3.4/3.4
22112B
22381C 6.7/6.7 3.8/3.4
22752A 6.7/6.7
22762A 6.7/6.3 3.4/3.4
22942D 6.7/6.7 3.8/3.8
23061A 6.7/6.7 3.4/3.4
23082D 6.7/6.3 3.4/3.4
23256D 6.7/6.7 3.4/3.4
23293A 6.7/6.7 3.8/3.4
23393A 6.7/6.7 3.4/3.4
23403D 6.7/6.7 3.8/3.4
23452D
23523B 3.4/3.4
23583C
23662C 6.7/6.3 3.8/3.4
2369ID 6.7/6.7 3.4/3.4
23793C 6.7/6.3
23892A 6.7/6.7 3.4/3.4
23952B 6.7/6.7 3.4/3.4
Ladywel 1 parents BFLP Data
High blood pressure group
Ladywel1 Banl Hindlll Bgll SacI
number f^-adreno Renin f j-adreno Insulin
receptor receptor
1008F 3.4/3.4 9.0/6.2 6.2/6.2 7.5/6.0
1059F 3.4/3.4 9.0/9.0 6.2/6.2 6.0/6.0
1059M 3.4/3.4 9.0/6.2 6.2/6.2 6.0/6.0
1225F 3.4/3.4 9.0/6.2 6.2/6.2 6.0/6.0
1462M 3.7/3.4 6.2/6.2 6.0/6.0
1467F 3.4/3.4 9.0/6.2 6.2/6.2 7.5/7.5
1467M 3.4/3.4 6.2/6.2 7.5/7.5
1507M 3.7/3.4 9.0/9.0 6.2/4.7
1507F 3.4/3.4 6.2/4.7
1705F 3.7/3.7 6.2/6.2 6.2/6.2
1705M 3.4/3.4 9.0/9.0 6.2/4.7
2067M 3.4/3.4 9.0/9.0 6.2/4.7
2067F 3.4/3.4 9.0/9.0 6.2/6.2
2122F 3.7/3.4 9.0/9.0 6.2/6.2 7.5/7.5
2122M 3.7/3.4 9.0/9.0 6.2/6.2 6.0/6.0
2537F 3.4/3.4 9.0/6.2 6.2/4.7 7.5/6.0
2537M 3.7/3.4 9.0/9.0 6.2/6.2 7.5/6.0
1062F 3.4/3.4 9.0/9.0
1095F 3.4/3.4 6.2/4.7
1095M 3.4/3.4 9.0/6.2 6.2/4.7 6.0/6.0
1129F 3.4/3.4 9.0/9.0 6.2/6.2 7.5/7.5
1129M 3.4/3.4 9.0/9.0 6.2/6.2
1195F 3.7/3.4 9.0/9.0 6.2/4.7 7.5/6.0
1195M 3.7/3.4 9.0/6.2 6.2/6.2
1206F 3.7/3.4 9.0/9.0 6.2/6.2 7.5/6.0
1206M 3.4/3.4 9.0/9.0 6.2/6.2 7.5/6.0
1220F 3.7/3.4 6.2/6.2 6.2/6.2 7.5/6.0
1220M 3.4/3.4 9.0/6.2 6.2/4.7 6.0/6.0
1310F 3.7/3.4 9.0/9.0 6.2/6.2 6.0/6.0
1310M 3.7/3.7 9.0/6.2 6.2/6.2
2202F 3.7/3.4 6.2/6.2 6.2/6.2 6.0/6.0
2430F 3.4/3.4 9.0/6.2 6.2/6.2 6.0/6.0
2430M 3.4/3.4 9.0/6.2 6.2/6.2 7.5/6.0
2514F 3.4/3.4 9.0/9.0 6.2/6.2 7.5/7.5
2520F 3.7/3.4 9.0/9.0 6.2/4.7 6.0/6.0
2520M 3.4/3.4 6.2/6.2 6.2/6.2 6.0/6.0
2586F 3.4/3.4 9.0/6.2 6.2/4.7 6.0/6.0
2586M 3.7/3.4 9.0/9.0 6.2/4.7 7.5/6.0
1136F 3.7/3.4 9.0/6.2 6.2/4.7 7.5/6.0
1136M 3.7/3.4 9.0/6.2 6.2/6.2
1677M 3.4/3.4 9.0/9.0 6.2/4.7
2042F 3.4/3.4 9.0/6.2 6.2/4.7
2042M 3.7/3.4 9.0/6.2 6.2/4.7
2325F 3.4/3.4 9.0/9.0 6.2/6.2 6.0/6.0
2325M 3.7/3.4 9.0/6.2 6.2/4.7
2568F 3.7/3.4 9.0/6.2 6.2/6.2
Ladywel1 Dral Tthlll Bel Bell
lumber oQ-adreno glucocort glucocort Fibrinog
receptor -icoid -icoid
receptor receptor
1008F 6.7/6.7 4.5/4.5 5.3/5.3
1059F 6.3/6.3 2.3/2.3
1059M 6.7/6.3 3.4/3.4 4.5/2.3 5.3/4.2
1225F 6.7/6.7 4.5/2.3
1462M 6.7/6.7 2.3/2.3 4.2/4.2
1467F 6.7/6.7 3.8/3.4
1467M 3.4/3.4 2.3/2.3 5.3/5.3
1507M 6.7/6.7 3.8/3.4 2.3/2.3
1507F 6.7/6.3 3.8/3.4 5.3/4.2
1705M 3.4/3.4
2067M 6.7/6.7 3.4/3.4 2.3/2.3
2067F 6.7/6.7
2122F 6.7/6.7 3.4/3.4 4.5/2.3 5.3/4.2
2122M 6.7/6.3 3.8/3.4 2.3/2.3 5.3/4.2
2537F 6.7/6.7 3.8/3.4 5.3/4.2
2537M 6.7/6.7 3.8/3.4 5.3/4.2
1026F
1026M
1095F 6.7/6.7 2.3/2.3
1095M 6.7/6.3 3.8/3.8 2.3/2.3 5.3/4.2
1129F 6.7/6.3 3.8/3.4 4.5/2.3 5.3/5.3
1129M 6.7/6.7 3.4/3.4 4.5/4.5 5.3/4.2
1195F 6.7/6.7 3.8/3.4 4.5/2.3 5.3/4.2
1195M 6.7/6.3
1206F 6.7/6.7 3.4/3.4 4.5/2.3 5.3/5.3
1206M 6.7/6.7 3.8/3.4 2.3/2.3 5.3/5.3
1220F 6.7/6.7 4.5/2.3 5.3/5.3
1220M 6.7/6.3 3.4/3.4 2.3/2.3 5.3/5.3
1310F 6.7/6.7 3.4/3.4 4.5/4.5 5.3/5.3
1310M 6.7/6.3 4.5/2.3 5.3/5.3
2202F 6.7/6.7 3.4/3.4 4.5/2.3 5.3/5.3
2430F 6.7/6.3 3.4/3.4 2.3/2.3 5.3/5.3
2430M 6.7/6.3 4.5/4.5 5.3/5.3
2514F 6.7/6.7 4.5/2.3 5.3/5.3
2520F 6.7/6.3 3.4/3.4 2.3/2.3 5.3/5.3
2520M 6.7/6.7 3.4/3.4 4.5/2.3 5.3/4.2
2586F 6.7/6.3 3.8/3.4 2.3/2.3 5.3/5.3
2586M 6.7/6.7 3.4/3.4 4.5/2.3 5.3/5.3
1136F 6.7/6.7 4.5/2.3 5.3/5.3
1136M 6.7/6.7 4.5/2.3 5.3/5.3
1677M 6.7/6.7 2.3/2.3 5.3/5.3
2042F 6.3/6.3 2.3/2.3 5.3/5.3
2042M 6.7/6.7 2.3/2.3 5.3/5.3
2325F 3.8/3.4 4.5/2.3 5.3/5.3
2325M 6.7/6.7 3.4/3.4 4.5/2.3 5.3/5.3
2568F 6.2/6.2 4.5/4.5 5.3/4.2
2568M 6.7/6.7 4.5/2.3 5.3/5.3
1670F 6.7/6.7 2.3/2.3 5.3/4.2
1670M 6.7/6.7 3.4/3.4 4.5/2.3 5.3/4.2
2568M 3.4/3.4 9.0/9.0 6.2/6.2
1670F 3.4/3.4 9.0/6.2 4.7/4.7
1670M 3.4/3.4 9.0/9.0 6.2/6.2
Low blood pressure group
Ladywell BanI Hindlll 11 SacI
number $2~adreno Renin g(-adreno Insulin
receptor receptor
1184F 3.7/3.4 9.0/6.2 6.2/6.2
1184M 3.7/3.4 9.0/6.2
1342F 3.7/3.4 9.0/6.2 6.2/4.7
1368F 3.4/3.4 6.2/6.2 6.2/6.2
1368M 3.7/3.4 9.0/9.0 6.2/4.7
1424M 3.7/3.4 6.2/6.2 6.2/6.2
1583F 3.7/3.4 9.0/9.0 6.2/6.2
1583M 3.4/3.4 9.0/9.0 6.2/6.2
1593F 3.7/3.4 9.0/6.2 6.2/4.7
1593M 3.7/3.4 9.0/6.2 6.2/6.2
2426M 3.7/3.4 9.0/6.2 6.2/6.2
HOOF 3.4/3.4 9.0/9.0 6.2/6.2
1100M 3.4/3.4 9.0/9.0 6.2/6.2
121 IF 3.4/3.4 6.2/6.2 7.5/6.0
1211M 3.4/3.4 9.0/9.0 6.2/6.2 6.0/6.0
1290F 3.4/3.4 9.0/6.2 6.2/6.2 7.5/6.0
1290M 3.4/3.4 9.0/6.2 6.2/6.2 6.0/6.0
2025F 3.7/3.4 9.0/9.0 6.2/6.2 6.0/6.0
2025M 3.4/3.4 9.0/9.0 6.2/6.2 7.5/6.0
2068F 3.4/3.4 9.0/6.2 6.2/6.2 7.5/6.0
2068M 3.4/3.4 9.0/9.0 6.2/6.2 6.0/6.0
2105F 6.2/4.7
2105M 3.7/3.4 9.0/9.0 6.2/6.2 6.0/6.0
2133F 3.4/3.4 9.0/9.0 6.2/4.7
2133M 3.7/3.4 9.0/9.0 6.2/6.2 7.5/6.0
2238F 3.4/3.4 9.0/9.0 6.2/6.2 6.0/6.0
2238M 3.4/3.4 9.0/9.0 6.2/4.7
2401F 3.7/3.4 9.0/6.2 4.7/4.7
2401M 3.4/3.4 9.0/9.0 6.2/4.7 7.5/6.0
2475F 3.4/3.4 9.0/9.0 6.2/4.7 7.5/6.0
2475M 3.4/3.4 9.0/9.0 6.2/6.2 7.5/6.0
2530F 3.7/3.4 9.0/9.0 6.2/6.2 7.5/6.0
2530M 3.4/3.4 9.0/9.0 6.2/6.2
1259F 3.7/3.4 9.0/9.0 6.2/6.2 6.0/6.0
1259M 3.7/3.4 9.0/9.0 6.2/6.2 6.0/6.0
1298M 3.4/3.4 9.0/6.2 6.2/6.2
2389F 3.7/3.4 9.0/6.2 4.7/4.7 7.5/7.5
2389M 3.4/3.4 6.2/6.2 6.2/4.7
2449F 3.7/3.4 9.0/6.2 6.2/4.7 7.5/6.0
2449M 3.7/3.4 9.0/9.0 6.2/4.7 7.5/6.0
2476F 3.4/3.4 9.0/6.2 6.2/6.2 7.5/6.0
2476M 3.4/3.4 6.2/6.2 6.2/6.2 7.5/6.0
2609F 3.7/3.4 9.0/9.0 6.2/6.2 7.5/7.5
2609M 3.7/3.4 9.0/6.2 6.2/6.2 7.5/6.0
2637F 3.4/3.4 9.0/6.2 6.2/4.7 7.5/6.0
2637M 3.4/3.4 9.0/6.2 6.2/4.7 6.0/6.0
1684F 3.4/3.4 9.0/9.0 6.2/4.7
1684M 3.4/3.4 9.0/9.0
Ladywel1 Oral Tthlll Bel Bell
number o^j^adreno glucocort glucocort Fibrinog
receptor -icoid icoid
receptor receptor
1184F 4.5/2.3 5.3/4.2
1342F 6.7/6.7 3.4/3.4
1368F 6.7/6.7 3.8/3.4 4.5/4.5 5.3/4.2
1368M 6.7/6.7 3.8/3.4 4.5/2.3 5.3/4.2
1424M 6.7/6.7 2.3/2.3
1583F 6.7/6.7 3.4/3.4 5.3/5.3
1583M 6.7/6.7 3.4/3.4 4.5/4.5 5.3/5.3
1593F 6.7/6.7 3.4/3.4 4.5/2.3
1593M 6.7/6.3 3.4/3.4 4.5/2.3 5.3/5.3
2426M 6.7/6.7 4.5/2.3 5.3/5.3
HOOF 6.7/6.7
1100M 6.7/6.7
121 IF 6.7/6.7 2.3/2.3
1211M 6.7/6.3 3.4/3.4 4.5/2.3 5.3/5.3
1290F 6.7/6.7 3.4/3.4 2.3/2.3 5.3/5.3
1290M 6.7/6.7 3.8/3.4 4.5/4.5 5.3/4.2
2025F 3.4/3.4 2.3/2.3 5.3/5.3
2025M 6.3/6.3 3.4/3.4
2068F 6.7/6.3 3.4/3.4 2.3/2.3 5.3/5.3
2068M 6.7/6.7 5.3/5.3
2105F 6.3/6.3 5.3/5.3
2105M 6.7/6.7 2.3/2.3 5.3/5.3
2133F 6.3/6.3
2133M 4.5/2.3 5.3/4.2
2238F 6.7/6.7 4.5/2.3
2238M 6.7/6.7 2.3/2.3 5.3/5.3
240IF 6.7/6.3 4.5/2.3
2401M 6.7/6.3 5.3/5.3
2475F 6.7/6.7
2475M 6.7/6.3 2.3/2.3 5.3/4.2
2530F 6.7/6.3 3.8/3.4 5.3/5.3
2530M 6.7/6.7 3.8/3.4
1259F 6.7/6.7 3.8/3.4 4.5/2.3 5.3/5.3
1259M 6.7/6.3 2.3/2.3 5.3/5.3
1298M 6.7/6.3 3.4/3.4 2.3/2.3 5.3/5.3
2389F 6.7/6.3 3.8/3.8 4.5/2.3 5.3/5.3
2389M 6.7/6.7 3.4/3.4 4.5/2.3
2449F 6.7/6.3 3.4/3.4 2.3/2.3 5.3/5.3
2449M 6.7/6.3 3.8/3.4 4.5/4.5 5.3/4.2
2476F 6.7/6.7 3.8/3.4 2.3/2.3 5.3/5.3
2476M 6.7/6.7 3.8/3.4 4.5/2.3 5.3/5.3
2609F 6.7/6.7 3.4/3.4 4.5/2.3 5.3/4.2
2609M 6.7/6.7 3.4/3.4 4.5/2.3 5.3/5.3
2637F 6.7/6.7 4.5/2.3 5.3/4.2
2637M 6.7/6.7 4.5/2.3 5.3/5.3
1684F 6.7/6.7 3.4/3.4
1684M 6.7/6.7 3.4/3.4
1062F 6.7/6.7 3.4/3.4 4.5/4.5 5.3/4.2
1062M 3.4/3.4 4.5/2.3 5.3/4.2
APPENDIX IV
Ang lot ens inogen PCS data
Group B offspring (high offspring/high parent blood pressure)
Ladywel1 no. Heteroduplex Genotype
formation M235T T174M
10082 -ve W WW
10083 -ve W WW
10252 -ve VW MM
10371 -ve WV WW
10592 -ve W ww
10622 -ve VW WM
10943 -ve WV m
10953 +ve VM WM
11232 -ve
11352 -ve ww MM
11951 -ve ww WM
12062 -ve VW WM
12132 +ve VM WM
12251 -ve W WM
13003 +ve VM WM
14013 -ve W WW
14582 -ve WW WW
14672 +ve VM WM
15082 -ve VW WW
15771 -ve W WM
16111 -ve WW WW
16531 -ve WW WW
17551 -ve WW WW
17671 -ve
20131 -ve ww MM
21222 -ve ww WM
23523 ww WW
23952 -ve ww WW
24301 -ve VW WM
24516 -ve ww WM
24721 ww WM
24821 -ve
25143 -ve VM WM
25371 +ve WM WM
25942 -ve WW WM
25962 -ve ww
26132 -ve ww WM
Group C offspring (low offspring/low parent blood pressure)
Ladywel1 no. Heteroduplex Genotype
format ion M235T TV
10121 -ve
11001 -ve WV WM
11002 -ve
11252 -ve WW WM
11611 -ve WW WV
12111 -ve
12112 +ve WM WM
12902 +ve WM WM
12942 +ve WM WM
12982 +ve WM WM
13122 -ve WW WW
13862 +ve WM WM
14024 +ve WM WM
14323 WW WW
14672 +ve
14763 -ve WW WM
14792 +ve VM WM
15691 -ve WW VM
16182 -ve WW WW
16382 -ve
20091 -ve WW WW
20152 -ve WW m
20252 -ve VW WM
20253 WW VW
20351 -ve WW ww
20682 +ve WM WM
21052 -ve WW WW
21332 -ve WW WM
21451 -ve WW WW
22381 +ve WM WM
23662 +ve WM WM
23793 -ve WW WM
24011 -ve
24521 -ve MM MM
24531 WW WM
24751 -ve WW WM
24752 -ve ww WM
24762 -ve ww WV
25361 -ve ww MM
25544 -ve
25852 -ve ww WM
26093 -ve
26372 -ve ww WW
W;wild type M;mutant
+ve; scored positive for heteroduplex formation 
-ve; scored negative for heteroduplex formation
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